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Abstract 
Perioperative mortality after thoracoabdominal oesophagectomy for cancer 
is about 4%. Stratifying this risk may assist patients to make treatment 
choices, facilitate comparative audit, and enhance research. I aimed to 
explore prediction modelling of this risk, using the Northern 
Oesophagogastric Cancer Unit (NOGCU) database. 
The first section is a systematic review of prediction models and candidate 
predictors from ‘high surgical volume’ centres. Three models were externally 
validated but overestimated higher risk mortality; discrimination was 
moderate. Two groups used prediction models to reduce mortality in 
practise but there were no clinical impact studies. Candidate predictor 
definitions and associations with mortality were varied. Age predicts 
mortality and should be included as a continuous predictor in any model. 
Risk of bias in primary studies was poorly reported. 
In section two, I explored the risk of perioperative mortality using logistic 
regression on 1575 records from the NOGCU database, from 1991 to 2009. 
Comorbidity fields required extensive cleaning and recoding, and there were 
variable amounts of missing data, which caused spurious associations. I 
compared a prespecified model containing age, operation, albumen and 
cardiorespiratory comorbidity with a statistical stepwise elimination model 
and used split-sample validation. Age, gender, operation, white cell count, 
cardiac risk index, operation and weight loss were associated with mortality 
but only age, gender, operation and weight loss were significant in 
multivariate analysis. Discrimination was moderate, at best, for all models 
and the prediction range was only to a maximum 20%. The best calibrated 
models contained age, operation and gender, and originated from the most 
complete datasets. 
These models are not suitable for individual risk prediction but could be 
developed as risk adjusters for provider profiling and research. The sample 
sizes and high quality data required for further development are most likely 
to be achieved in larger scale studies, data syntheses or clinical databases.
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Preface 
The work for this thesis was carried out during my long term involvement 
as a consultant in anaesthesia and intensive care working with the 
Northern Oesophago-Gastric Cancer Unit (NOGCU). My interest in 
perioperative risk arose from observing the serious complication rate of 
oesophagectomy. Despite our advances in medicine it is impossible to not be 
struck by the enormous impact this operation has on patient’s lives. If there 
was an alternative viable treatment, patients would surely take it. 
I became interested in clinical prediction models as a way of perhaps 
identifying patients whose risk of surgery was so great that, given reliable 
information on their likely outcome of surgery, they might wish to choose an 
alternative treatment. This coincided fortuitously with access to our clinical 
database, set up in 1990 by Professor Griffin when he first established the 
Northern Oesophago-Gastric Cancer unit. I decided to try and find out 
whether nearly two decades of information might offer some answers. I 
carried out this project under the auspices of the Institute of Health and 
Society at Newcastle University, because of their expertise in a range of 
methods used in evidence based medicine. This thesis is the end result. 
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Chapter 1:  Introduction 
In this thesis I have set out to investigate whether it is possible to use the 
Northern Oesophago-Gastric Cancer Unit (NOGCU) clinical database to 
develop an effective clinical prediction model for perioperative mortality 
after thoracoabdominal oesophagectomy. The ability to reliably predict 
serious complications of high risk surgery, which may have uncertain 
success, may help patients and clinicians to weigh the risks and benefits 
and make informed choices about treatment. It can also enhance comparison 
of outcome performance between different centres by adjusting for 
important risk factors. Risk stratification may also enhance experimental 
and diagnostic research by selecting patients who are likely to benefit most 
from the intervention (Hernández et al., 2004; Steyerberg, 2009a). For 
example, ‘goal directed fluid therapies’ (Abbas and Hill, 2008) to improve 
outcome and ‘cardiopulmonary exercise testing’ (Older et al., 1999) for risk 
stratification, are currently enthusiastically supported by some groups, but 
their role remains controversial (Moonesinghe et al., 2011). In prospective 
studies of these interventions, risk stratification may improve study design 
and clarify their role (Hernández et al., 2004). 
The Northern Oesophago-Gastric Cancer Unit is a regional centre for the 
treatment of stomach and oesophageal cancer. At its inception in 1990 an 
integrated clinical database was set up, which has evolved and now contains 
extensive clinical information about NOGCU patients, who have received 
treatment. For each patient it contains demographic information, tumour 
details, comorbidities, treatment and complications. The NOGCU database 
is used for clinical audit and has been used to report the outcomes and 
univariate associations of comorbidity with mortality in 228 patients 
(Griffin et al., 2002), but has not hitherto been used to study clinical 
prediction models of perioperative mortality or morbidity. 
1.1 Epidemiology of oesophageal cancer 
The pattern of oesophageal cancer in the United Kingdom (UK) has changed 
over recent decades. The incidence has increased from 6.5 to 9.8 per 100,000 
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of the population, between 1975 and 2008 (Cancer Research UK), and is the 
ninth most common cancer accounting for 3% of all UK cancer. In 2008 
there were 8,173 new cases in the UK (Cancer Research UK). Most striking 
has been the increase amongst UK males, where the incidence has increased 
from 8.8 to 14.5 per 100,000. The male to female ratio has increased to 
between 5 and 10 to 1, and in 2003 UK men were reported to have the 
highest incidence in Europe (Wild and Hardie, 2003). 
The pattern of tumour characteristics in the UK has also changed. Until the 
early 1990’s, squamous cell cancer was most common (Powell et al., 2002). 
This is typically situated in the middle and upper oesophagus, and is 
associated with low socioeconomic status, poor nutrition, alcohol intake and 
smoking. It is still the commonest histological type in many developing 
areas, such as Asia and Southern Africa. However, in the last twenty years 
oesophageal adenocarcinoma has become predominant in the UK (Vizcaino 
et al., 2002). Adenocarcinoma occurs in the lower oesophagus or 
oesophagogastric junction and is not associated with patient socioeconomic 
status. 
1.2 Treatment options 
The options for treatment are primarily defined by tumour stage (Griffin, 
2009), with curative surgical resection considered the definitive treatment 
in early tumours (Wu and Posner, 2003). Chemo- or chemo-radiotherapy, 
with or without surgery, is more common in more advanced tumours and 
palliative treatments are used in the very advanced stages. Sadly most 
tumours are not amenable to surgical resection when they are detected, and 
currently only about 25% of patients undergo attempted curative surgery 
(Rouvelas et al., 2005; Al-Sarira et al., 2007). Within these broad categories 
of treatments there is considerable debate as to which methods produce the 
best outcomes. The introduction of newer and less invasive techniques may 
be an attractive option if outcomes match those of current surgical resection 
methods. For instance, endoscopic tumour resection or photodynamic 
therapy may be used for both early tumour treatment and advanced 
palliation, and minimally invasive surgical techniques are increasingly 
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under investigation, as are chemo- and radiotherapy regimes (Allum et al., 
2011). With no apparent reduction in the incidence of oesophageal cancer 
and newer treatments coming on line, outcome information is likely to play 
an important role in clinical decision making, audit and research. 
1.3 Which outcome to investigate? 
Treatments for oesophageal cancer incur considerable morbidity, mortality 
and uncertain success rates and therefore a range of potential categories of 
outcome are important. Clearly the likelihood of complete cure and long 
term survival will be a prime concern. If major surgery can reasonably 
guarantee prolonged survival at little risk, for instance for a very early 
cancer, this is likely to be the treatment of choice for many people. However, 
in more advanced cancers when long term survival cannot be guaranteed, 
other considerations may be important. For example, oesophagectomy seems 
to diminish quality of life in patients who do not survive more than two 
years (Blazeby et al., 2000), and to a greater degree than chemo-
radiotherapy, which has similar survival rates for locally advanced cancer 
(Avery et al., 2007). Quality of life measures such as the validated EORTC 
QLQ-C30 and QLQ-OES18 (Blazeby et al., 2003) were not routinely 
recorded in the NOGCU database, and therefore this was not an option in 
this work. 
Perioperative morbidity (defined as any clinically significant nonfatal 
complication (Moonesinghe et al., 2011)) has a much higher incidence than 
mortality. It is associated with prolonged length of hospital and critical care 
stay, increased use of resources and is a predictor of mortality (Moonesinghe 
et al., 2011). It is also increasingly associated with reduced medium term 
survival after major abdominal surgery (Khuri et al., 2005; Schiesser et al., 
2008). A standardised morbidity score, the Postoperative Morbidity Survey 
(POMS) has been developed and validated in major abdominal surgery 
(Bennett-Guerrero et al., 1999; Grocott et al., 2007), but most studies report 
morbidity in a wide variety of ways. This inconsistency, and the potential 
need to recode and interpret the data retrospectively, gives considerable 
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scope for misinformation bias in the outcome. I therefore chose not to study 
this outcome. 
Perioperative mortality after oesophagectomy is considerable compared with 
many other procedures, and is therefore likely to remain important when 
considering treatment options or comparing providers. It is a much ‘cleaner’ 
outcome, and ‘all cause’ mortality should be free of interpretational bias, as 
no cause needs to be attributed to it, removing the need to ‘blind’ the data 
reporter. However, it is statistically uncommon and therefore makes 
identifying reliable predictors more difficult than, for instance, for the more 
frequent morbidity. It is important to specify the time period during which 
mortality is reported. For example, 30 day mortality is frequently used to 
enable standardised comparisons to be made. However, advances in 
perioperative care mean that deaths associated with the procedure 
frequently occur after this period (Griffin et al., 2002; Cromwell et al., 2010), 
and therefore do not necessarily convey the full nature of the procedure. 
Longer defined periods of follow up (e.g. 90 days) may include out of hospital 
deaths, which will inevitably be more difficult to account for (Moonesinghe 
et al., 2011). Confining the outcome to deaths recorded in hospital is more 
likely to be reliable as follow up should be easier. Because of these factors I 
have chosen to study ‘all cause’, in hospital perioperative mortality 
associated with the primary tumour resection. 
1.4 Perioperative mortality after oesophagectomy 
Perioperative mortality from oesophagectomy has steadily decreased from 
72% in 1941(Ochsner and DeBakey, 1941), to 29% between 1960 and 1979 
(Earlam and Cunha-Melo, 1980), 13% between 1980 and 1988 (Muller et al., 
1990), and 6.7% between 1990 and 2000 (Jamieson et al., 2004) This trend 
has been observed in the United Kingdom (Al-Sarira et al., 2007), the 
United States (Hofstetter et al., 2002; Dimick et al., 2005b), Sweden 
(Rouvelas et al., 2005), France (Sauvanet et al., 2005) and the Far East 
(Jamieson et al., 2004). Developments in the surgical and perioperative 
management of oesophageal cancer are likely to have contributed to these 
improvements in the last four decades. These have included improved 
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patient selection and tumour staging, perioperative nutritional support, 
improvements in anaesthetic techniques and the concentration of skills in 
“large volume” centres. Despite this progress, the perioperative mortality 
rate is still daunting with most centres currently reporting in-hospital 
mortality rates of about 5% (McCulloch et al., 2003; Steyerberg et al., 2006; 
Cromwell et al., 2010). Overall complication rates for oesophagectomy can 
reach 60% and in-hospital mortality up to 14 % (McCulloch et al., 2003). 
The causes of perioperative mortality are typically associated with 
anastomotic breakdown, necrosis of the gastric remnant, or respiratory and 
cardiovascular complications, which may be primary or secondary to 
surgical complications (Law et al., 1994; Griffin et al., 2002; Law et al., 2004). 
Surgical mechanical failure is a major cause of death, which it would seem, 
is unlikely to be predicted by preoperative comorbidity. However, nutritional 
state and general health may cause impaired healing (Law et al., 1973; 
Fekete and Belghiti, 1988) as may the tissue hypoxia that can result from 
cardiorespiratory impairment. Perhaps a proportion of anastomotic or 
gastric breakdown may be predictable. 
Transthoracic oesophagectomy involves chest wall surgery, prolonged 
operating time, one lung ventilation, mechanical retraction of lung tissue, 
thoracic lymphadenectomy and potentially large and complex body fluid 
shifts. With these intraoperative physical insults to the chest wall and lung, 
it is unsurprising that respiratory complications are frequent and serious, 
with reported rates up to 32% (Law et al., 1994; Whooley et al., 2001; Law et 
al., 2004). Respiratory complications are also a major cause of mortality, for 
example contributing up to 55% of all perioperative fatalities (Whooley et al., 
2001; Law et al., 2004). The incidence of cardiorespiratory complications 
would suggest that comorbidity of these systems may predict outcome. 
1.5 Studying prediction of perioperative mortality 
There are three main steps to predicting prognosis. Firstly the development 
of a suitable prediction model, secondly its validation and finally assessing 
its clinical impact (Moons et al., 2009b). In this project I will be using data 
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collected prospectively from a cohort of patients who have undergone 
oesophagectomy, but the data will necessarily be analysed retrospectively. 
This gives scope for model development and some degree of validation, but 
external validation and clinical impact studies are beyond the scope of this 
project. 
Patient variability and heterogeneous causes of mortality mean that single 
predictors are unlikely to effectively predict outcome. Multivariable models 
are likely to be more effective and therefore selection of candidate predictors 
will be an important initial step in prediction (Moons et al., 2009b). 
Perioperative mortality after oesophagectomy has been associated with a 
variety of predictors including age, tumour stage, pulmonary dysfunction, 
impaired general health, smoking, diabetes, cardiac dysfunction and hepatic 
dysfunction (Pennefather, 2007). All these candidate predictors are 
represented in some form in the NOGCU database and will be considered. 
The overall dataset is about 1576 cases of gastric and oesophageal surgery 
with about 87 deaths. This is a relatively small dataset so in an ideal 
situation we would be able to use existing information to select predictors 
with known ‘weights’ and apply these directly to our dataset. We could then 
update and recalibrate the model to suit our population (Steyerberg, 2009i). 
This would require prior knowledge of which predictors to include, together 
with their form and magnitude. In the absence of this information, predictor 
exploration and selection would become important. 
A range of other multivariable models to predict mortality have already 
been described (Shende et al., 2007), for instance the ‘Physiological and 
Operative Severity Score for the enumeration of Mortality and Morbidity’, 
known as POSSUM (Copeland et al., 1991; Prytherch et al., 1998; Tekkis et 
al., 2004) and the ‘Rotterdam’ model (Steyerberg et al., 2006). It is possible 
that any of these may be applicable and perform acceptably for our data. 
However, there are no systematic reviews, which address the applicability of 
these prediction models, or supply the prerequisite knowledge to enable 
selection of candidate predictor for model development; therefore it will be 
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one of my objectives to use systematic review methods to supply this 
information. 
An important step before modelling the outcome is to prepare a suitable 
dataset and select appropriate predictors. This includes evaluating data 
quality, the extent of missing values and determining how important 
predictors are to be handled (Royston et al., 2009). After selecting a set of 
candidate predictors I will use standard recognised methods to select and 
investigate the performance of potential clinical prediction models. These 
methods have been described by Steyerberg (Steyerberg, 2009e) and by 
Moons, Royston, Altman and colleagues (Altman et al., 2009; Moons et al., 
2009a; Moons et al., 2009b; Royston et al., 2009). 
For a prognostic prediction model to be accepted in clinical practise it should 
be reliable and “transportable” to new patient groups. Reliability is assessed 
by validation procedures, which include calibration (a measure of accuracy) 
and discrimination (a measure of whether the model can allocate correct 
outcome between different risk groups). A patient, who is deciding whether 
to undergo a major procedure, requires accurate estimates for outcomes; this 
is calibration. If the problem is deciding whether to allocate further 
diagnostic stratification tests, identifying high or low risk groups may be 
important; this is discrimination (Steyerberg, 2009b). Another important 
aspect of prediction models is whether their predictors are easily 
“transportable” to new patient groups. 
1.6 Summary of the aims and objectives of the thesis 
1.6.1 Aim of thesis 
To study a clinical prediction model of perioperative mortality after 
oesophagectomy based on data from the NOGCU clinical database, and to 
consider its potential for application and further development. 
1.6.2 Objectives of the thesis 
1. To carry out an original systematic review to: 
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i. Assess existing clinical prediction models of perioperative mortality 
after oesophagectomy, which could be used for risk stratification in 
patients of a ‘high volume’ unit in the United Kingdom. 
ii. Identify candidate pre-operative predictors, which should be 
considered for inclusion in any such prediction model, and if possible 
to estimate their effects on perioperative mortality. 
2. To develop and internally validate a clinical prediction model for 
perioperative mortality after oesophagectomy, using data from the NOGCU 
clinical database and to consider further development. 
1.7 Outline structure of thesis 
In Chapter 2 I use systematic review methodology to identify and assess the 
performance and applicability of existing clinical prediction models. I also 
use these methods to identify and, where possible, quantify the effects of 
candidate predictors, which may be considered for inclusion in the 
prediction model, which I intend to study. 
In Chapter 3 I report an investigation of the data contained in the NOGCU 
database and attempt to prepare a suitable dataset, with which to explore a 
clinical prediction model. In particular I investigate data quality, missing 
data, and the structure of relevant predictors. 
In Chapter 4 I use logistic regression to explore a clinical prediction model of 
perioperative mortality using a subset of data from the NOGCU clinical 
database. The model will be developed and validated using split sample 
design. 
Finally, in Chapter 5, the general discussion, I report a narrative summary 
of the work carried out in this thesis and discuss the potential applications 
of suitable prediction models. I will go on to discuss potential areas for 
further development of such models for oesophageal surgery. 
The appendices will contain supplementary information and are listed in 
the Table of Contents.
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Chapter 2:  A systematic review of clinical prediction models and their 
candidate predictors for perioperative mortality after oesophagectomy 
2.1 Introduction 
The first step in this project is to identify existing clinical prediction models 
of perioperative mortality, and to determine whether they can be validated 
on the NOGCU database and subsequently applied to prospective patients, 
who present to this unit. The second step is to identify from published 
studies, which preoperative predictors should be considered for inclusion in 
any future clinical prediction model, and whether their effects can be 
quantitatively estimated from data synthesis. There were no published 
systematic reviews to answer these questions and therefore I decided this 
would be an appropriate starting point. 
Unlike studies of therapeutic interventions, the methods for systematic 
reviewing for clinical prediction are less well developed. Consequently, I 
constructed the review methods from several sources. These included 
generic methodological recommendations for systematic reviews (Centre for 
Reviews and Dissemination, 2009) and recommendations of the Ottawa 
Methods Centre for reporting them (‘Preferred reporting items for 
systematic reviews and metanalyses: the PRISMA statement’ (Moher et al., 
2009)). I also drew on recommendations for primary prognostic study 
methods (Altman and Lyman, 1998), the reporting of systematic reviews of 
prognostic studies (Altman and Riley, 2005), metanalyses of observational 
studies (Stroup et al., 2000), and recommendations for the assessment of the 
potential risk of bias in systematic reviews of prognostic studies (Hayden et 
al., 2006). There are no specific Cochrane guidelines for prognostic reviews, 
but there is a Cochrane group, the Cochrane Prognostic Review Network 
(Cochrane Prognosis Methods Group, 2011), which is developing the 
methodology, and with whom I consulted. 
I intended to apply lessons from this review to patients from our United 
Kingdom regional centre and therefore the inclusion criteria for primary 
studies reflected two important characteristics of our centre. Firstly, the 
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NOGCU carries out at least fifty subtotal oesophagectomies annually, and 
can reasonably be classified as a ‘high volume’ centre, so studies were only 
included if the reporting centre performed at least 10 procedures per year 
(Killeen et al., 2005). Studies using population or multicentre databases 
were also included as overall effects might be more generally applicable. 
Secondly, the data collection for our clinical database started in 1991; I 
therefore only included primary studies reported after 1990. This matches 
our data collection period and allows comparison of effects from periods of 
similar perioperative mortality rates. 
2.1.1 Aims and objectives of the systematic review 
 Aims 
1. The first aim is to identify clinical prediction models of perioperative 
mortality after oesophagectomy, which we could potentially validate on the 
NOGCU database and use for patients in a ‘high volume’ oesophagogastric 
cancer unit in the United Kingdom. 
2. The second aim is to clarify which individual predictors that were 
routinely collected pre-operatively, should be considered for inclusion in a 
prediction model, and whether their estimated effects are known well 
enough to incorporate from the outset. 
 Objectives 
1. To identify studies of prediction models and of individual predictors for 
perioperative mortality after oesophagectomy for cancer, which were carried 
out in ‘high volume’ surgical centres, or reported from multicentre studies or 
population databases after 1990. 
2. To report clinical prediction model reliability and ‘transportability’ to 
other populations. 
3. To report which individual predictors have been studied, their definitions 
and descriptions, and their effects on mortality. Consideration will also be 
given to including the summary effects in a quantitative data synthesis. 
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4. To report potential for risk of bias within primary studies. 
2.2 Systematic Review Methods 
I used the checklist of items from the PRISMA checklist (Moher et al., 2009) 
as a template for the reporting of this systematic review. Typically 
systematic reviews structure research questions by defining ‘concepts’ such 
as the population of interest (P), the intervention (I), the outcome 
comparison (C) and the study design (S), frequently abbreviated to ‘PICOS’. 
Studies of clinical prediction models do not neatly fit this structure, so I 
have defined four ‘concepts’ to define the inclusion criteria for this review. 
2.2.1 Inclusion criteria 
 Study Population 
1. The population of interest is adults undergoing elective oesophagectomy 
for oesophageal cancer. The primary studies should focus on, or contain 
an easily identifiable subgroup of patients, who underwent oesophageal 
cancer surgery. Oesophageal cancer resections in our centre were almost 
exclusively thoracoabdominal procedures and therefore only studies 
focussing on thoracoabdominal procedures were considered. 
2. I aimed to use the results of this review to inform a study on the NOGCU 
clinical database, which started to collect data in 1990, therefore I 
selected articles published or carried out, in or after 1990. 
3. Outcomes from complex major surgery, such as oesophagectomy, may be 
better in hospitals where larger volumes are carried out. This is because 
patient assessment, surgical skills and supporting services (radiology, 
anaesthesia, critical care, and nursing) are concentrated in fewer hands 
enabling them to improve through experience and clinical audit. There is 
evidence to support this both generally (Killeen et al., 2005), and for 
specific geographical regions, for example the UK (Bachmann et al., 2002; 
Al-Sarira et al., 2007), the USA (Birkmeyer et al., 2002; Allareddy et al., 
2007), and Sweden (Rouvelas et al., 2005). This effect is complex because 
of potential confounding by the caseload of individual surgeons 
(Birkmeyer et al., 2003; Dimick et al., 2005a; Migliore et al., 2007), 
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teaching hospital status (Dimick et al., 2004; Verhoef et al., 2007) and 
the use of small samples to compare hospitals (Dimick et al., 2004). 
Despite this controversy, the weight of opinion seems to favour this view 
and therefore I only selected studies from ‘high volume centres’. Defining 
a ‘high volume’ is difficult. Killeen (Killeen et al., 2005) reviewed studies 
addressing this issue and the primary studies variously described ‘low 
volume’ as 2 to 13 and ‘high volume’ as 6 to 83. The investigators 
calculated the number of operations required by a ‘high volume’ centre 
needed to reduce perioperative mortality by 1 instance per year. In the 
case of oesophagectomy this appeared to be about 8 or 9 operated cases 
per year. I arbitrarily defined ‘high volume’ as enough cases to produce 
this annual reduction and included only reports from centres, which 
carried out at least 10 procedures per year. 
 Perioperative clinical outcomes 
Articles were considered if they specified ‘all cause’ mortality associated 
with the hospital admission for the main surgical procedure, and a specified 
time period, e.g. ‘in-hospital’ or ’30-day’ mortality. 
 Study design 
Observational or randomised studies (including cohort, clinical database, 
prospective or retrospective studies), which attempted to develop clinical 
prediction models, or estimate the effects of preoperative predictors on 
perioperative mortality were considered. 
 Prognostic predictors 
For the purposes of the searches, ‘prognostic predictor’ included any 
individual preoperative predictor of perioperative mortality, and any clinical 
prediction model (combining more than one predictor). These general 
concepts were mapped to search terms, which included general terms (risk 
assessment, risk assessment tools) as well as more specific ones  (e.g. 
cardiovascular comorbidity and its methods of assessment). Only articles 
which considered methods likely to be routinely available preoperatively, 
were considered. 
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2.2.2 Exclusion criteria 
1. Studies of laparoscopic, thoracoscopic, minimally invasive and endoscopic 
procedures. 
2. Studies mainly carried out, or published, before 1990 (see main 
introduction for discussion of mortality rates over time). 
2. Studies carried out in centres where less than 10 cases per year on 
average were estimated to have been performed over the study period. 
3. Studies were confined to English language reports because this was likely 
to constitute the largest reading and reporting audience. 
2.2.3 Search strategy 
 Electronic databases 
The search strategy was developed and carried out using Ovid Technologies, 
initially through the British Medical Association ‘Medline Plus’, but 
subsequently using Newcastle University Library Ovid Technology. Both 
accessed the Medline and Embase databases produced by the National 
Library of Medicine in the USA. 
 Search terms 
The general concepts, which described the inclusion criteria, were specified 
and further mapped to specific terms using Collins Thesaurus, relevant 
journal articles, OVID Medline Medical Subject Heading (MeSH) mapping 
and its’ permuted index function (Appendix A. ). Searching the literature for 
studies on prognosis is more complex than for therapeutic interventions 
because of the wide range of study designs, the variety of synonyms for 
prognostic and observational studies, and a lack of standardised 
methodology. Therefore, I also incorporated other validated ‘filters’ 
(Appendix B. ), which have been used in this type of study, and I also 
consulted with Erika Gwynnett (Newcastle University Walton Librarian), to 
facilitate search strategy development. The original ‘concepts’, which 
defined the inclusion criteria, were combined to produce search output, 
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which was focussed on the defined population, but which had high 
sensitivity to include as many types of prediction and prognostic study as 
possible. The concepts were combined using logical operators as follows: 
‘Population’ AND ‘study type’ AND (‘prognostic predictor’ OR ‘clinical 
outcome’).The search was run initially in April 2009, and updated on 
18/09/2010 using the Ovid ‘Autoalert’ for ‘selective dissemination of 
information’. The full search strategy is listed in Appendix C.  
 Alterations to search strategy during or after the searches 
After initial searches, it was clear that several studies (known to myself) 
were missing and so the search strategy was modified as below: 
1. The search term “Ivor adj Lewis” was added. 
2. The “P” in “Possum” was capitalised 
3. The text word oesophagectomy was shortened to ‘oesoph’ to retrieve any 
term with this root. 
 Selection of articles from electronic databases 
I screened article titles to identify potentially relevant articles. Two 
reviewers, IW & Mahindra Chincholkar (anaesthesia specialist registrar; 
MC) screened titles and abstracts from this subset and examined full text 
versions of selected articles for inclusion criteria.  
 Other search sources 
Hand searches were made of reference lists from primary research studies, 
review articles (Pennefather, 2007; Shende et al., 2007), standard texts 
(Shaw, 2008), and personal collections of articles (IW and Dr I Shaw, 
consultant anaesthetists in the NOGCU, Royal Victoria Infirmary, 
Newcastle upon Tyne). The article selection process is summarised in Figure 
1.
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Figure 1 Selection process for included articles 
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2.2.4 Data extraction 
The data items, which I intended to extract from each study are 
summarised in (Table 1). 
Table 1 Data items for extraction from primary studies 
Main data category Data item 
Study description Author, publication date, period of data collection, 
study design, geographical location, number/type 
of centre or database, 
Characteristics of study sample Sample size, mean annual operative volume for 
study period, male/female ratio, tumour histology 
incidence, use of neoadjuvant therapy, surgical 
procedure, definition of perioperative mortality, 
‘hospital mortality’ rate for study sample 
Predictors investigated Description & definition, of predictors and their 
effect on perioperative mortality 
Performance of clinical prediction models Modelling method, model fitting, calibration, 
discrimination, observed effect of clinical 
application in practise 
 
I based assessment for potential bias on recommendations for systematic 
reviews of prognostic studies (Hayden et al., 2006) and primary prognostic 
study design (Altman and Lyman, 1998; Altman and Riley, 2005). I adapted 
these for the prediction of perioperative mortality in oesophageal cancer 
resection and they are listed in Table 2 on the following page. The scoring 
criteria for individual items are explained in the table and are: M, fully met; 
P, partially met; N, not met; U, unclear; na, not applicable.
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Table 2 Items to evaluate risk of bias in primary studies adapted from Hayden 
(Hayden et al., 2006)  
Main category of potential bias Items to consider in assessing 
potential for bias 
Scoring method 
The sample adequately 
represents the population of 
interest 
Patients who were eligible for 
surgery but excluded are 
described and reasons given 
(e.g. surgical reasons or 
unfitness) 
Reported, described and 
quantified, M; incomplete report 
e.g. surgical exclusions only, not 
quantified, P; not reported, N; 
unclear, U 
The sample includes all patients 
undergoing oesophagectomy 
during the stated period 
Evidence that all 
oesophagectomies were 
included in the sample (e.g. 
statement that consecutive 
cases were included), M; 
excluded oesophagectomies 
from sample described, P; 
otherwise U # 
Sample  key characteristics are 
described adequately including 
gender distribution, tumour 
histology, surgical procedure, 
neoadjuvant therapy, surgical 
operative volume, geographical 
location, period of study, study 
type, overall study mortality rate 
All characteristics described, M; 
partially described, P; not 
described, N; otherwise unclear, 
U 
The data represents the sample 
Follow up rate is reported and 
acceptable (Kristman et al., 
2004) 
Number of survivors and 
fatalities stated, with no losses 
to follow up, or evidence that 
losses are MAR or MCAR§, or 
less than 5% of sample, M;  
follow up rate is deducible from 
article, P; unreported or unclear 
or unknown, U 
Patients lost to follow up differ 
in characteristics from the 
sample 
Characteristics of patients lost to 
follow up reported, M; not 
reported or missing not stated, 
unclear, or unknown U.  
Prospective or retrospective 
data collection 
Prospective, P; retrospective, R; 
unclear or unknown, U 
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Main category of potential bias Items to consider in assessing 
potential for bias 
Scoring method 
The data represents the sample 
Evidence of data validation Data audit or double entry 
described, M; partial validation 
e.g. data cross checked with 
more than one database, P; not 
stated or not done, N; unclear,  
U 
Missing values reported All missing values reported, M; 
missing value quantities  
possibly deducible from tables 
or partially stated, P; no report 
or unclear, U;  
Description of missing value 
procedures (Vach, 1997) 
No missing values, values MAR 
or MCAR§, or acceptable missing 
value procedure reported and 
described for all relevant missing 
data, M; partial missing data 
handling procedure, e.g. some 
information given, P;  no report 
or unclear, U 
Records with missing values 
differ from the rest of the 
sample in other characteristics 
Characteristics and outcome of 
records with missing values 
compared with rest of sample, 
M; no report or unclear, U 
Important prognostic factors  
adequately measured (age, 
gender, cardiovascular, 
respiratory, nutritional and 
immune status; activity 
capacity; tumour stage, 
histology, surgical procedure, 
neoadjuvant therapy) 
Adequate description or 
definition of prognostic factor  
(e.g. “transportable” to another 
population) 
All prognostic factors in 
prediction model clearly defined 
and/or described, M; some 
prognostic factors described or 
not fully “transportable”, P; 
prognostic factors not defined, 
N; unclear, U 
Valid measurement of 
prognostic factor. 
All main prognostic factors 
measured appropriately, M; 
some  factors measured 
appropriately, P; not measured 
appropriately, N; unclear  U 
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Main category of potential bias Items to consider in assessing 
potential for bias 
Scoring method 
Prognostic factors Continuous variables used or 
otherwise handled appropriately 
Continuous variables used, M; 
predefined cut points with 
rational basis, P; ‘data-driven’ or 
unhelpful cut points, N; unclear, 
U 
Outcome is adequately 
measured 
Clear definition of outcome 
(follow up 30 to 90 days or “in 
hospital” mortality). 
Period of follow up to 
perioperative mortality clearly 
defined, M; deducible from text, 
P; not stated, N; unclear U 
Potential known confounders of 
prognostic variables are 
accounted for (includes all 
important prognostic variables 
if single variable is investigated) 
Important potential cofounders, 
if not investigated as prognostic 
variables are defined, measured 
and recorded 
All important confounders 
defined,  measured and 
recorded, M; some defined, 
measured and recorded, P; none 
recorded, N; unclear, U 
Important potential cofounders 
are included in study design or 
accounted for in the data 
analysis 
Important confounders included 
in study design prospectively, or 
included in prognostic model, M; 
confounders tabulated to allow 
statistical analysis, P; not 
recorded, N; unclear, U 
Appropriate data analysis 
Description of appropriate 
statistical model 
Selection of statistical model and 
variables is appropriate and 
based on conceptual model, M; 
inappropriate model, N; unclear, 
U 
Sufficient information given to 
assess adequacy of analysis 
Adequate model description and 
presentation of appropriate 
results, including regression 
coefficients or equivalent & 
statistical significance, variable 
collinearity and interaction, & 
model testing, M; statistical 
model described but incomplete 
details, P; inadequate 
information or unclear , U 
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Main category of potential bias Items to consider in assessing 
potential for bias 
Scoring method 
Appropriate data analysis 
Adequate sample size; two 
sample size calculated with on 
line calculator (Type I error 5%, 
Type II error 20%)(Pezzullo, 
Updated May 2009); at least 10 
events per predictor variable in 
linear regression   
Sample size is large enough to 
detect  statistically significant 
differences for clinically 
significant outcomes, M; sample 
too small, N; unclear, U 
# If the description was, “we included 100 oesophagectomies in the study sample”, this 
could have been a selected sub-group and therefore did not fully meet the criteria for no 
selection bias. Studies based on large population databases or where data was submitted 
from several centres were classified as not satisfying our criteria for clearly representing a 
defined population, because the process of case selection from multiple centres is unlikely to 
be reliably known. 
§ Abbreviations: MAR, Missing at random; MCAR, Missing completely at random
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The data was extracted into a data entry form and transferred into an Excel 
2003 spreadsheet. Factual items were extracted by myself and checked 
independently by MC (second reviewer). Items, which addressed potential 
for bias in primary studies, were extracted independently by two reviewers 
(IW/MC) into an Excel 2003 spreadsheet. Discrepancies and disagreements 
were resolved by ‘face to face’ discussion. Most disagreements were due to 
unclear reporting of definitions, and difficulties finding relevant data in the 
studies. The final results were entered into the spreadsheet by IW. 
Data synthesis 
The criteria for attempting a quantitative data synthesis of the estimated 
effects of individual predictors were: 
1. Whether definitions of the predictors and outcomes across candidate 
studies were consistent. 
2. Whether the summary effects of predictors were reported in a way to 
allow a quantitative synthesis. 
3. Whether the estimated potential for bias would support combination of 
summary effects.
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2.3 Results 
2.3.1 Organisation of results 
1. Summary of included and excluded studies. 
2. Description of included studies. 
3. Geographical location of studies 
4. Type of study centre and source of data 
5. Size of study samples 
6. Description of clinical prediction models. 
7. Description of the effects of candidate predictors on mortality.  
8. Potential risk of bias in primary studies 
9. Table 12 Characteristics of studies fulfilling inclusion criteria (end of 
chapter). 
10. Table 13 Excluded studies and reasons for exclusion (end of chapter). 
11. Table 14 Studies of clinical prediction models (end of chapter). 
2.3.2 Summary of included and excluded studies 
At the time of the initial searches (5/12/2007), no relevant systematic 
reviews had been retrieved from Medline, Embase or Cochrane databases. 
Fifty four studies fulfilled the inclusion criteria and these are referenced in 
Table 12 at the end of the chapter. Excluded studies are listed in Table 13 at 
the end of the chapter. Reasons for exclusion were: unclear definition or 
follow up period for perioperative mortality (Bonavina et al., 2003; Di 
Martino et al., 2005; Alexiou et al., 2006; Morgan et al., 2007; Skipworth et 
al., 2009), data collection before 1990 (Lund et al., 1990; Charoenpan et al., 
1993; Gulliford et al., 1993; Liedman et al., 1995), outcome not clearly 
defined as perioperative mortality (Ferguson and Durkin, 2002; Mokart et 
al., 2005; Jiao et al., 2006; Baba et al., 2008; Lagarde et al., 2008; Wright et 
al., 2009), no relationship or unclear perioperative mortality (Karl et al., 
2000; Nozoe et al., 2002; Blazeby et al., 2005b), operative volume less than 
our predefined inclusion criteria (Cariati et al., 2002; Golubovi and 
Golubovi, 2002), expanded data from previous study (Bartels et al., 2000), no 
identifiable group of oesophagectomies (Chamogeorgakis et al., 2007). 
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2.3.3 Description of included studies 
Ten studies developed clinical prediction models (Law et al., 1994; Zhang et 
al., 1994; Bartels et al., 1998; Liu et al., 2000; Bailey et al., 2003; McCulloch 
et al., 2003; Tekkis et al., 2004; Sanz et al., 2006; Ra et al., 2008; Steyerberg, 
2009a). Three studies evaluated existing prediction models (Zafirellis et al., 
2002; Schroder et al., 2006; Lagarde et al., 2007) and three compared and 
evaluated existing models (Lai et al., 2007; Nagabhushan et al., 2007; Zingg 
et al., 2009). All studies, except evaluation and validation studies, 
investigated the effect of prognostic variables on ‘in-hospital’, ‘30 day’ or 
time defined ‘in hospital’ mortality. 
2.3.4 Geographical location of studies 
Twenty six studies were based in Europe. Thirteen were in the United 
Kingdom(Adam et al., 1996; Alexiou et al., 1998; Griffin et al., 2002; 
Zafirellis et al., 2002, {Leigh, 2006 #60; Rahamim et al., 2003; Tekkis et al., 
2004; Abunasra et al., 2005; Alexiou et al., 2005; Murray et al., 2007; 
Nagabhushan et al., 2007; Forshaw et al., 2008)}, 3 in Germany (Bartels et 
al., 1998; Gockel et al., 2005; Schroder et al., 2006), 3 in France (Thomas et 
al., 1996; Jougon et al., 1997; Sauvanet et al., 2005), 2 in Italy (Ruol et al., 
2007(b)), 2 in the Netherlands (Han-Geurts et al., 2006; Lagarde et al., 
2007), and one from each of Spain(Sanz et al., 2006), Sweden(Johansson and 
Walther, 2000) and the Irish republic(Healy et al., 2008). Nine were based in 
the USA (Ferguson et al., 1997; Ellis Jr et al., 1998; Sabel et al., 2002; Bailey 
et al., 2003; Rentz et al., 2003; Atkins et al., 2004; Moskovitz et al., 2006; 
Finlayson et al., 2007; Ra et al., 2008), 5 in Hong Kong (Law et al., 1994; 
Poon et al., 1998; Whooley et al., 2001; Law et al., 2004; Lai et al., 2007), 5 in 
Japan (Saito et al., 1993; Zhang et al., 1994; Kuwano et al., 1998; Fang et al., 
2001; Kinugasa et al., 2001), and one each from Australia (Liu et al., 2000), 
and Taiwan(Tsai et al., 2003). One was based jointly between the 
Netherlands and the USA (Steyerberg et al., 2006). 
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2.3.5 Type of study centre and source of data 
Most studies were from single centres, and a few were based on two or three 
centres. Two studies from the USA used data from the Department of 
Veteran Affairs National Surgical Quality Improvement Program, sampling 
109 centres (Bailey et al., 2003; Rentz et al., 2003) and one used the 
Nationwide Inpatient Sample, a national database containing hospital 
discharge data on all paying patients (Finlayson et al., 2007). Ra (Ra et al., 
2008) used data from the Surveillance, Epidemiology and End Results 
Program (SEER-Medicare) to identify patients with oesophageal cancer and 
linked this to the Medicare Provider Analysis and Review file to collect 
information about patients who had oesophagectomy. Steyerberg 
(Steyerberg et al., 2006) used the SEER population database, a Netherlands 
registry and surgical centre in the Netherlands. 
Of the European studies, Sauvanet (Sauvanet et al., 2005) collected 
voluntarily submitted data from members of the French Association of 
Surgery in 37 centres. In the United Kingdom, one study used the 
Assessment of Stomach and Oesophageal Cancer Outcomes from Treatment 
(ASCOT) database, and the Risk Scoring Collaborative to collect data from 
36 centres (Tekkis et al., 2004), and the audit report from the database of 
the Association of Upper Gastrointestinal Surgeons of Great Britain and 
Ireland included data from 37 UK centres(Griffin et al., 2002).In a study 
from Hong Kong, data from 14 Hospital Authority hospitals was collected 
through the Hospital Authorities Integrated Administration System and 
Central Management System (Lai et al., 2007). 
2.3.6 Size of study samples 
In single centre studies sample sizes ranged from 32 (Liu et al., 2000) to 785 
(Tsai et al., 2003) (median 382.5). In larger multicentre or population 
database studies, the sample size ranged from 538 (Tekkis et al., 2004) to 
27957 (Finlayson et al., 2007) (median 1192). Estimated annual surgical 
volumes were available or deducible all individual units (sample size or 
operated cases averaged over the study period) and ranged from 9.17 
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(Nagabhushan et al., 2007) to 63.16 (Atkins et al., 2004) (median 37.51, 
excluding multiunit or population database studies). Male to female ratios 
were deducible or stated in all but 2 (Rentz et al., 2003; Murray et al., 2007) 
studies, and ranged from 1.9 (Nagabhushan et al., 2007) to 110 (Bailey et 
al., 2003) (median 3.6). 
2.3.7 Clinical prediction models (Table 14) 
Bailey (Bailey et al., 2003), Ra (Ra et al., 2008) and Steyerberg (Steyerberg, 
2009a) developed prediction models using regression methods on data from 
USA population databases. Bailey (Bailey et al., 2003) used the Veterans 
Affairs National Surgical Improvement Program. Ra (Ra et al., 2008) and 
Steyerberg (Steyerberg et al., 2006) used records from the Surveillance, 
Epidemiology and End Results (SEER) Medicare database. Tekkis (Tekkis 
et al., 2004) developed a POSSUM score specifically for oesophagogastric 
surgery (O-POSSUM) from UK clinical databases and McCulloch developed 
a clinical prediction model from a subset of the ASCOT database (McCulloch 
et al., 2003). Bartels (Bartels et al., 1998), Law (Law et al., 1994), Liu (Liu et 
al., 2000), Sanz (Sanz et al., 2006) and Zhang (Zhang et al., 1994) modelled 
mortality on data from their own clinical centres. 
Steyerberg (Steyerberg et al., 2006) validated the prediction model using 
bootstrap methods on the modelling sample and applied the model to a 
SEER cohort from a subsequent period, and also to cohorts from a 
Netherlands population database and clinical centre. A simple scoring 
system was developed to predict 30 day mortality, which included age, 
comorbidity count, type of neoadjuvant therapy, and hospital surgical 
volume mortality. Discrimination was reported as poor (receiver operator 
AUC 0.56-0.7) but calibration was described as excellent for SEER patients 
and pooled data, but reported as “problematic” when applied to cohorts from 
the Netherlands. 
Bartels and Zhang (Zhang et al., 1994; Bartels et al., 1998) validated their 
models on prospective samples from their own centres. Bartels used 
multivariate and discriminant analysis to associate degrees of organ 
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dysfunction with mortality, and created a risk score. Similar mortality rates 
were observed in high risk groups in modelling and validation samples. 
Zhang used multivariate regression methods to develop a risk score, which 
had similar specificities in modelling, and validation samples, but whose 
sensitivity deteriorated considerably. 
Tekkis (Tekkis et al., 2004) developed the O-POSSUM on 70% of a randomly 
split sample, and validated on 30%. The O-POSSUM fitted the data well 
and discriminated well (C-index was 74.6%). It also compared favourably 
with the P-POSSUM, which overestimated mortality by about 20%. 
Studies which validated models on development samples (apparent internal 
validation (Steyerberg et al., 2006)) reported that model fit and 
discrimination was acceptable (Law et al., 1994; Bailey et al., 2003; Ra et al., 
2008). Liu and Sanz did not report formal validation procedures (Liu et al., 
2000; Sanz et al., 2006). 
Four studies compared and externally validated POSSUM models in 
oesophagogastric surgery (Zafirellis et al., 2002; Lagarde et al., 2007; Lai et 
al., 2007; Nagabhushan et al., 2007). Discrimination and calibration were 
poor for the original POSSUM and O-POSSUM (Zafirellis et al., 2002; 
Lagarde et al., 2007). The P-POSSUM performed reasonably in a 
comparison with O- and the original POSSUM (Lai et al., 2007), but poorly 
in other comparisons with the O-POSSUM (Tekkis et al., 2004; 
Nagabhushan et al., 2007). Overestimation of predicted mortality was 
common (Lagarde et al., 2007; Lai et al., 2007; Nagabhushan et al., 2007). 
Schroder (Schroder et al., 2006) evaluated Bartels’ (Bartels et al., 1998) 
model prospectively on 126 patients. Discrimination and calibration were 
not formally tested but sensitivity and specificity were deducible from the 
results. Schroder’s predicted ‘high’ risk group had 16.7% mortality, 
considerably lower than in Bartels original modelling study, again 
suggesting a tendency to over estimate mortality predictions. 
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Zingg (Zingg et al., 2009) compared the performance of the ‘Rotterdam’ 
(Steyerberg et al., 2006), ‘Munich’ (Bartels et al., 1998), and ‘Philadelphia’ 
(Ra et al., 2008) models along with the American Society of 
Anesthesiologists (ASA) physical status score (Saklad, 1941) on cohorts of 
transthoracic oesophagectomies from Switzerland and Australia. 
Discrimination and details of calibration were not reported. The 
Philadelphia and Rotterdam models had some predictive value assessed on 
Nagelkerke’s R squared from logistic regression in pooled data but 
calibration (Hosmer-Lemeshow) was poor. Only the Philadelphia score had 
any value in the Swiss cohort. The Munich score was reported to be an 
ineffective predictor. 
2.3.8 Candidate predictors and perioperative mortality 
 Age: Summary of studies which investigated age 
Thirty two studies examined the effect of age on perioperative mortality and 
their details are summarised in Table 3, Table 4 and Table 5 (Law et al., 
1994; Zhang et al., 1994; Adam et al., 1996; Thomas et al., 1996; Ferguson et 
al., 1997; Jougon et al., 1997; Alexiou et al., 1998; Ellis Jr et al., 1998; Poon 
et al., 1998; Johansson and Walther, 2000; Fang et al., 2001; Kinugasa et al., 
2001; Griffin et al., 2002; Sabel et al., 2002; Bailey et al., 2003; McCulloch et 
al., 2003; Rahamim et al., 2003; Rentz et al., 2003; Tsai et al., 2003; Atkins 
et al., 2004; Law et al., 2004; Tekkis et al., 2004; Abunasra et al., 2005; 
Sauvanet et al., 2005; Moskovitz et al., 2006; Schroder et al., 2006; 
Steyerberg et al., 2006; Finlayson et al., 2007; Ruol et al., 2007(a); Ruol et 
al., 2007(b); Ra et al., 2008; Park et al., 2009). Sixteen studies used 
categorical age groupings and one reported (Griffin et al., 2002) mean for 
survivors and non-survivors. One divided the sample at 50 (Tsai et al., 2003) 
and four divided the sample into three age groups (45-63, 63-71, and 71-89) 
(Rahamim et al., 2003); 65-69, 70-79 and over 80 (Finlayson et al., 2007); 
under 70, 70-79 and 80-86 (Alexiou et al., 1998); under 50, 50-69 and over 70 
(Adam et al., 1996)). These studies are summarised in Table 3. 
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Table 3 Effect of age on perioperative mortality from studies which compared groups 
of patients in different age categories 
Study design Author Mortality % OR, r, p value Comments 
Comparison  <> 70  Sabel 4 vs 2% na  > 70 "average" 77.1, range 70, 95; < 70 
"average" 57.9, range 21, 69. Operative 
rate in eligible patients 37% of < 70, 18% > 
70 
 Kinugasa 10.9 vs 5.4 na  
 Fang 7.6 vs 3.3% p=0.082  
 Ruol(b) 6.5 vs 1.7% p=0.12  
 Ruol(a) 1.9 vs 2.7% p=0.778 Distribution: 67.3%, 70-74; 27%, 75-79; 
5.7% >=80. Operative rate 57.3 <70, 
46.5% >70 
 Jougon 7.8% vs 5.3% p=0.53 > 70, mean 75, range 70-84, 35 patients 
over 75 
 Thomas 10.7% vs 11.2% "not 
significant" 
% only; "operability" 62.5% < 70, 81.5% > 
70 
 Ellis Jr 5.3% vs 2.4% p=0.149 > 70; median 74, range 70-87; operative 
rate 89.8%, >70; 90.2% <70 
 Poon 18% vs 14.4% p=0.27 Operability 48% > 70, 65% < 70 
 Johansson 0 vs 2.7% na  
Other study designs      
<> 50 Tsai 5.4 vs 3% na  
45-63, 63-71, and 71-
89 
Rahamim 12 vs 6.2%  > 70;  median 75, (range 71-88) 
65-69, 70-79, >=80  Finlayson  p<0.0001 for 3 
groups 
 
<70, 70-79, 80-86  Alexiou 
(1998) 
6.5% vs 4.7% 0.51 for 3 
groups 
Patients considered unfit for surgery: 
2.3% < 70, 8% >70  
<50, 50-69 and >70  Adam na na 30 day mortality 
< 50, 50-59, 60-70, 70-
79, >80  
Moskovitz  9% vs 4.7% na Hazard ratio for mortality >80, 3.9 
(p<0.01, CI 1.5, 10.6). 
Mean age of survivors 
and non-survivors 
Griffin  p=0.028 Mean for survivors 62.3 vs 68.9 for non 
survivors  
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 Age: Studies which investigated age over and under 70 
None of the ten studies, which investigated patients under and over 70, 
found statistically significant differences in mortality (Thomas et al., 1996; 
Jougon et al., 1997; Ellis Jr et al., 1998; Poon et al., 1998; Johansson and 
Walther, 2000; Fang et al., 2001; Kinugasa et al., 2001; Sabel et al., 2002; 
Ruol et al., 2007(a); Ruol et al., 2007(b)). This was the most frequently 
reported design for age effect studies. Five studies recorded mortality rates 
between 2 and 3.8 times greater in the over 70s  (Ellis Jr et al., 1998; Fang 
et al., 2001; Kinugasa et al., 2001; Sabel et al., 2002; Ruol et al., 2007(b)), 
but the studies were too small to detect differences at a significance 
probability of 0.05 and power of 0.8 as calculated on ‘statpages.org (Pezzullo, 
Updated May 2009). Two studies recorded similar mortality rates in the age 
groups (Jougon et al., 1997; Poon et al., 1998) and three found small, non-
statistically significant increases in mortality in younger patients (Thomas 
et al., 1996; Johansson and Walther, 2000; Ruol et al., 2007(a)).The 
mortality rates for over and under 70 were also extractable from other study 
designs. Because of the frequency of this study design and the small sample 
sizes I decided to attempt a data synthesis of the summary results for over 
and under 70 year olds using a random effects synthesis, with age category 
as the intervention (Revman version 5 (Cochrane Information Management 
System, 2011). The results (Zhang et al., 1994; Adam et al., 1996; Alexiou et 
al., 1998; Rahamim et al., 2003; Law et al., 2004; Abunasra et al., 2005; 
Moskovitz et al., 2006; Finlayson et al., 2007; Park et al., 2009) were 
incorporated into a forest plot (Figure 2 on following page) and a pooled odds 
ratio calculated. The data synthesis produced an odds ratio of 1.91 (95% CI 
1.65, 2.22) for age over 70.
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Figure 2 Forest plot and data synthesis for the effect of age younger and older than 
70 years 
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 Age: Other age groupings 
Rahamin (Rahamim et al., 2003) found a 1.6 times increase in  30 day 
mortality in over 71 year olds compared with 63-71, and 2.37 times in 45-63. 
Finlayson (Finlayson et al., 2007) found operative mortality was 19.9% in 
octogenarians, 13.4% in 70-79 year olds and 8.8% in 65-69 year olds 
(statistically significant). Alexiou (Alexiou et al., 1998) found no difference in 
mortality between under 70s, 70-79 and over 70 year olds, despite an 
increased incidence of post-operative complications in the older groups. 
Adam (Adam et al., 1996) also concluded there was no difference in 
mortality between three age groups (under 50, 50-69 and over 70). 
Age: Studies which included age in multivariate studies 
Age was included in 15 multivariable studies (Table 4) of outcome (Law et 
al., 1994; Zhang et al., 1994; Ferguson et al., 1997; Bailey et al., 2003; 
McCulloch et al., 2003; Rentz et al., 2003; Atkins et al., 2004; Law et al., 
2004; Tekkis et al., 2004; Abunasra et al., 2005; Sauvanet et al., 2005; 
Schroder et al., 2006; Steyerberg et al., 2006; Ra et al., 2008; Park et al., 
2009) of which 6 included age as a continuous variable shown in Table 5 
(Bailey et al., 2003; Atkins et al., 2004; Tekkis et al., 2004; Abunasra et al., 
2005; Schroder et al., 2006; Steyerberg et al., 2006). Eleven of 22 studies 
reported statistically significant associations between age and perioperative 
mortality in multivariable designs (Law et al., 1994; Ferguson et al., 1997; 
Griffin et al., 2002; Rahamim et al., 2003; Rentz et al., 2003; Law et al., 
2004; Abunasra et al., 2005; Sauvanet et al., 2005; Finlayson et al., 2007; Ra 
et al., 2008; Park et al., 2009).
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Table 4 Effects of age on perioperative mortality from multivariate studies 
Study design Author Mortality % 
or relative 
risk 
OR, r, p value Comments 
Miscellaneous age 
groupings 
Law 2004 11 vs 2.8% 1.1433 (95% CI 
1.0690-
1.2229); 
p=0.002 
Not clear whether age category or 
continuous(OR) 
 Law 1994  0.052(r); 
p<0.001 
Categories <> 62; selected from 
discriminant analysis; not clear if 
regression coefficient is for category 
or continuous 
 Ferguson RR 2.8 p=0.001 Relative risk for 67 vs 50 
Categorical age group 
comparisons 
Rentz  0.41(r) 30 day mortality for <> 65 
 Sauvanet  p=0.001 <> 60; no numerical details 
 Abunasra 9.3 vs 3.2% 4.87(95% CI, 
1.35, 17.55) 
for over 73.2; 
p<0.001  
OR adjusted in multiple regression. 
Age groups <59.5, 59.5-67.8, 67.9-
73.2, >73.2 (quartiles).  <> 70 derived 
from results tables. 
 McCulloch  na <60,61-70,71-80,=>81 
 Park  P<0.001 <50,,50-59(OR 1.35),60-
69(OR1.68),70-
79(OR2.64),80+(OR3.84) 
 Zhang 27% vs 4.5% na  
 Ra  30 day mortality; > 80 compared with 65-69: OR 1.88 
(95%CI 1.08, 1.36), p= 0.025. OR 70-79 compared 
with 65-69: 1.54 (CI 1.01, 2.35).  
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Table 5 Effects of age on perioperative mortality from multivariable studies with age 
as a continuous variable 
Study design Author Mortality % or 
relative risk 
OR, r, p value Comments 
Age as continuous 
variable 
Bailey  OR 1.05 (r 0.05, se 
0.01); p=0.0001 
Multivariate 
adjusted (r). 30 
day mortality 
 Schroder  OR 9.6 (95% CI 
2.6-32.7); p=0.001 
Unclear whether 
age category or 
continuous. 
Adjusted 
 Tekkis  1.06(1.03,1.08)  
 Atkins  0.066 (r); p=0.003 30 day mortality 
 Steyerberg  OR 1.4(1.2,1.7) OR per decade; 30 
day mortality 
 Abunasra  OR 1.97 Adjusted OR 
 Age: effect of age over 80 
Moskovitz (Moskovitz et al., 2006) showed an increase in perioperative 
mortality in octogenarians (nearly three times compared with patients 
between 70 and 79) and confirmed this effect in a multivariable logistic 
regression, which controlled for various comorbidities and demonstrated 
acceleration in the effect of age on perioperative mortality in the ninth 
decade. Other studies also reported a marked effect in octogenarians 
(Moskovitz et al., 2006; Finlayson et al., 2007; Park et al., 2009) 
 Age: Distribution of comorbidities 
Most studies recorded the distribution of gender, tumour and operative 
details, and use of neoadjuvant therapy, between the age groups (Thomas et 
al., 1996; Jougon et al., 1997; Alexiou et al., 1998; Ellis Jr et al., 1998; Poon 
et al., 1998; Johansson and Walther, 2000; Fang et al., 2001; Kinugasa et al., 
2001; Rahamim et al., 2003; Tsai et al., 2003; Alexiou et al., 2005; Finlayson 
et al., 2007; Ruol et al., 2007(a); Ruol et al., 2007(b)). Cardiac and 
respiratory morbidities and some other comorbidities (e.g. incidence of 
diabetes, liver disease and renal disease) were also recorded in  some 
studies (Thomas et al., 1996; Jougon et al., 1997; Alexiou et al., 1998; Poon et 
al., 1998; Fang et al., 2001; Kinugasa et al., 2001; Moskovitz et al., 2006; 
Finlayson et al., 2007; Ruol et al., 2007(a); Ruol et al., 2007(b)). The 
incidence of cardiovascular and respiratory disease was generally higher in 
the elderly groups (Jougon et al., 1997; Poon et al., 1998; Fang et al., 2001; 
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Kinugasa et al., 2001; Moskovitz et al., 2006; Ruol et al., 2007(a); Ruol et al., 
2007(b)) but the opposite was found in the study by Alexiou (Alexiou et al., 
1998). 
 Cardiovascular comorbidity 
Twelve studies investigated the effect of cardiovascular comorbidity on 
perioperative mortality (Law et al., 1994; Zhang et al., 1994; Ferguson et al., 
1997; Alexiou et al., 1998; Bartels et al., 1998; Kuwano et al., 1998; Liu et 
al., 2000; Griffin et al., 2002; Bailey et al., 2003; Law et al., 2004; Abunasra 
et al., 2005; Gockel et al., 2005; Schroder et al., 2006). These are listed in 
Table 6 on the following page. Comorbidity was coded in a large variety of 
ways and only two (Zhang et al., 1994; Gockel et al., 2005) found an 
association with perioperative mortality. Five studies (Bartels et al., 1998; 
Atkins et al., 2004; Tekkis et al., 2004; Steyerberg et al., 2006; Ra et al., 
2008) demonstrated a relationship between outcome and composite 
comorbidity scores, which incorporated some element of cardiac morbidity.
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Table 6 Studies which included an investigation of the effect of cardiac comorbidity on perioperative mortality 
Study author Definition of preoperative morbidity Comments 
Law ( 2004) Pre-existing cardiac disease, abnormal ECG (ischaemia/arrhythmia), abnormal CXR No values reported 
Alexiou History (IHD, hypertension, myocardial infarction, peripheral vascular disease, DVT) No values reported 
Ferguson NYHA heart failure score, hypertension, beta or calcium channel blockers, previous MI (p=0.1) For NYHA heart failure 
Bailey Congestive heart failure, dyspnoea at rest, history of CVA,  (p non-significant) No values reported 
Law (1994) Abnormal chest xray & cardiograph,  (p non-significant) No values reported 
Liu Mild arrythmia, hypertension, valve disease without symptoms, aortic stenosis, angina, old 
infarction (p=0.0001 for hypertension only) 
For hypertension only 
Kuwano ECG abnormalities requiring treatment, myocardial ischaemia, arrythmia, valve disease, abnormal 
scintography,  (p non-significant) 
No values reported 
Schroder Composite score(physician defined cardiac risk, electrocardiograph, chest xray),  (p non-
significant) 
No values reported 
Griffin MI, CABG, hypertension, symptoms, ECG, exercise test, (p non-significant) Incidence of cardiovascular disease, 44% in 
non-survivors, 31% in survivors 
Gockel History of coronary heart disease, MI, arterial hypertension, valvular disease, arrhythmia 
requiring treatment, congestive heart failure, peripheral occlusive disease  (p=0.0172) 
 
Zhang Abnormal ECG (p=0.06) r, 3.4 in logistic regression for abnormal ECG 
Whooley Abnormal ECG(ischaemia, arrhythmia); previous cardiac history,  (p non-significant)  
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 Respiratory comorbidity 
Nine of 14 studies (Law et al., 1994; Bartels et al., 1998; Liu et al., 2000; 
Rentz et al., 2003; Abunasra et al., 2005; Alexiou et al., 2005; Sanz et al., 
2006; Schroder et al., 2006; Healy et al., 2008) reported an association 
between pre-existing pulmonary disease or pulmonary function, and 
mortality. These are summarised in Table 7 and Table 8. Three studies 
included pulmonary components (Bartels et al., 1998; Tekkis et al., 2004; 
Steyerberg et al., 2006) in composite scores which were associated with 
mortality. Healy (Healy et al., 2008) reported an association between 
preoperative dyspnoea and mortality. 
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Table 7 Studies of the effect of respiratory comorbidity on mortality: physiological 
measures 
Study author Definition of 
preoperative 
morbidity 
Odds ratio(OR), 
regression 
coefficient®, 
relative risk(RR) 
or mortality 
rate% 
Probability 
significance (p 
value) for predictor 
effect 
Notes 
Law (2004) 
Spirometry & 
gases 
 ns No values 
Ferguson 
Spirometry, 
arterial gases, CO 
diffusion 
 
0.085, 
FEV1(univariate) 
FEV1 ns in 
multivariate 
model. 
Law (1994) 
Spirometry 
(incentive), 
arterial gases, 
chest xray 
 
Incentive 
spirometry(<0.001), 
PCO2 (0.032), 
abnormal chest 
xray(<0.001) 
Incentive 
spirometry 
predictive in 
multivariate 
model 
Liu Spirometry  0.049 
FEV1/FVC; no 
values 
Kuwano Spirometry  ns not predictive 
Bartels 
Spirometry and 
arterial gases 
RR 1.7 for 
impaired 
respiratory 
function 
(composite) 
<0.05 for VC & 
arterial pO2 and 
Discriminant 
analysis to 
maximise relative 
risk for VC<90% 
predicted, 
PaO2<70mmHg. 
Schroder As in Bartels 
1.56(95% CI 1.01, 
3.4) 
0.049 
Respiratory 
function score 
calculated as 
unweighted 
Bartels score 
Griffin 
Spirometry, 
arterial gases 
 ns not predictive 
Abunasra Spirometry 
4.72 (1.01, 21.99) 
for highest vs 
lowest quartile 
FEV1, 0.001; FEV1, 
0.004; FVC, 0.014; 
note %predicted 
Lowest relative to 
highest quartile 
Sanz 
Spirometry, 
arterial gases 
RR 1.1(95% CI 0.7-
3.5), p=0.014 for 
multivariate 
model 
0.03  
Zhang Spirometry  ns  
Healy Spirometry  ns not predictive 
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Table 8 Studies of the effect of respiratory morbidity on mortality: clinical history 
Author Description of respiratory disease used for 
prediction 
 Comments 
Law Pre-existing pulmonary disease ns No values 
Alexiou Pre-existing pulmonary disease P=0.15 No values 
Rentz Severe COPD, dyspnoea, current pneumonia Dyspnoea:  
regression 
coefficient 
in logistic 
regression: 
0.41 
(p=0.0477) 
 
Bailey Severe COPD, dyspnoea at rest  Not predictive 
Law Chronic respiratory disease  Not predictive  
Gockel Chronic obstructive pulmonary disease, use of 
bronchodilators 
0.0059 
univariate: 
p= 0.0099 
multivariate 
 
Healy Dyspnoea 1.08(1,1.7); 
multivariate 
(p=0.041); 
p<0.001 
univariate 
 
Griffin History of chronic lung disease Present in 
44% of non-
survivors & 
22% 
survivors 
 
 Exercise or activity capacity 
These studies are summarised in Table 9. Of three studies of 
cardiopulmonary exercise capacity (Law et al., 1994; Murray et al., 2007; 
Forshaw et al., 2008), one (Law et al., 1994) reported an association of ‘stair 
climbing capacity’ with mortality. Of five studies of activity or general 
health, the following four reported an association with mortality. Ferguson 
(Ferguson et al., 1997) reported the Zubrod (Oken et al., 1982), health and 
activity score, Bartels (Bartels et al., 1998) reported the Karnovsky health 
score (Karnofsky, 1984), Healy the EORTC QOL questionnaire (Healy et al., 
2008), and Bailey and Rentz used undefined scores (Bailey et al., 2003; 
Rentz et al., 2003).
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Table 9 Studies which investigated exercise or activity capacity as predictors of perioperative mortality 
Author Description of exercise or activity capacity used in study 
Relative risk(RR),  mortality rate(%), odds ratio (OR), 
or regression coefficient® with significance (p) 
Notes 
Cardiopulmonary exercise testing    
Law (1994) Stair climbing RR 2.9 in high risk group (p=0.015) 
Discriminant analysis to maximise RR for 
high risk group. Multivariate model 
Forshaw 
Cardiopulmonary exercise testing (anaerobic threshold, VO2 
max) 
  Not predictive (one  death) 
Murray Shuttle walk test  
5/8 patients who could not walk 340 
metres died; all survived if walked 340 
metres 
General health or activity scores   
Healy EORTC QOL  P=0.02 
Dyspnoea(p<0.001), fatigue(p=0.003) 
and nausea & vomiting (p=0.025) are 
components of QOL associated with 
perioperative mortality. Only dyspnoea 
predictive in multivariate model. 
Rentz Undefined "diminished functional health"   
Bailey Functional status (unclear definition) r, 0.48(s.e. 0.18), p=0.007 for multivariate model  
Ferguson Zubrod performance score P=0.03 Included in multivariate model 
Bartels Karnovsky index <0.001 for karnovsky index less than 80% 
Discriminant analysis to maximise RR of 
Karnovsky 
Composite morbidity scores   
Atkins Charlson comorbidity score r=0.89 (p=0.05) not predictive 
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 Nutritional status 
Sixteen authors (Saito et al., 1993; Law et al., 1994; Ferguson et al., 1997; 
Bartels et al., 2000; Liu et al., 2000; Griffin et al., 2002; Bailey et al., 2003; 
Rentz et al., 2003; Atkins et al., 2004; Law et al., 2004; Abunasra et al., 2005; 
Alexiou et al., 2005; Gockel et al., 2005; Sauvanet et al., 2005; Han-Geurts et 
al., 2006; Sanz et al., 2006; Healy et al., 2008) examined the effect of  a 
variety of measures of nutritional or immune status on perioperative 
mortality. These are summarised in Table 10 and Table 11. Three of 9, who 
investigated serum albumen found associations (Law et al., 1994; Rentz et 
al., 2003; Atkins et al., 2004; Sanz et al., 2006), one found an association 
nd arm 
circumference)(Saito et al., 1993), one with arm circumference (Law et al., 
1994), and one with a composite “general status” measure, which included 
weight loss (Bartels et al., 2000). Only one (Law et al., 1994) of 12, who 
investigated weight loss found any association with mortality.
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Table 10 Studies of nutritional status and its effect on perioperative mortality: 
serum protein, albumen and white cell count 
Study author Description of nutritional 
measure 
Odds ratio(OR), 
regression 
coefficient(r), relative 
risk(RR); (p value)  
Notes 
 ALBUMEN   
Law(2004)   Not predictive 
Ferguson  0.43 Not predictive 
Rentz  r=0.056, p=0.0135 Less than 35 gm/L 
Law(1994)  0.001 Not predictive in multivariate 
model 
Bartels   Not predictive 
Sanz  0.02 p=0.01 in multivariate model 
Griffin  ns Not predictive 
Atkins  r=0.078, ns Not predictive 
Saito  ns Not predictive 
    
 SERUM PROTEIN   
Ferguson Total serum protein 0.27 Not predictive 
    
 WHITE CELL COUNT   
Ferguson Lymphocyte count 0.55 Not predictive 
Law(1994) White cell count   Not predictive 
Saito Lymphocyte, T cell, B cell ns Not predictive 
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Table 11 Studies of nutritional state; measures of loss of body mass & miscellaneous 
other measurements 
Study author Description of nutritional 
measure 
Odds ratio(OR), 
regression 
coefficient(r), 
relative risk(RR); (p 
value)  
Comments 
 WEIGHT LOSS   
Alexiou   Not predictive 
Ferguson Weight loss during previous 6 
months 
0.87 Not predictive 
Law(1994) % weight loss 0.048 Not predictive in multivariate 
model 
Sauvanet 3 groups: <10%, 10-20%,>20% 0.161 Not predictive 
Liu Weight loss during previous 6 
months 
 Not predictive 
Abunasra Body mass index(quartiles) 0.433 for trend in 4 
quartiles 
Not predictive 
Gockel Body mass index 0.072 Not predictive 
Bartels % Weight loss   Not predictive 
Griffin % weight loss ns Not predictive; weight loss 4.7% 
in survivors, 6.9% in non-
survivors. 
Healy % weight loss   
Atkins % weight loss r=-0.54, p=0.25 Not predictive 
Saito % of ideal body weight ns Not predictive 
 OTHER   
Law(1994) Hand grip strength, tricep 
skinfold 
Hand grip (p=0.003); 
mid-arm 
circumference RR 3.0 
in high risk group,( 
p<0.001) 
Mid arm circumference included 
in multivariate model 
Gockel Nutritional score combining 
alcohol/tobacco use  
P=0.222 Not predictive 
Saito 21 separate variables measuring 
aspects of immune and 
nutritional state 
 In univariate analysis arm muscle 
circumference and α2-
macroglobulin were significant 
predictors (p<0.05). A "host 
defence index" was constructed 
to predict mortality (included 
albumen, B cell count, albumen 
& 7 other serum proteins) 
Han-Geurts PNI (‘prognostic nutritional 
index’), NRI(‘nutritional risk 
index’), BMI & weight loss 
  
 Other candidate predictors 
Nine studies investigated the effect of tumour characteristics (Zhang et al., 
1994; Whooley et al., 2001; Law et al., 2004; Abunasra et al., 2005; Alexiou 
et al., 2005; Gockel et al., 2005; Sanz et al., 2006; Steyerberg et al., 2006; 
Healy et al., 2008). Three (Abunasra et al., 2005; Gockel et al., 2005; Sanz et 
al., 2006) reported tumour site to influence outcome and one reported 
tumour stage to influence outcome. Nine studies (Law et al., 1994; Ferguson 
et al., 1997; Whooley et al., 2001; Rentz et al., 2003; Abunasra et al., 2005; 
Gockel et al., 2005; Sauvanet et al., 2005; Sanz et al., 2006; Healy et al., 
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2008) included investigation of surgical approaches to oesophagectomy. Only 
Gockel (Gockel et al., 2005) reported a perioperative difference between 
transhiatal and transthoracic procedures but it was unclear which was 
favoured. Of six studies (Whooley et al., 2001; Bailey et al., 2003; Atkins et 
al., 2004; Law et al., 2004; Schroder et al., 2006; Steyerberg et al., 2006) of 
neoadjuvant therapy, only one (Steyerberg et al., 2006) reported an 
increased perioperative mortality with radiotherapy alone or with 
chemotherapy, compared to chemotherapy alone. 
Other predictors reported to be associated with perioperative mortality 
included renal impairment (Zhang et al., 1994; Bailey et al., 2003), hepatic 
impairment (Bailey et al., 2003; Gockel et al., 2005), alcohol use (Bailey et 
al., 2003), tobacco use (Law et al., 1994; Liu et al., 2000), ASA grade (Griffin 
et al., 2002), low white cell count (Griffin et al., 2002), gender (Griffin et al., 
2002), cholesterol (Sanz et al., 2006), and an “index of medical deprivation” 
(Leigh et al., 2006). Two (Zhang et al., 1994; Bailey et al., 2003) of eleven 
studies (Zhang et al., 1994; Ferguson et al., 1997; Bartels et al., 1998; 
Kuwano et al., 1998; Liu et al., 2000; Bailey et al., 2003; Law et al., 2004; 
Alexiou et al., 2005; Gockel et al., 2005; Sanz et al., 2006; Steyerberg et al., 
2006) found an association between diabetes mellitus and perioperative 
mortality. 
 Potential risk of bias in primary studies 
The pattern of how well the potential risks for bias, as outlined by Hayden 
(Hayden et al., 2006), were managed or reported across the primary studies 
is shown in Figure 3. The risk of bias profile for individual primary studies 
is shown in Appendix E. 
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 .  
Figure 3 Reporting & management of potential for bias across included primary studies
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A minority of studies reported potential selection bias, e.g. patients, who 
were eligible for surgery but were excluded (Law et al., 1994; Jougon et al., 
1997; Forshaw et al., 2008; Healy et al., 2008). Reasons for exclusion from 
surgery were described in two studies (Jougon et al., 1997; Forshaw et al., 
2008). Some investigators also chose to study a particular age group or 
surgical operation (Moskovitz et al., 2006) 
In twenty three studies (about 40%) it was not clear whether study samples 
included all consecutive cases. Twenty six (48%) included all operated cases 
in their analyses. One study excluded patients who had had neoadjuvant 
therapy (Tsai et al., 2003) and one selected only those receiving neoadjuvant 
therapies (Ruol et al., 2007(b)). Twelve (22%) studies fully or partially 
accounted for patients who were excluded from surgery but were potentially 
eligible (Law et al., 1994; Jougon et al., 1997; Alexiou et al., 1998; Sanz et 
al., 2006; Forshaw et al., 2008) and three reported reasons for exclusion 
(Law et al., 1994; Jougon et al., 1997; Forshaw et al., 2008).Thirty five 
studies (65%) and sixteen studies (30%) respectively, completely or partially, 
reported important sample characteristics. 
Fifteen studies (28%) collected data prospectively (often into clinical 
databases), thirteen (24%) retrospectively (for example, extracting data from 
clinical records) and in 26 (48%) it was unclear. Data validation techniques 
such as audit were only clearly or partially described in eight studies (Adam 
et al., 1996; Bailey et al., 2003; Rahamim et al., 2003; Tekkis et al., 2004; 
Moskovitz et al., 2006; Al-Sarira et al., 2007; Park et al., 2009), with 43 
(80%) making no reference to data validation. Only 9 (17%) studies reported 
missing values and/or their handling (Ferguson et al., 1997; Zafirellis et al., 
2002; Tekkis et al., 2004; Sauvanet et al., 2005; Leigh et al., 2006; 
Steyerberg et al., 2006; Lagarde et al., 2007; Lai et al., 2007; Nagabhushan 
et al., 2007). Three studies (6%) reported procedures to ensure patient follow 
up (Adam et al., 1996; Jougon et al., 1997; Takagawa et al., 2008) and thirty 
four (63%) reported enough information to enable deduction of follow up 
rate. No studies reported any details of cases, which were lost to follow up. 
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Thirty six studies reported all the prognostic variables, which I thought 
important for this review, and the remainder reported varying numbers. 
Thirty provided definitions of predictors and their methods of measurement, 
sixteen provided these for some predictors and in two it was unclear. There 
was considerable heterogeneity in defining cardiorespiratory and nutritional 
comorbidities. Seventeen studies (31%) treated potentially continuous 
variables (e.g. age) as continuous and 36 (67%) as categorical. 
I defined confounding variables predominantly as predictors likely to be 
important predictors of mortality and associated in some way with other 
predictors (e.g. age and cardiovascular disease). Nineteen studies (35%) 
recorded confounding variables as specified in our methods, and twenty four 
(44%) recorded some. Fourteen (26%) accounted for confounders in study 
design or analysis and thirty (56%) partially accounted for confounders, for 
example, by tabulating their distribution between study groups. In nine 
(17%), reporting of confounders was unclear. 
 Data analysis 
Forty one (76%) studies described appropriate adequate statistical methods 
and eleven (20%) described appropriate methods but incompletely. In two 
studies, the methods were unclear. Thirty one studies (57%) reported 
enough data to assess analysis. In fourteen studies of binary predictors, 
notably age categories, the sample sizes were too small to detect statistical 
significance on measured observations, and it was unclear in twenty six 
studies, particularly those using regression. One study of the forty where 
regression techniques were used, reported description of interaction 
between prognostic factors, collinearity between variables or sensitivity to 
extreme values. 
 Ranking studies by ‘risk of bias’ 
It was difficult to use ‘potential risk of bias’ scores to select the most reliable 
studies because individual study context can be important. There were a 
heterogeneous mix of study designs and aims, therefore I did not try and 
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draw conclusions based on ranking scores for having satisfied the criteria 
for minimising risk of bias 
 Publication bias 
Formal statistical methods (e.g. funnel plots) require directly comparable 
presentation of study effects (for instance relative risk), similar 
interventions, and at least five constituent studies (Rothstein et al., 2005). 
The only studies with comparable results were those comparing outcomes in 
patients under and over 70 years. The samples in these studies may have 
been quite heterogeneous because of the unknown prevalence of the very 
elderly and cardiorespiratory disease and therefore the interpretation of 
statistical estimation of publication bias should be tempered with caution. 
The funnel plot of the distribution of effects of the age grouping between 
studies is shown in Figure 4 (overleaf). This was constructed using in 
Revman (Cochrane Information Management System, 2011). There is no 
strong evidence of publication bias in these studies, as the odds ratios are 
symmetrically distributed around the pooled estimate. The one possible 
outlier was the study by Johansson (Johansson and Walther, 2000), but this 
had only two fatalities in a small sample size. 
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Figure 4 Funnel plot of odds ratios for effect of age over and below 70 on 
perioperative mortality generated in Revman. See text for explanation. 
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2.4 Discussion 
2.4.1 Summary 
Ten studies of prediction models fitted our inclusion criteria. Only the 
POSSUM based models (Zafirellis et al., 2002; Tekkis et al., 2004; Lagarde 
et al., 2007; Lai et al., 2007; Nagabhushan et al., 2007), the ‘Munich’ (Bartels 
et al., 1998) and ‘Rotterdam’ models  (Steyerberg et al., 2006) had been 
validated on patient samples from populations outside the development 
sample. In these studies, performance degraded and overestimation of 
mortality risk in higher risk groups was common. There were no formal 
clinical impact studies, but two were reported to reduce perioperative 
mortality (Bartels et al., 1998; Tsai et al., 2003) after they had been 
implemented in practise. The lack of consistent definition and ‘face validity’ 
of some of the predictors made these models difficult to transfer to new 
populations. 
Forty four studies investigated the effect of comorbidity on perioperative 
mortality. The reported effects of preoperative comorbidity predictors on 
outcome were inconsistent but age appeared to be convincingly associated 
with mortality. Other comorbidity variables were defined inconsistently and 
it was difficult to draw conclusions about their potential role or effect. 
Cardiorespiratory disease, nutritional state, activity levels, and site of 
tumour were variably reported to affect outcome. 
In many studies of prediction models and comorbidity effects, potential 
sources of bias were not reported or addressed. The details of statistical 
modelling were sometimes difficult to follow, and the age predictor was 
frequently included as a categorical rather than continuous variable, risking 
loss of information. Only the ‘Rotterdam’ model appeared potentially 
applicable to our patients from the NOGCU and only age appeared 
conclusively important for prediction models. The effects of other 
comorbidity predictors are still at an exploratory stage. 
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2.4.2 Prediction Models 
Model development entails a series of stages from initial data exploration, 
through modelling and validation to clinical application (Wallace et al., 
2011). Clinical impact studies are uncommon, with most studies focussing 
on model development, internal validation and a few on external validation 
(Bouwmeester et al., 2012). This was the case for the studies included in this 
review. 
The POSSUM based models were the most frequently tested on new 
populations. The POSSUM (the ‘Physiological and Operative Severity Scores 
for the Enumeration of Mortality and Morbidity’) (Copeland et al., 1991) was 
developed as an audit tool for perioperative outcome in 1991 and has been 
applied to various surgical groups subsequently. However, the original 
POSSUM did not perform well in new groups, specifically overestimating 
mortality in oesophagectomy (Zafirellis et al., 2002). This is not surprising 
as the POSSUM was developed on a heterogeneous group of surgical 
patients including emergencies. Some of the higher scoring items in the 
POSSUM score included items most likely to be found in patients presenting 
for emergency surgery, rather than for major elective surgery e.g. impaired 
conscious level, heart failure, renal failure, severe respiratory impairment. 
These items may bias predictions in an elective surgical population and lack 
‘face validity’ as the patients scoring on these items are unlikely to be 
presenting for major elective surgery. 
The O-POSSUM was developed to focus on oesophagogastric surgery. It was 
developed by Tekkis (Tekkis et al., 2004) from United Kingdom databases 
containing data from oesophagogastric cancer centres (McCulloch et al., 
2003; Tekkis et al., 2004). The O-POSSUM excluded surgical process 
variables but incorporated age as an independent variable, although this 
was represented again in the Physiological Severity Score part of the 
POSSUM. Performance was acceptable in development and internal 
validation but deteriorated when applied to new populations (Tekkis et al., 
2004; Lagarde et al., 2007; Lai et al., 2007; Nagabhushan et al., 2007). 
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Overestimation of mortality was a common problem with all POSSUM 
models (Lagarde et al., 2007; Lai et al., 2007; Nagabhushan et al., 2007). 
Differences between modelling and validation samples could have impaired 
performance. The original O-POSSUM was developed on a sample 
containing 79.5% elective patients (mortality 9.4%), 7.5% emergencies 
(mortality 26.9%) and 13.1% unknown (19.1% mortality). Differences in 
validation samples included the use of 30 day instead of ‘in hospital’ 
mortality (Nagabhushan et al., 2007), only using elective cases (Lagarde et 
al., 2007; Nagabhushan et al., 2007), different operations (Lagarde et al., 
2007) (Lai et al., 2007) and overall mortality rates (Lagarde et al., 2007). 
Differences in comorbidities may also have affected Lai’s Hong Kong 
validation study (Alexiou et al., 2006; Lai et al., 2007). The P-POSSUM 
(Prytherch et al., 1998), which had been developed on a United Kingdom 
mixed surgical population to improve on the original POSSUM, performed 
well on the Hong Kong sample but poorly elsewhere (Nagabhushan et al., 
2007). 
The ‘Munich’ model (Bartels et al., 1998), which classified patients into 
three ascending risk groups, successfully identified a high risk group, in a 
subsequent sample from the same centre, with a similar mortality to that in 
the modelling sample (25%). It was later introduced into clinical practise 
and reported to reduce 90 day mortality rate from over 10% to about 5%, but 
at the expense of excluding 24 patients from surgery, but there were no 
formal clinical impact studies. However, when validated externally the high 
risk group had in-hospital mortality of 16.7% (Schroder et al., 2006), again 
suggesting overestimation when applied in new populations. This model 
would be unlikely to be applicable elsewhere because of differences in 
prognostic variable definition e.g. “subjective cardiac assessment by 
cardiologist” and some risk items (e.g. hepatic impairment) suggest that the 
model was applied to patients who may not be currently considered for 
surgery. 
Steyerberg’s model (Steyerberg et al., 2006) was developed on a population 
database from the USA and validated on data from the same database as 
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well as population and clinical databases from the Netherlands. The model 
calibrated well but discrimination was poor. The risk score was simple and 
reproducible but the comorbidity items were necessarily general and did not 
discriminate layers of risk e.g. cardiac morbidity scoring. This was the only 
model that could possibly be applied to data from the NOGCU. 
2.4.3 Candidate predictors for perioperative mortality 
 Age 
It might be expected that an increase in age would be associated with 
increasing perioperative morbidity and mortality because of increasing 
incidence and severity of comorbidity, and a reduced capacity to respond to 
physiological stress (Priebe, 2000; Park et al., 2009). However, this was not 
clearly reflected in the primary studies included in this review. 
Most of the primary studies divided patients into age categories. The most 
common cut-off, by far was 70 years and none found statistically significant 
associations with mortality. There were frequently reported differences, but 
the samples were too small to achieve statistical significance. Studies, which 
used age categories, were unable to show the proportion of very old patients, 
and therefore it was not clear whether the effect of extreme old age was 
investigated. Combining the pooled results of studies, which divided groups 
at 70 years, suggested that age is an important predictor (odds ratio 1.91 for 
over 70). Ideally it should also be included as a continuous variable to 
incorporate information from across the whole range of old age. 
Confounding could also have influenced the effect of age on outcome. For 
example, both the incidence and severity of cardiovascular disease are likely 
to increase in extreme old age (Priebe, 2000) and be associated with 
perioperative mortality. In the primary studies included in this review, the 
incidence of cardiovascular and respiratory disease was generally higher in 
the elderly groups (Jougon et al., 1997; Poon et al., 1998; Fang et al., 2001; 
Kinugasa et al., 2001; Moskovitz et al., 2006; Ruol et al., 2007(a); Ruol et al., 
2007(b)). The distribution of these comorbidities were generally reported but 
not included in statistical analysis. Differing resection rates and choice of 
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procedure between age groups (Thomas et al., 1996; Sabel et al., 2002; Ruol 
et al., 2007(a)) and levels of perceived fitness (Jougon et al., 1997; Alexiou et 
al., 1998; Moskovitz et al., 2006) may also bias the effects of age. Many 
studies did not record this information. 
 Nutritional status 
The nutritional effects of gastro-oesophageal cancer have been described by 
Gupta (Gupta and Ihmaidat, 2003). Nutritional compromise is common in 
gastro-oesophageal cancer, caused by both local mechanical effects and 
neoplastic systemic effects (Fekete and Belghiti, 1988). Protein-calorie 
malnutrition has been demonstrated in hospitalised cancer patients (Nixon 
et al., 1980) and is associated with impaired cardiac muscle, respiratory 
muscle and skeletal muscle function as well as intestinal muscle atrophy. 
Protein-calorie malnutrition has also been associated with immune system 
impairment in oesophageal cancer and may potentially increase the 
possibility of post-operative infection (Law et al., 1973). Postoperatively, 
malnutrition has been associated with increased rates of anastomotic 
breakdown (Fekete and Belghiti, 1988) and postoperative respiratory 
complications (Windsor and Hill, 1988). In this review, five (Saito et al., 
1993; Law et al., 1994; Rentz et al., 2003; Atkins et al., 2004; Sanz et al., 
2006) of sixteen studies, which investigated nutritional status, found an 
association between a variety of measures of nutritional status and 
perioperative mortality. Reported measures included serum albumen, a 
variety of measures of loss of body mass and immunological studies. This 
provided only weak evidence that the nutritional or immune status 
measures, which were studied here, should be considered as candidate 
predictors. There is physiological rationale for the inclusion of a nutritional 
measure, but the heterogeneous nature of the studies, definitions and 
results means that we are at an early data exploration stage and unable to 
draw conclusions to guide selection of predictors. 
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 Cardiovascular comorbidity 
Serious cardiac complications in a population of mixed major surgical 
procedures have been reported to be about 2.5% (Lee et al., 1999) and 
preoperative cardiovascular disease has been associated with increased 
morbidity and mortality in many studies of non-cardiac surgery (Mangano, 
1990; Eagle et al., 1997). Myocardial infarction and cardiac mortality 
combined, has been reported in ‘high risk surgery’ to be over 4% in patients 
who had medically treated coronary heart disease (Eagle et al., 1997). These 
rates are also influenced by other comorbidities including peripheral 
vascular disease, where there was an observed cardiac morbidity of 8%  
(L'Italien et al., 1996), and increasing age (Priebe, 2000). More recently, in a 
mixed surgical population with cardiovascular comorbidity, total cardiac 
complications were about 6% and mortality about 1.5% (2008). Of course it 
may be that other causes of mortality may be associated with cardiac 
comorbidity, for instance generalised vascular disease may be associated 
with an increased risk of multiorgan failure or anastomotic breakdown. 
Cardiac comorbidity may then have a stronger predictive effect. 
In the articles included in this review, where the information was available, 
between 9 % and 15% of perioperative mortality was attributable to cardiac 
causes (Law et al., 1994; Whooley et al., 2001; Law et al., 2004; Alexiou et al., 
2005). This means cardiac mortality might be about 1-2% in studies where 
all cause mortality was between 5% and 10%. If we assume that deaths, 
which are primarily attributable to cardiac comorbidity, are cardiac in 
nature, it is not surprising that of seventeen studies, which investigated this, 
only four found any association. This is because the sample sizes were small 
relative to the attributable mortality (Zhang et al., 1994; Bartels et al., 1998; 
Liu et al., 2000; Tekkis et al., 2004; Gockel et al., 2005; Steyerberg et al., 
2006). 
One of the problems in this review was the lack of consistent definition for 
reporting or scoring cardiac comorbidity. Many studies have used stratified 
scores for cardiac risk for non-cardiac surgery. The most commonly used is 
probably the Revised Cardiac Risk Index (RCRI) (Lee et al., 1999), which 
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stratified into groups with cardiac event rates from 0.5% to 11%. A recent 
validation study (Boersma et al., 2005) examined the predictive performance 
of the RCRI on patients, which included oesophagectomy, with an overall 
cardiac mortality of 0.8% and all cause mortality of 4%, in keeping with the 
studies in this review. Predicted mortalities ranged from 0.3% in RCRI 
Class 1 to 3.6% in Class 4. The authors found that the addition of age and 
operation detail also added to the predictive performance. 
It seems reasonable that, although most studies in our review did not 
identify preoperative cardiovascular morbidity as an independent risk factor 
for perioperative mortality, other evidence supports its consideration in 
prediction models. Despite the relatively low prevalence of attributable 
outcomes and possibly high risk scores, it may be worth considering the use 
of a standardised risk score such as the RCRI. 
 Respiratory comorbidity 
Transthoracic oesophagectomy involves chest wall surgery, prolonged 
operating time, one lung ventilation, mechanical retraction of lung tissue, 
thoracic lymphadenectomy and potentially large and complex body fluid 
shifts. Unsurprisingly, respiratory complications are common with rates 
reported up to 32% (Law et al., 1994; Whooley et al., 2001; Law et al., 2004). 
These complications are also a major cause of mortality, for example 
contributing up to 55% of all perioperative fatalities (Whooley et al., 2001; 
Law et al., 2004). It seems reasonable that respiratory comorbidity should 
be a candidate predictor for a prediction model. 
Predictors for post-operative pulmonary complications in non-cardiothoracic 
surgery have been examined in a systematic review by Smetana (Smetana et 
al., 2006), which was used to develop a stratification guideline by the 
American College of Physicians (Qaseem et al., 2006). They reported that for 
age over 60, chronic obstructive pulmonary disease, congestive heart failure, 
functional dependence, ASA grade, and serum albumen less than 35 
grams/litre were all considered important predictive factors. Spirometry was 
also associated with pulmonary complications but no better than clinical 
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examination. Abnormal chest radiography has shown to correlate with 
pulmonary complications, but was considered to be potentially helpful only 
in patients with established cardiopulmonary disease or those over the age 
of 50. Cessation of smoking was also associated with a modest reduction in 
post-operative pulmonary complications, but only if instigated at least two 
months before surgery. There was some evidence that acute mental state 
change (excluding stable mental disease or dementia), alcohol intake, 
impaired renal function and weight loss also had a moderate correlation. 
Obesity, asthma and oropharyngeal bacterial colonisation had no predictive 
effect on pulmonary complication rate. There was not enough evidence to 
conclude whether exercise capacity, diabetes or HIV had any effect. 
In this review about half of the studies, which included respiratory 
comorbidity as a predictor, found an association with mortality but again 
there was no consistency in marker definitions, which included a history of 
respiratory disease, spirometry and smoking history. Given the frequency of 
post-operative respiratory complications and their association with 
mortality, together with the published evidence, respiratory comorbidity 
should at least be considered as candidate predictors. However, the most 
useful method of including respiratory risk is unclear and therefore this 
predictor is at an exploratory stage. 
 Exercise and activity capacity 
Seven (Law et al., 1994; Bartels et al., 1998; Bailey et al., 2003; Rentz et al., 
2003; Murray et al., 2007; Forshaw et al., 2008; Healy et al., 2008) of eight 
studies, which investigated exercise or activity capacity found an association 
with perioperative mortality, however these included a wide range of 
assessment tools from self-reported levels of daily activity, through to scores 
of general wellness to objectively measured cardiorespiratory capacity. 
Although one would expect some form of exercise capacity to be included in 
a risk score, it is far from clear which is the most appropriate. 
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 Other comorbidity predictors 
Diabetes, renal function, liver function, alcohol intake, level of social 
deprivation, surgical procedure, and tumour site and stage were all variably 
associated with perioperative outcome. Findings were inconclusive, 
definitions varied and potential confounders not included in analyses. 
Interpretation and applicability to other datasets was difficult because the 
relative incidences of these predictors are likely to be small and their 
importance unclear. 
 Potential risk of bias in primary studies 
In this section I discuss some issues pertaining to risk of bias in the primary 
studies and I have grouped these into main categories as described in 
Hayden’s study of systematic reviews for prognostic studies (Hayden et al., 
2006). 
 Does the sample adequately represent the population of interest? 
Selection bias in study samples may prevent reliable generalisation to new 
populations. For example, different approaches between centres, as to what 
is an acceptable level of ‘fitness for surgery’ may introduce selection bias. 
Since this is potentially related to predictors for this prediction model and 
unlikely to be controllable, the reasons for excluding patients from surgery 
should be reported. 
The ideal unbiased sample would be an unselected consecutive series 
described as, for example, “100 consecutive cases”. Only a minority of 
studies clearly reported a consecutive case series or case selection 
procedures and it was frequently unclear whether there could have been 
selection bias. Because of the lack of reporting clarity, I may have 
overestimated the real risk of potential for selection bias in some of these 
studies. 
‘Loss to follow up’ can produce biased underestimates of mortality in 
longitudinal cohort studies (Butler et al., 2001) but it is not clear what the 
scale of effect may be. A simulation study (Kristman et al., 2004) 
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demonstrated that small losses (from 5%), which occur ‘not at random’, i.e. 
are influenced by the outcome, can bias binary outcome estimates in cohort 
studies, and large effects can occur if follow up losses exceed 20% and 
depend on both outcome and prognostic variables. If losses to follow up are 
completely random or depend only on prognostic factors, considerable losses 
can be incurred without biasing the results, although precision will be 
affected. 
I specified perioperative mortality as periods of follow up from 30 to 90 days 
and “in hospital mortality”. Adequate follow up rate was considered to be 
met if there was a clear statement that all fatalities and survivors were 
accounted for; this was considered to “partially met” if it required deduction 
from the results. Although follow up rates in this type of study from single 
centres are likely to reasonably complete, a statement of mortality rate 
alone cannot exclude the possibility that cases may have been lost to follow 
up, particularly mortality rates within a set period (e.g. 30 day mortality), 
when patients could have died after discharge home or to a facility providing 
a lower level of care. Unless it was reported that all survivors are known to 
have been accounted for, I considered that follow up was not fully reported. 
 Does the data represent the sample? 
Fourteen studies were retrospective but in twenty, it was unclear whether 
data collection was retrospective or prospective. Retrospective studies are 
open to bias from case selection, missing records, and misclassification error 
(Sackett et al., 2006). A possible solution would be to ‘blind’ data collectors to 
outcome but this would be very resource intensive, and impractical for a 
clinical database. A more realistic solution is to include data validation 
procedures, however only eight studies gave clear evidence of data 
validation by data audit or checking with other data sources. This was 
reported more frequently, in presumably better resourced and planned 
population database or prospective studies. 
Prognostic variables were generally described in enough detail to be 
reproducible. However definitions (e.g. cardiac and respiratory morbidity) 
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varied between studies, making comparisons difficult. About half the studies 
recorded other potentially important predictors (comorbidity, tumour 
histology and stage, neoadjuvant therapy) but considerably less took 
account of all important variables in analysis. 
These studies were observational and randomisation was not part of study 
design. Without randomisation, confounding variables may distribute in a 
non-random way. Ideally, known confounders should be reported and 
accounted for at analysis; for instance, age could be a confounder for cardiac 
or respiratory disease. Many studies reported the distribution of some but 
not all important predictors between groups, e.g. age categories, but they 
were not generally included in the analysis. 
Only eight studies reported missing values and their handling methods and 
no studies reported whether patients with missing values were 
representative of the main sample in other important characteristics. 
Reporting missing data is important because it can both impair study 
efficiency by reducing the effective sample size, and introduce bias if the 
extent of missing data is associated with outcome (Steyerberg, 2009f). 
 Data analysis 
A majority of studies appeared to use appropriate statistical methods for 
data analysis, but details were frequently scanty and some difficult to follow. 
Regression methods were the commonest methods used in generating 
prognostic models; however it was commonly difficult for the reviewers to 
find details in the manuscript. Most studies which used regression did not 
report collinearity between variables, model fitting, or interactions between 
variables e.g. age and cardiorespiratory morbidity. 
Small samples can exacerbate the problems of overoptimistic statistical 
significance and result in unrealistic effect sizes in multiple regression 
methods, particularly those which rely on ‘data driven’ selection methods 
(Steyerberg et al., 1999). Samples should be large enough to account for the 
multiple comparisons, interactions between variables and the use of 
categorical variables. Sample size in studies with binary outcomes are 
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driven by the number of outcome events and prevalence of predictor and 
outcome; it has been suggested that adequate samples should have at least 
ten (some have suggested twenty) events for each potential variable 
investigated (Vach, 1997). 
In this review, sample sizes were frequently too small to detect potentially 
important differences in outcomes, particularly when age had been 
investigated as a categorical variable. 
 Synthesis of results 
Data synthesis of pooled results can be carried out for appropriate summary 
statistics of predictor effects (Deeks, 2001). However, there was much 
heterogeneity in study design, reporting of summary statistics, sample 
characteristics and prognostic variable definition. There was also 
considerable variation in reporting potential for bias and therefore data 
pooling was inappropriate for most predictors. However, studies of age 
categories below and above 70 years were reported in a way to enable data 
pooling and I did this because all of these studies reported no significant 
effect of age, but used small sample sizes. Pooling the data resulted in a 
summary odds ratio of 1.9 for age over 70. However, care should be 
exercised in interpreting this because the proportion of very elderly and 
those with other comorbidities in each category was not always obvious. 
 Strengths and weaknesses of this review 
I carried out this systematic review using recommended methods (Altman, 
2001; Hayden et al., 2006; Centre for Reviews and Dissemination, 2009; 
Moher et al., 2009) and focussed on studies which, as far as possible, might 
apply to patients currently managed in our unit. The strengths and 
potential weaknesses within the review are discussed below. 
 Review Methods 
The methodology for systematic reviews of prognostic studies is not as well 
developed as that for interventional studies. There are summary guidelines 
from the Centre for Reviews and Dissemination , a Cochrane group is 
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developing methodology (Centre for Reviews and Dissemination) and there 
are reporting guidelines (Moher et al., 2009) but much is unvalidated 
including methods of optimal search strategies and assessment of potential 
for bias. 
A prospective review protocol carried out in a ‘linear’ fashion is an ideal 
method of reducing bias. Inevitably, issues arose during the review process 
which required protocol revision and the process then became iterative 
rather than linear. For example, some studies known to the reviewers were 
not retrieved by the search strategy and during the searches important 
predictors became apparent (e.g. surgical volume), requiring protocol 
revision. During data extraction, some items, which had been defined to 
assess potential for bias, also required redefinition, because of 
interpretation difficulties for the data extractors. These iterative processes 
clearly leave room for potential bias within the review, but have been 
recognised by other investigators and some degree of iteration is considered 
inevitable (Moher et al., 2009) (Pope et al., 2007). 
 Article selection 
There was a dilemma as to whether to retrieve studies which closely 
matched our population of interest or whether to search a broader literature 
(“splitting” vs “lumping”) (Pope et al., 2007). I chose the broader approach 
because this would increase our chances of determining whether 
comorbidities had a general effect, and we were not clear whether factors, 
which defined our local population (e.g. type of surgical procedure), were 
important. A broader approach also potentially reduces the potential for 
bias, which may be inherent in selecting particular populations (Grimshaw 
et al., 2003). However, it became clear that certain criteria, which define our 
local centre, also affected outcome, and these were used as inclusion criteria 
(e.g. surgical volume). I also confined selection to studies from ‘high volume’ 
centres published or mainly carried out after 1990, and the reasons for this 
have been discussed above. 
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 Publication bias 
Publication bias occurs when the published research literature is 
systematically unrepresentative of the population of completed studies 
(Rothstein et al., 2005). This occurs in various forms and aspects of this 
review could have been at risk of this bias. The most well known is the 
association of favourable outcome, large effects or statistical significance 
with publication. This is particularly so for randomised trials (Song et al., 
2000) but has also been shown in prognostic studies of Barrett’s oesophagus 
(Shaheen et al., 2000). Conversely, studies of prognostic models and their 
constituent variables, with unfavourable results may not be published. 
Outcome bias can arise from selective reporting of study methods and 
results. Several of these biases have been reported in studies of mortality 
after oesophagectomy, including reporting ‘30 day’ rather than ‘in hospital’ 
mortality, variable patient selection for surgery, selective reporting of 
denominator values, and institutional selection (Jamieson et al., 2004). 
Language bias is another potential cause of publication bias. Specifically, 
studies with statistically significant results are more likely to be published 
in English (Rothstein et al., 2005). In our review, only articles written in 
English were included because the reading population of interest is most 
likely to be English speaking or publish in English. 
Studies with statistically significant results are more likely to be cited by 
others (Rothstein et al., 2005). Part of our search strategy included hand 
searching book chapters, reviews and the reference lists within the articles 
selected, and therefore citation bias was a potential risk in this review. 
My searches focussed on the electronic bibliographic databases MEDLINE 
and EMBASE. Searches of electronic databases routinely retrieve only a 
fraction of the available studies because of imperfections in search 
algorithms. This is possibly a greater problem for prognostic study searches 
because they are at an earlier stage of development. Considerable numbers 
of studies may be published in sources not indexed with the major electronic 
databases, the so called ‘grey’ literature. Our searches did not include a full 
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search of all grey literature sources, however we (IW/MC) hand searched 
book chapters, review articles and the articles retrieved from the electronic 
searches, even though these may be susceptible to their own biases. We 
contacted local known experts (Dr Ian Shaw) for further information, and 
we did not contact original study authors for study details because of 
resource constraints. 
 Data extraction 
There were differences between the reviewers in interpretation of risk of 
bias items, requiring discussion and in some cases revision of definitions. 
This may have been exacerbated by a lack of clarity in item definition, but 
difficulty in finding important items because of poor reporting caused 
considerable difficulty. 
2.5 Key findings 
1. Several prediction models have been developed to predict perioperative 
mortality after oesophagectomy. Performance on external validation has 
been disappointing; overestimation of mortality rates has been common 
and none have been subject to formal prospective clinical impact studies. 
Only the Rotterdam (Steyerberg et al., 2006) model is transferrable to 
our data.  
2. Age should be considered a candidate predictor for any prediction model 
and included as a continuous variable, particularly to incorporate the 
effect of more extreme old age. 
3. There is clinical knowledge to support the inclusion of other comorbidity 
predictors such as cardiorespiratory, nutritional and physical capacity 
measures as candidate predictors, but the evidence from this review is 
weak. This was compounded by a variety of inconsistent definitions of 
predictors and small sample size studies. 
4. Several important risks of potential bias were poorly reported or not 
addressed in the primary studies. These included potential selection bias, 
data validity, and missing data. 
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Table 12 Characteristics of studies fulfilling inclusion criteria1 
 Author 
publication date 
Study design; study 
period; sample size (n) 
Perioperative mortality 
definition; mortality rate (%) 
Geographical location, number of 
centres or databases, average 
annual operative volume 
Histology; 
 use of neoadjuvant therapy; 
 surgical procedure 
Prediction 
models 
Bailey (Bailey et al., 
2003) 
Clinical prediction model, 
internal validation 
1991 to 2000 
n= 1777 
30 day 
Mortality 10.0% 
USA 
Population database; 109 centres 
Operative volume  not applicable 
Histology: all malignant (no detail) except 268 benign 
Neoadjuvant na 
Surgical procedure: na 
 Steyerberg 
(Steyerberg et al., 
2006) 
Clinical prediction model, 
external validation 
1991 to 2002 
n= 3592 
30 day 
Mortality 8% 
USA/Netherlands 
Population database and clinical 
centre 
Operative volume  na/yr 
Histology: 2118 (a),  1307 (s),  164 (o) 
Neoadjuvant 878 (neo) 
Surgical procedure: na 
 Ra (Ra et al., 2008) Clinical prediction model, 
internal validation 
1997 to 2003 
n= 1172 
In hospital & 30 day 
Mortality 13.7% 
USA 
Population database 
Operative volume  not applicable 
Histology: na 
Neoadjuvant na 
Surgical procedure: na 
 Tekkis (Tekkis et al., 
2004) 
Clinical prediction model, 
internal validation 
1994 to 2000 
n= 538 
In hospital 
Mortality 8.6% 
UK 
Regional & national clinical 
databases (36 centres) 
Operative volume  77/yr 
Histology: 317 (a),  118 (s),  103 (o) 
Neoadjuvant na 
Surgical procedure: 45 TH,  297 Rt 2-stage ,  106 
thoracoabdominal,  22 3-stage,  68 other 
 Law (Law et al., 
1994) 
Clinical prediction model  
1982 to 1992 
n= 523 
In hospital & 30 day 
Mortality 15.5% 
Hong Kong 
Single centre 
Operative volume  63/yr 
Histology: All (s) 
Neoadjuvant na 
Surgical procedure: 80 TH,  303 LTan,  2 LT,  45 3-phase,  18 
split sternum,  43 E,  32 phary'laryngo'esophagectomy 
                                            
1 (Abbreviations: Histology; (a) adenocarcinoma, (s) squamous carcinoma, (o) other. Operation; TT transthoracic, T thoracotomy, RT right thoracotomy, LT left thoracotomy, lap laparotomy, Abd 
abdominal, TH transhiatal, LTan Lewis-Tanner, M McKeown, LTA left thoracoabdominal, IL Ivor-Lewis, E esophagogastrectomy,  Tscopic  thoracoscopic, CTA cervico-thoracoabdominal) 
 
2. Systematic Review  (Table: Characteristics of included studies) 
65 
 
 Author 
publication date 
Study design; study 
period; sample size (n) 
Perioperative mortality 
definition; mortality rate (%) 
Geographical location, number of 
centres or databases, average 
annual operative volume 
Histology; 
 use of neoadjuvant therapy; 
 surgical procedure 
 Liu (Liu et al., 2000) Clinical pred
2
iction model 
1994 to 1997 
n= 32 
In hospital 
Mortality 13% 
Australia 
Single centre 
Operative volume  25/yr 
Histology: na 
Neoadjuvant na 
Surgical procedure: 2 TH,  29 IL, 1 3-stage  
 Bartels (Bartels et 
al., 1998) 
Clinical prediction model, 
external validation, clinical 
application 
1982 to 1996 
n= 764 
30 day & 90 day 
Mortality 15.2% 
Germany 
Single centre 
Operative volume  56/yr 
Histology: na 
Neoadjuvant na 
Surgical procedure: "transmediastinal" for adeno,  TT for 
squamous,  no quantities 
 Sanz (Sanz et al., 
2006) 
Clinical prediction model 
1987 to 1999 
n= 114 
In hospital 
Mortality 12.3% 
Spain 
Single centre 
Operative volume  9/yr 
Histology: 39 (a),  73 "epidermoid",  2 (o) 
Neoadjuvant na 
Surgical procedure: 13 TH,  101 TT  
 McCulloch P 
(McCulloch et al., 
2003) 
Predictor effect study 
1999 to 2002 
n= 365 
In hospital 
Mortality 12% 
UK 
Subset of ASCOT National 
database(multiple centres 
reporting gastric and oesophageal 
surgery) 
Operative volume  Centres 
allocated to one of 3 categories of 
volume 
Histology: na 
Neoadjuvant 26% 
Surgical procedure: IL 67.1%, LTA 6.8%, TT 10.4%, M(3 stage) 
7.9%, other 7.7% 
 Zhang (Zhang et al., 
1994) 
Clinical prediction model, 
external validation, clinical 
application 
1986 to 1989 
n= 100 
45 day 
Mortality 13% 
Japan 
Single centre 
Operative volume  37/yr 
Histology: na 
Neoadjuvant na 
Surgical procedure: All Lap & RT (assumed) 
                                            
2 (Abbreviations: Histology; (a) adenocarcinoma, (s) squamous carcinoma, (o) other. Operation; TT transthoracic, T thoracotomy, RT right thoracotomy, LT left thoracotomy, lap laparotomy, Abd 
abdominal, TH transhiatal, LTan Lewis-Tanner, M McKeown, LTA left thoracoabdominal, IL Ivor-Lewis, E esophagogastrectomy,  Tscopic  thoracoscopic, CTA cervico-thoracoabdominal) 
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 Author 
publication date 
Study design; study 
period; sample size (n) 
Perioperative mortality 
definition; mortality rate (%) 
Geographical location, number of 
centres or databases, average 
annual operative volume 
Histology; 
 use of neoadjuvant therapy; 
 surgical procedure 
Validation 
studies 
Schroder (Schroder 
et al., 2006) 
Predictor effect study, 
external validation 
1997 to 2002 
n= 126 
In hospital 
Mortality 5.6% 
Germany 
Single centre 
Operative volume  21/yr 
Histology: 68 (a),  54(s),  4(o) 
Neoadjuvant 46 chemotherapy 
Surgical procedure: 126 IL  
 Lai (Lai et al., 2007) External validation, 
comparison 
2001 to 2005 
n= 545 
In hospital 
Mortality 5.5% 
Hong Kong 
Administrative database (14 
centres) 
Operative volume  na/yr 
Histology: All (s) 
Neoadjuvant na 
Surgical procedure: "thoracic" 
 Nagabhushan 
(Nagabhushan et 
al., 2007) 
External validation, 
comparison 
 1990 to 2002 
n= 110 
30 day 
Mortality 10.2 
UK 
Single centre 
Operative volume  9/yr 
Histology: 80 (a),  29 (s),  1 (o) 
Neoadjuvant na 
Surgical procedure: 27 TH,  55 IL,  28 other  
 Lagarde (Lagarde et 
al., 2007) 
External validation 
 1993 to 2005 
n= 663 
In hospital 
Mortality 3.6% 
Netherlands 
Single centre 
Operative volume  52/yr 
Histology: 476 (a),  187 (s) 
Neoadjuvant 114 (neo) 
Surgical procedure: 424 TH,  239 TT  
 Zafirellis (Zafirellis 
et al., 2002) 
External validation 
1990 to 1999 
n=
3
 204 
30 day 
Mortality 12.8% 
UK 
Single centre 
Operative volume  21/yr 
Histology: 156 (a),  45 (s),  3 (o) 
Neoadjuvant 39 (neo) 
Surgical procedure: 9 TH,  158 IL,  7 M,  22 Tscopic,  8 LTA  
 Zingg (Zingg et al., 
2009) 
External validation, 
comparison 
1990 to 2007 
n= 346 
In hospital & 30 day 
Mortality Australia 8.0%, 
Switzerland 4.7% 
Australia/Netherlands/Switzerland 
Two centre 
Operative volume  Australia 
(unclear); Zurich 9.4/yr 
Histology: Aus 76%(a), 16%(s), Switz 73%(a), 42%(s) 
Neoadjuvant Aus (54.5%), Switz 25.9% 
Surgical procedure: All TT  
                                            
3 (Abbreviations: Histology; (a) adenocarcinoma, (s) squamous carcinoma, (o) other. Operation; TT transthoracic, T thoracotomy, RT right thoracotomy, LT left thoracotomy, lap laparotomy, Abd 
abdominal, TH transhiatal, LTan Lewis-Tanner, M McKeown, LTA left thoracoabdominal, IL Ivor-Lewis, E esophagogastrectomy,  Tscopic  thoracoscopic, CTA cervico-thoracoabdominal) 
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 Author 
publication date 
Study design; study 
period; sample size (n) 
Perioperative mortality 
definition; mortality rate (%) 
Geographical location, number of 
centres or databases, average 
annual operative volume 
Histology; 
 use of neoadjuvant therapy; 
 surgical procedure 
Candidate 
predictor 
effect 
studies 
Han-Geurts (Han-
Geurts et al., 2006) 
Predictor effect study  
1996 to 2003 
n= 400 
In hospital 
Mortality 5.5% 
Netherlands 
Single centre 
Operative volume  50/yr 
Histology: 277 (a),  118(s),  59(o) 
Neoadjuvant 174 
Surgical procedure: TH for distal tumour, TT and Abd for 
proximal,  no quantities 
 Sabel (Sabel et al., 
2002) 
Pr
4
edictor effect study 
1991 to 1998 
n= 117 
30 day 
Mortality 2.6% 
USA 
Two 
Operative volume  15/yr 
Histology: 93 (a),  24 (s) 
Neoadjuvant 104 (adj)  (34 neoadjuvant) 
Surgical procedure: 3 TH,  98 IL  
 Tsai (Tsai et al., 
2003) 
Predictor effect study 
1985 to 2000 
n= 785 
30 day 
Mortality 5.2% (30 day) 
Taiwan 
Single centre 
Operative volume  49/yr 
Histology: All (s) 
Neoadjuvant none 
Surgical procedure: RT ("in most") 
 Rahamim 
(Rahamim et al., 
2003) 
Predictor effect study 
1979 to 1999 
n= 596 
30 day 
Mortality 8.2% 
UK 
Single centre 
Operative volume  30/yr 
Histology: 378 (a),  185 (s),  33 (o) 
Neoadjuvant 71 (adj), 19 (neo) 
Surgical procedure: 1 TH,  518 IL,  54 LTA,  23 M  
 Moskovitz 
(Moskovitz et al., 
2006) 
Predictor effect study 
1996 to 2005 
n= 751 
In hospital & 60 day 
Mortality %  5.8 
USA 
Single centre 
Operative volume  91/yr 
Histology: na 
Neoadjuvant na 
Surgical procedure: 569 T,  201 Abdo 
 Finlayson (Finlayson 
et al., 2007) 
Predictor effect study 
1994 to 2003 
n= 27957 
In hospital 
Mortality 12.5% 
USA 
Population database  
Operative volume  not applicable 
Histology: na 
Neoadjuvant na 
Surgical procedure: na 
 Law (Law et al., 
2004) 
Predictor effect study 
1990 to 2001 
n= 421 
In hospital & 30 day 
Mortality 4.8% 
Hong Kong 
Single centre 
Operative volume  35/yr 
Histology: All (s) 
Neoadjuvant 143 (includes chemoradiation) 
Surgical procedure: 219 LT, 86 3 phase,  44 E, 39 TH, 25 
Tscopic,  5 split sternum, 3 staged 
 Fang (Fang et al., 
2001) 
Predictor effect study 
1986 to 1998 
n= 441 
In hospital & 30 day 
Mortality 4.1% 
Japan 
Single centre 
Operative volume  34/yr 
Histology:  about 90% (s),  about 7% (o) 
Neoadjuvant 27 
Surgical procedure: All CTA 
                                            
4 (Abbreviations: Histology; (a) adenocarcinoma, (s) squamous carcinoma, (o) other. Operation; TT transthoracic, T thoracotomy, RT right thoracotomy, LT left thoracotomy, lap laparotomy, Abd 
abdominal, TH transhiatal, LTan Lewis-Tanner, M McKeown, LTA left thoracoabdominal, IL Ivor-Lewis, E esophagogastrectomy,  Tscopic  thoracoscopic, CTA cervico-thoracoabdominal) 
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 Author 
publication date 
Study design; study 
period; sample size (n) 
Perioperative mortality 
definition; mortality rate (%) 
Geographical location, number of 
centres or databases, average 
annual operative volume 
Histology; 
 use of neoadjuvant therapy; 
 surgical procedure 
 Alexiou (Alexiou et 
al., 1998) 
Predictor effect study 
1987 to 1997 
n= 166 
In hospital & 30 day 
Mortality 6.0% 
UK 
Single centre 
Operative volume  18/yr 
Histology: All (s) 
Neoadjuvant None 
Surgical procedure: 9 TH,  101 IL,  45 LT 
 Kinugasa (Kinugasa 
et al., 2001) 
Pred
5
ictor effect study 
1981 to 1999 
n= 204 
60 day 
Mortality 6.9% 
Japan 
Single centre 
Operative volume  11/yr 
Histology: na 
Neoadjuvant 154 (neo) 
Surgical procedure: 204 tot,  193 R TT ,  8 L TT,  3 blunt 
esophagectomy  
 Ferguson (Ferguson 
et al., 1997) 
Predictor effect study 
1980 to 1995 
n= 269 
In hospital & 30 day 
Mortality 13% 
USA 
Single centre 
Operative volume  17/yr 
Histology: na 
Neoadjuvant na 
Surgical procedure: 54 TH,  110 LT, 81 Lap & RT,  24 other 
 Rentz (Rentz et al., 
2003) 
Predictor effect study 
1991 to 2000 
n= 945 
30 day 
Mortality 10% 
USA 
Population database; 109 centres 
Operative volume  95/yr 
Histology: na 
Neoadjuvant na 
Surgical procedure: 383 TH,  562 TT  
 Ruol(a) (Ruol et al., 
2007(b)) 
Predictor effect study 
1992 to 2005 
n= 269 
In hospital & 30 day 
Mortality 2.2% 
Italy 
Single centre 
Operative volume  59/yr 
Histology: 22% (a),  78% (s) 
Neoadjuvant 182 chemo- & radio-, 83 chemo-, 4 
radiotherapy 
Surgical procedure: McKeown 97, IL 126, Lap+L cervicotomy 
46) ,  IL for mid/lower , McKeown for upper,  no quantities  
 Alexiou (Alexiou et 
al., 2005) 
Predictor effect study 
1987 to 1997 
n= 523 
In hospital & 30 day 
Mortality 5.3% 
UK 
Single centre 
Operative volume  60/yr 
Histology: 339(a),  166 (s),  18 (o) 
Neoadjuvant na 
Surgical procedure: 28TH, 146IL,  276LT,  71 
Lthoracolaparotomy,  2 Mckeown  
 Adam (Adam et al., 
1996) 
Predictor effect study 
1982 to 1992 
n= 597 
30 day 
Mortality 6.9% 
UK 
Single centre 
Operative volume  60/yr 
Histology: 370 (a),  216(s),  11(o) 
Neoadjuvant na 
Surgical procedure: 13 TH,  584 TT (573 Lap & LT)  
                                            
5 (Abbreviations: Histology; (a) adenocarcinoma, (s) squamous carcinoma, (o) other. Operation; TT transthoracic, T thoracotomy, RT right thoracotomy, LT left thoracotomy, lap laparotomy, Abd 
abdominal, TH transhiatal, LTan Lewis-Tanner, M McKeown, LTA left thoracoabdominal, IL Ivor-Lewis, E esophagogastrectomy,  Tscopic  thoracoscopic, CTA cervico-thoracoabdominal) 
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 Author 
publication date 
Study design; study 
period; sample size (n) 
Perioperative mortality 
definition; mortality rate (%) 
Geographical location, number of 
centres or databases, average 
annual operative volume 
Histology; 
 use of neoadjuvant therapy; 
 surgical procedure 
 Sauvanet (Sauvanet 
et al., 2005) 
Predictor effect study 
1985 to 2000 
n= 1192 
In hospital 
Mortality 6.4% 
France 
37 centres 
Operative volume  not available 
Histology: All (a) 
Neoadjuvant 132 chemoradiation,  31 chemo,  3 
radiotherapy 
Surgical procedure: 772 TT (636 Lap & RT, 128 Lap & LT, 8 
Lap & TT & cervicot),  420 Lap(some TH)   
 Kuwano (Kuwano et 
al., 1998) 
Predictor effect study 
1
6
989 to 1993 
n= 178 
In hospital & 30 day 
Mortality 3.4% 
Japan 
Single centre 
Operative volume  36/yr 
Histology: na 
Neoadjuvant na 
Surgical procedure: 173 Lap & RT,  5 non T 
 Griffin (Griffin et 
al., 2002) 
Predictor effect study 
1990 to 2000 
n= 228 
In hospital & 30 day 
Mortality 4.0% 
UK 
Single centre 
Operative volume  23/yr 
Histology: 146 (a),  75 (s),  7 (o) 
Neoadjuvant na 
Surgical procedure: 228 IL  
 Abunasra 
(Abunasra et al., 
2005) 
Predictor effect study 
1990 to 2003 
n= 652 
In hospital & 30 day 
Mortality 5.6% (30 day) 
UK 
Single centre 
Operative volume  58/yr 
Histology: 523(a),  238 (s),  37 (o) 
Neoadjuvant None 
Surgical procedure: 17 TH,  202 IL,  412 LT,  135 Lap & LT,  7 
M 
 Ruol(b) (Ruol et al., 
2007(b)) 
Predictor effect study 
1992 to 2005 
n= 739 
In hospital & 30 day 
Mortality 2.6% 
Italy 
Single centre 
Operative volume  57/yr 
Histology:  449(s), 260(a), 30(o) 
Neoadjuvant na 
Surgical procedure: 487 IL,  103 Lap & cervicotomy,   149 M 
 Jougon (Jougon et 
al., 1997) 
Predictor effect study 
1980 to 1993 
n= 540 
In hospital 
Mortality 5.7% 
France 
Single centre 
Operative volume  39/yr 
Histology: 214 (a),  307 (s),  19 (o) 
Neoadjuvant 47 (neo) 
Surgical procedure: 5 TH,  181 IL,  216 Lap & LT, 131 Lap & RT 
& cervicot,  7 other  
 Thomas (Thomas et 
al., 1996) 
Predictor effect study 
1979 to 1994 
n= 386 
In hospital & 30 day 
Mortality 11.1% 
France 
Single centre 
Operative volume  34/yr 
Histology: 132 (a),  254 (s),  51 (o)  
Neoadjuvant 51 chemotherapy   
Surgical procedure: 153 Lap & RT & cervicot,  82 Lap & RT,  
125 Lap & cervicot,  26 LT,   
                                            
6 (Abbreviations: Histology; (a) adenocarcinoma, (s) squamous carcinoma, (o) other. Operation; TT transthoracic, T thoracotomy, RT right thoracotomy, LT left thoracotomy, lap laparotomy, Abd 
abdominal, TH transhiatal, LTan Lewis-Tanner, M McKeown, LTA left thoracoabdominal, IL Ivor-Lewis, E esophagogastrectomy,  Tscopic  thoracoscopic, CTA cervico-thoracoabdominal) 
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 Author 
publication date 
Study design; study 
period; sample size (n) 
Perioperative mortality 
definition; mortality rate (%) 
Geographical location, number of 
centres or databases, average 
annual operative volume 
Histology; 
 use of neoadjuvant therapy; 
 surgical procedure 
 Ellis Jr (Ellis Jr et al., 
1998) 
Pre
7
dictor effect study 
1970 to 1997 
n= 505 
In hospital & 30 day 
Mortality 3.0% 
USA 
Two centres 
Operative volume  19/yr 
Histology: 335 (a),  155 (s),  15 (o) 
Neoadjuvant 46 (neo) 
Surgical procedure: 103 TH,  147 IL,  169 LT, TA 11,  25 other, 
(some unresected) 
 Poon (Poon et al., 
1998) 
Predictor effect study 
1982 to 1996 
n= 737 
In hospital & 30 day 
Mortality 10.6% 
Hong Kong 
Single centre 
Operative volume  50/yr 
Histology: 22 (a),  668 (s),  47 (o) 
Neoadjuvant na 
Surgical procedure: 113 TH,  608 TT,  16 Tscopic  
 Atkins (Atkins et al., 
2004) 
Predictor effect study 
1996 to 200 
n= 379 
 30 day 
Mortality %  5.80474934 
USA 
Single centre 
Operative volume  54/yr 
Histology: 228 (a),  70 (s),  17 (o) 
Neoadjuvant na 
Surgical procedure: 130 TH,  179 IL,  70 other(inc 35 LT) 
 Forshaw (Forshaw 
et al., 2008) 
Predictor effect study 
2004 to 2006 
n= 78 
In hospital (not explicit) 
Mortality 1.3% 
UK 
Single centre 
Operative volume  28/yr 
Histology: 58 (a),  13 (s),  7 (o) 
Neoadjuvant 50 (neo) 
Surgical procedure: 39 TH,  29 2-stage (23 lap assisted) ,  5 3-
stage,  5 LTA 
 Gockel (Gockel et 
al., 2005) 
Predictor effect study 
1985 to 2004 
n= 424 
In hospital ("mortality rate") 
& 30 day  
Mortality 11.5% 
Germany 
Single centre 
Operative volume  23/yr 
Histology: 152 (a),  234 (s),  38 (o) 
Neoadjuvant na 
Surgical procedure: 186 TH,  231 Lap & TT ,  7 free jej graft 
 Murray (Murray et 
al., 2007) 
Predictor effect study 
2002 to 2005 
n= 51 
30 day 
Mortality 9.8% 
UK 
Single centre 
Operative volume  31/yr 
Histology: na 
Neoadjuvant na 
Surgical procedure: na 
 Saito (Saito et al., 
1993) 
Predictor effect study, 
external validation 
1983 to 1991 
n= 99 
In hospital & 30 day 
Mortality 13.3% (10/32 first 
period, 3/67 second period) 
Japan 
Single centre 
Operative volume  11/yr 
Histology: na 
Neoadjuvant na 
Surgical procedure: All TT  
                                            
7 (Abbreviations: Histology; (a) adenocarcinoma, (s) squamous carcinoma, (o) other. Operation; TT transthoracic, T thoracotomy, RT right thoracotomy, LT left thoracotomy, lap laparotomy, Abd 
abdominal, TH transhiatal, LTan Lewis-Tanner, M McKeown, LTA left thoracoabdominal, IL Ivor-Lewis, E esophagogastrectomy,  Tscopic  thoracoscopic, CTA cervico-thoracoabdominal) 
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 Author 
publication date 
Study design; study 
period; sample size (n) 
Perioperative mortality 
definition; mortality rate (%) 
Geographical location, number of 
centres or databases, average 
annual operative volume 
Histology; 
 use of neoadjuvant therapy; 
 surgical procedure 
 Whooley (Whooley 
et al., 2001) 
Predictor effect study 
19
8
82 to 1998 
n= 710 
In hospital & 30 day 
Mortality 11% 
Hong Kong 
Single centre 
Operative volume  42/yr 
Histology: All (s) 
Neoadjuvant na 
Surgical procedure: 119 TH,  414 LT, 93 3-phase,  63 E,  21 
split sternum  
 Johansson 
(Johansson and 
Walther, 2000) 
Predictor effect study 
1984 to 1996 
n= 139 
In hospital & 30 day 
Mortality 1.4% 
Sweden 
Single centre 
Operative volume  13/yr 
Histology: 57 (a),  60 (s),  22 (o) 
Neoadjuvant 6 (neo) 
Surgical procedure: All Lap & RT (+/_ cervicot)  
 Healy (Healy et al., 
2008) 
Predictor effect study 
1999 to 2005 
n= 169 
In hospital 
Mortality 4.3% 
Ireland 
Single centre 
Operative volume  29/yr 
Histology: 118 (a),  52 (s),  6 (o) 
Neoadjuvant 48% (neo) 
Surgical procedure: 3 TH,  111 Lap & RT,  41 3-stage,  9 E,  5 
total gastrectomy 
 Leigh (Leigh et al., 
2006) 
Predictor effect study 
2001 to 2004 
n= 93 
30 day & 90 day 
Mortality 8.3% 
UK 
Population database 
Operative volume  not applicable 
Histology: na 
Neoadjuvant na 
Surgical procedure: na 
 Alibhakshi 
(Alibakhshi et al., 
2009) 
Predictor effect study 
2000 to 2006 
n= 480 
In hospital 
Mortality 2.9% 
Iran 
Single centre 
Operative volume  77/yr 
Histology: 29(a), 451(s) 
Neoadjuvant excluded from study 
Surgical procedure: TH (lower third) 286,  IL or M 194(mid or 
upper) 
 Braiteh (Braiteh et 
al., 2009) 
Predictor effect study 
1999 to 2005 
n= 621 
30 day & in hospital 
Mortality 3.4% 
USA 
Single centre 
Operative volume  62/yr 
Histology: 539(a), 61(s) 
Neoadjuvant 400 (chemo, 8 chemo, 1 rad) 
Surgical procedure: RT & unknown other 
 Park (Braiteh et al., 
2009) 
Predictor effect study 
1995 to 2007 
n= 7277 
In hospital 
Mortality 11% 
UK 
ICNARC database 
Operative volume  not applicable 
Histology: na 
Neoadjuvant na 
Surgical procedure: na 
                                            
8 (Abbreviations: Histology; (a) adenocarcinoma, (s) squamous carcinoma, (o) other. Operation; TT transthoracic, T thoracotomy, RT right thoracotomy, LT left thoracotomy, lap laparotomy, Abd 
abdominal, TH transhiatal, LTan Lewis-Tanner, M McKeown, LTA left thoracoabdominal, IL Ivor-Lewis, E esophagogastrectomy,  Tscopic  thoracoscopic, CTA cervico-thoracoabdominal) 
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 Author 
publication date 
Study design; study 
period; sample size (n) 
Perioperative mortality 
definition; mortality rate (%) 
Geographical location, number of 
centres or databases, average 
annual operative volume 
Histology; 
 use of neoadjuvant therapy; 
 surgical procedure 
 Tagagawa 
(Takagawa et al., 
2008) 
Predictor effect study 
1994 to 2004 
n= 222 
In hospital 
Mortality 4% 
Japan 
Single centre 
Operative volume  42/yr 
Histology: 200(s), 22(o) 
Neoadjuvant 190 
Surgical procedure: RT 198,  TH 24 
 Takeno (Takeno et 
al., 2008) 
Predic
9
tor effect study 
1990 to 2001 
n= 70 
In hospital (unclear 
definition) 
Mortality 6% 
Japan 
Single centre 
Operative volume  17/yr 
Histology: All (s) 
Neoadjuvant na 
Surgical procedure: TT 51, other 19 
 
                                            
9 (Abbreviations: Histology; (a) adenocarcinoma, (s) squamous carcinoma, (o) other. Operation; TT transthoracic, T thoracotomy, RT right thoracotomy, LT left thoracotomy, lap laparotomy, Abd 
abdominal, TH transhiatal, LTan Lewis-Tanner, M McKeown, LTA left thoracoabdominal, IL Ivor-Lewis, E esophagogastrectomy,  Tscopic  thoracoscopic, CTA cervico-thoracoabdominal) 
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Table 13 Excluded studies and reasons for exclusion 
Study Reason for exclusion of study 
from review 
Jiao(Jiao et al., 2006), Bonavina(Bonavina et al., 2003), 
Morgan(Morgan et al., 2007), Alexiou(Alexiou et al., 2006), Di 
Martino(Di Martino et al., 2005) 
Period of follow up for mortality 
undefined 
Lund(Lund et al., 1990), Gulliford(Gulliford et al., 1993), 
Liedman(Liedman et al., 1995), Charoenpan(Charoenpan et 
al., 1993) 
Data collection before 1990 
Mokart(Mokart et al., 2005) Outcome “sepsis” 
Ferguson(Ferguson et al., 1997) Outcome “respiratory complications” 
Nozoe(Nozoe et al., 2002), Karl(Karl et al., 2000), 
Blazeby(Blazeby et al., 2005a) 
Predictor variable and mortality 
relationship unstated 
Chamogeorgakis(Chamogeorgakis et al., 2007) Outcome in thoracic surgery for various 
conditions 
Cariati(Cariati et al., 2002), Golubovi(Golubovi and Golubovi, 
2002) 
Low surgical volume centres (average 
annual caseload 3 & 2.9) 
Bartels(Bartels et al., 2000) 
 
Report of previous study with an extra 
71 patients 
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Table 14 Studies of clinical prediction models 
Author Study design Modelling method Validation methods Performance Comments 
Bailey (Bailey et al., 
2003) 
Clinical prediction 
model 
Multivariate logistic regression Calibration & discrimination in 
modelling sample 
C-index 0.69, Hosmer-
Lemeshow 3.01 (p=0.93)  
Predictors of 30 day 
mortality included age, 
diabetes, functional status, 
neoadjuvant, BUN, alcohol 
intake, ascites, alkaline 
phosphatase 
Ra (Ra et al., 2008) Clinical prediction 
model; internal 
validation 
Logistic regression;generation 
of risk score from  SEER 
data
10
base 
Comparison of predicted and 
observed mortality in 
modelling sample 
Predicted & observed mortality 
reasonably matched in 
modelling sample but over 
predicted by about a quarter in 
high risk group 
Predictors of mortality: age 
over 80, Charlson score 
(Charlson et al., 1987), 
hospital surgical volume. 
Uncontrolled study of 
clinical application reduced 
mortality from 7% to 3%. 
                                            
10 Key: BUN, blood urea nitrogen; SEER, Surveillance Epidemiology and End Results National Cancer Institute (2012) Surveillance Epidemiology and End Results. Available 
at: http://seer.cancer.gov/.; ROC, receiver operator curve; AUC, area under curve; HL, Hosmer Lemeshow 
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Author Study design Modelling method Validation methods Performance Comments 
Steyerberg 
“Rotterdam” 
(Steyerberg et al., 
2006) 
Clinical prediction 
model; external 
validation 
Logistic regression model 
developed on Medicare-SEER 
database; validated on later 
SEER sample, Eindhoven 
Canc
11
er Registry & Rotterdam 
clinical database 
Calibration and discrimination 
on modelling and validation 
samples 
ROC: AUC for modelling cohort 
0.66 (0.65 on internal 
validation); AUC range 0.56-0.7 
in external validation cohorts. 
Calibration stated to be good 
for combined data (results not 
given) 
  
                                            
11 Key: BUN, blood urea nitrogen; SEER, Surveillance Epidemiology and End Results ibid.; ROC, receiver operator curve; AUC, area under curve; HL, Hosmer Lemeshow 
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Author Study design Modelling method Validation methods Performance Comments 
Bartels “Munich” 
(Bartels et al., 1998) 
Clinical prediction 
model with 
validation and 
clinical application 
study on prospective 
samples from same 
centre 
Correlation of preoperative 
predictors (and levels of 
abnormality) with composite 
out
12
come ('normal', 
'prolonged', 'severe', 'fatal') 
between 1982 & 1991 (n=432). 
Discriminant analysis modelled 
3 levels  of organ 
dysfunction('normal', 
'compromised', 'severely 
impaired') with postoperative 
mortality. Validated on 121 
patients (1992-1993). Clinical 
application 1994-1996.   
Descriptive comparison of 
predicted and observed 
mortality in same centre 
prospective sample. 
3 risk groups for 30 day 
mortality in modelling sample: 
3.6%, 8.7% and 28%. In 
prospective validation sample 
mortality was 2%, 5%, & 25%, 
and 5 of 9 deaths predicted as 
"high" risk. 
30 day mortality in 
modelling sample predicted 
by Karnofsky index 
(Karnofsky, 1984), mental 
"cooperation", spirometry & 
arterial pO2, aminopyrine 
breath test, cirrhosis, 
cardiac risk. 
                                            
12 Key: BUN, blood urea nitrogen; SEER, Surveillance Epidemiology and End Results ibid.; ROC, receiver operator curve; AUC, area under curve; HL, Hosmer Lemeshow 
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Author Study design Modelling method Validation methods Performance Comments 
Law (Law et al., 
1994) 
Clinical prediction 
model 
Discriminant analysis identified 
risk factors; three level risk 
stratification based on sum of 
equ
13
ally weighted risk factors 
Sensitivity and specificity in 
modelling data 
Sensitivity 72%, specificity 74%, 
overall accuracy 74% on 
modelling data.  
Predictors of hospital 
mortality: age, mid-arm 
circumference, operative 
blood loss, spirometry, 
abnormal chest xray, 
curative vs palliative 
resection. Risk scored 
groups with 7%, 30%, 38% 
mortality.  
                                            
13 Key: BUN, blood urea nitrogen; SEER, Surveillance Epidemiology and End Results ibid.; ROC, receiver operator curve; AUC, area under curve; HL, Hosmer Lemeshow 
 
2. Systematic Review  (Table: studies of clinical prediction models) 
78 
 
Author Study design Modelling method Validation methods Performance Comments 
Liu (Liu et al., 2000) Clinical
14
 prediction 
model 
Multiple regression; composite 
score stratified 3 levels of risk 
(mortality 50%, 27% & 8%) 
No formal validation 
procedure 
  Multivariate regression: 
hypertension, smoking, 
spirometry predicted 
postoperative outcomes. 
Composite score of levels of 
predictor abnormality 
stratified mortality risk 
groups of 50%, 27% & 8% in 
modelling sample. 
McCulloch 
(McCulloch et al., 
2003) 
Clinical prediction 
model an validation 
on prospective 
sample from same 
data set 
Multivariate logistic regression Calibration (HL) & 
discrimination(ROC) on 
prospective sample of dataset 
Modelling sample: C-index 
0.79(0.03), Hosmer-Lemeshow 
7.33 (p=0.5), O:E ratio 1.04 
Validation sample: C-index 
0.68(0.08), Hosmer-Lemeshow 
7.39 (p=0.49), O:E ratio 0.82 
For mixed oesophagogastric 
case-mix physiological 
POSSUM,surgeon's 
assessment, tumour stage, 
operation were predictors 
of outcome.  
                                            
14 Key: BUN, blood urea nitrogen; SEER, Surveillance Epidemiology and End Results ibid.; ROC, receiver operator curve; AUC, area under curve; HL, Hosmer Lemeshow 
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Author Study design Modelling method Validation methods Performance Comments 
Sanz (Sanz et al., 
2006) 
Clinical prediction 
model 
Discriminant analysis to 
generate 3 level risk score: 
'low' (6.8% mortality), 
'intermediate' (12.5% 
mortality), 'high' (50% 
mor
15
tality) 
No validation procedures na Mortality associated with: 
Previous cancer, cirrhosis, 
abnormal spirometry, 
cholesterol, albumen. 
Composite risk score 
generated from these 
weighted variables. 
Discriminant analysis 
created three risk levels 
mortality rate 6.8%, 12.5% 
& 50% in modelling sample. 
Zhang (Zhang et al., 
1994) 
Clinical prediction 
model, external 
validation and 
clinical application 
Logistic regression to develop 
composite risk score. Validated 
prospectively on same centre 
sample. 
Sensitivity and specificity on 
modelling and validation 
samples 
Modelling sample: sensitivity 
0.75, specificity 0.99. 
Validation sample: sensitivity 
0.33, specificity 0.98.  
Mortality predicted by oral 
glucose tolerance test, 
tumour stage, age, 
abnormal ECG, creatinine 
clearance, operation type.  
                                            
15 Key: BUN, blood urea nitrogen; SEER, Surveillance Epidemiology and End Results ibid.; ROC, receiver operator curve; AUC, area under curve; HL, Hosmer Lemeshow 
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Author Study design Modelling method Validation methods Performance Comments 
Tekkis (Tekkis et al., 
2004) 
Clinical prediction 
mod
16
el; internal 
validation & 
comparison with P-
POSSUM 
Univariate & multiple  Bayesian 
logistic regression(include 
inter-hospital variation) 
Calibration (HL); 
discrimination(ROC) on 
random sample (30%) of 
modelling data 
C-index(95% CI): P-POSSUM 
74.3(69.4, 79.2), single level O-
POSSUM 74.6(69.9, 79.3); 
multilevel O-POSSUM 
79.7(75.6, 83.8). Hosmer-
Lemeshow P-POSSUM 28.8 
(p=0.001), single level O-
POSSUM 10.52 (p=0.23), 
multilevel O-POSSUM 10.15 
(p=0.254). 
Physiological POSSUM, age, 
urgency , POSSUM surgical 
stage predicted in-hospital 
mortality.  
Schroder (Schroder 
et al., 2006) 
External validation of 
Bartels model 
na Estimation of mortality in risk 
groups defined by Bartels 
model; no statistical testing 
Observed mortality 2.9% in 
predicted "low" , 3.0% in 
"moderate", 16.7% in "high" 
risk groups 
Multivariate regression of 
variables used by Bartels 
identified age, general 
status and pulmonary 
function associated with 
composite outcome in 
Schroder's sample.  
                                            
16 Key: BUN, blood urea nitrogen; SEER, Surveillance Epidemiology and End Results ibid.; ROC, receiver operator curve; AUC, area under curve; HL, Hosmer Lemeshow 
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Author Study design Modelling method Validation methods Performance Comments 
Lai (Lai et al., 2007) External validation & 
comparison of 
POSSUM, O-
POSSUM
17
, P-
POSSUM 
na Calibration (Chi-square); 
discrimination (ROC)  
Calibration (Chi-square, for lack 
of fit): P-POSSUM (p=0.814), 
POSSUM(p<0.001), & O-
POSSUM(p<0.002). POSSUM & 
O-POSSUM over predicted 
mortality by factor of 2.7 and 
2.0 respectively. 
Discrimination(AUC, 95% CI): 
POSSUM 0.776 (0.689, 0.862), 
P-POSSUM 0.776(0.692, 0.861), 
O-POSSUM 0.676(0.586, 
0.766). 
  
                                            
17 Key: BUN, blood urea nitrogen; SEER, Surveillance Epidemiology and End Results ibid.; ROC, receiver operator curve; AUC, area under curve; HL, Hosmer Lemeshow 
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Author Study design Modelling method Validation methods Performance Comments 
Nagabhushan 
(Nagabhushan et al., 
2007) 
External validation & 
comparison of O- 
and P-POSSUM  
na Calibration; discrimination Calibration(HL): O-POSSUM 
(p=0.011), P-POSSUM (p= 
0.019). Observed/expected 
mortality ratio 0.89 for P-
POSSUM, 0.65 O-POSSUM. 
Mortality overstimated by a 
factor of 2 to 3 in higher risk 
group. Discrimination(AUC): P-
POSSUM 0.68(0.59-0.76); and 
O-POSSUM 0.61(0.5-0.72) 
  
Lagarde (Lagarde et 
al., 2007) 
External v
18
alidation 
of O-POSSUM model 
na Calibration, discrimination, 
observed/predicted mortality 
Observed/predicted mortality 
ratio 0.29; Hosmer-Lemeshow, 
p<0.001. Discrimination: (AUC, 
95% CI):  0.6 (0.47-0.72). 
  
                                            
18 Key: BUN, blood urea nitrogen; SEER, Surveillance Epidemiology and End Results ibid.; ROC, receiver operator curve; AUC, area under curve; HL, Hosmer Lemeshow 
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Author Study design Modelling method Validation methods Performance Comments 
Zafirellis (Zafirellis et 
al., 2002) 
External validation of 
POSSUM 
na Calibration, discrimination, 
observed/predicted mortality 
ROC: AUC 0.62 (0.52-0.71). 
Observed/expected mortality 
ratio 0.66(95% CI 0.43-0.97). 
Hosmer-Lemeshow statistic: 
p=0.002 
  
Zingg (Zingg et al., 
2009) 
Ext
19
ernal validation 
and comparison of 
Bartels (Munich), 
Steyerberg 
(Rotterdam) and Ra 
(Philadelphia) 
models. 
na Logistic regression of each risk 
model score on hospital 
mortality. Results given are p 
value for regression 
coefficient, Nagelkerke R-
Squared, Hosmer-Lemeshow 
Investigators concluded that 
no model could be applied 
generally 
  
                                            
19 Key: BUN, blood urea nitrogen; SEER, Surveillance Epidemiology and End Results ibid.; ROC, receiver operator curve; AUC, area under curve; HL, Hosmer Lemeshow 
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Chapter 3:  Preparation of a dataset and candidate predictors from the 
Northern Oesophago-Gastric Cancer Unit Clinical Database 
3.1 Introduction 
This chapter focuses on selecting and preparing a set of candidate predictors 
from the Northern Oesophagogastric Unit Database (NOGCU), with which 
to develop a clinical prediction model for perioperative mortality. I will 
describe the history and development of the database and the methods used 
to prepare the data and select the predictors. 
3.1.1 The Northern Oesophagogastric Unit (NOGCU) database 
This clinical database contains records on oesophagogastric cancer patients, 
who have been treated in the unit since 1990. Clinical information was 
recorded onto data entry forms by medical staff from the Unit, and 
transferred to a computerised database. Since 1996 the database has been 
run by a professional database manager, and more recently with the help of 
additional data entry staff. The recorded information includes a variety of 
demographic, pathological, comorbidity, treatment and outcome data. The 
number of data fields has reached as many as 199, however as decisions 
about relevance and redundancy have been made, modifications have been 
made and there are now about 130 fields. The database was initially 
maintained on Paradox software but was then moved to Microsoft Access 
and in 1996 was moved onto a Dendrite Clinical Systems database. 
3.1.2 Selection of predictor variables to consider for the clinical prediction model 
In the systematic review I identified several categories of patient specific 
predictor which should be considered for inclusion in the prediction model. 
These included age, operative procedure, tumour details, and several 
comorbidities (including cardiac, respiratory, nutritional, and exercise and 
activity capacity). I will consider predictors, which map to the categories 
above, have ‘face validity’ or have otherwise been reported to be associated 
with perioperative mortality in other non-cardiac surgery. 
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3.1.3 Managing Potential sources of bias in the NOGCU database 
Potential sources of bias in prognostic and clinical prediction models are 
well recognised (Altman and Lyman, 1998; Hayden et al., 2006). Several of 
these were identified in primary studies included in the systematic review 
and concerned the reporting of case selection, handling of missing data, and 
the use of categorical variables where continuous ones may have been better, 
e.g. for age at surgery. I will explore the extent to which these biases may be 
problematic, or may be addressed in the prediction modelling of NOGCU 
data. 
3.1.4 Ethical considerations and Data protection 
The Northern Oesophago-Gastric Unit database is registered with the 
Newcastle Hospitals Trust and has been considered by the Caldicott 
guardian, as required by the Data Protection Act, 1998. An individual’s 
right to privacy in respect of personal data are enshrined in common law, 
The Human Rights Act 1988, the Health and Social Care Act 2001 and the 
Data Protection Act 1998. The requirements for the use of identifiable 
personal data have been summarised in a Parliamentary Postnote (Cant, 
2005) and the practicalities of applying these requirements to 
epidemiological data have been described (Iverson et al., 2006). For medical 
research, and historical or statistical data, ”the fair processing requirement” 
may be relaxed provided that “the data are not used to take any decision 
relevant to that particular individual, that subsequent publication does not 
lead to identification of the subject, and that it is unlikely to cause 
substantial damage or distress”(Commissioner, 2002). 
3.1.5 Aim and objectives 
I aim to prepare a set of predictors from the NOGCU database to include in 
a clinical prediction model of perioperative mortality after oesophagectomy. 
3.2 Objectives 
1. To ensure ethical and data protection requirements for this project are 
met. 
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2. To select and clean a set of candidate predictor variables from the main 
NOGCU database, for potential inclusion in a clinical prediction model of 
perioperative mortality after oesophagectomy for cancer. 
3. To recognise and, if possible, address the main risks of bias within the 
data including: 
a. Selection bias 
b. Information bias. 
c. The frequency and patterns of missing values.
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3.3 Methods 
3.3.1 Ethics, data protection and confidentiality 
In November 2005, the local Research & Development Department advised 
that this study did not require full Ethical Committee consideration, as the 
project data would be anonymised. Since 2005, the Ethical Approval process 
was modified, so the study was resubmitted (December 2008), firstly for 
consideration by the local Research and Development department, and 
secondly, as recommended, to the National Research Ethics Service. They 
recommended that formal consideration by the local Ethics Committee was 
not required, as the project should be considered as “service evaluation and 
development” (Appendix D. ).The data was used with the full cooperation 
and knowledge of Professor S M Griffin (professor of surgery in the 
Northern Oesophagogastric Unit). 
3.3.2 Data storage 
The subset of data for analysis from the NOGCU clinical database was 
saved as a Microsoft Office Excel (97-2003) spreadsheet. Patient names, 
addresses and medical record numbers were removed from the records, 
however, an NOCGU database ‘key’ was retained. All data was 
subsequently stored or transported in this form, on removable data storage 
devices. All copies of the project data were encrypted with Truecrypt v4.3a 
(www.truecrypt.org). The encrypted files and their backups were password 
protected with randomly generated 64 digit passwords, which were in turn 
stored on separate password protected storage devices. 
3.3.3 General data management 
1. Each record was allocated a unique identifier for the study. The database 
key and the medical record number were removed to maintain 
confidentiality. 
2. The data was ‘cleaned’ using Microsoft Office Excel (97-2003) functions 
and custom code (Appendix F. ). Whenever a field variable was moved for 
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analysis, integrity was maintained by checking alignment with the 
corresponding record identifier and ‘date of birth field’. 
3. Reports summarising fields and records from the original NOGCU 
dataset were generated. 
4. Variables, which mapped to the following main categories, were selected 
for further examination and study: age, gender, tumour characteristics, 
surgical procedure, cardiorespiratory morbidity, other comorbidities 
(diabetes, renal or liver disease), exercise capacity, markers of 
nutritional state, all cause ‘in-hospital’ and ‘30’ day mortality. Identifier 
fields, which were required to calculate new variables or maintain data 
integrity, were also selected (date of birth, unique key). These were 
deleted when the relevant data operations had been performed. 
3.3.4 Data validation 
Data validation was performed in SPSS (Release 17.0.0.; August 23, 2008). 
SPSS Frequency Analysis was used to examine data ranges and summary 
statistics. 
1. Values of continuous data, which lay outside a prespecified plausible 
range were identified (SPSS Data Editor/Validation/Validate) and 
considered as missing. The limits of the acceptable ranges were set to 
represent values outside which, it was unlikely that patients would have 
been considered for surgery, or that the values could only have been 
errors. 
2. Missing value patterns and frequencies were analysed (SPSS Missing 
Value Analysis). 
3. Categorical values were validated using the Excel PivotTable function, 
which summarises all values that have been entered into a particular 
field. Only clearly erroneous values were excluded. 
4. Where possible, free text field contents were recoded into appropriate 
categorical codes, which varied depending on individual variables. 
5. Data validation was carried out between fields where possible. For 
example, related variables were cross checked (e.g. date of birth and 
reported age).
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3.4 Results 
The initial subset of data from the NOGCU included all patients who had 
undergone surgery between 5/4/1989 and 24/01/2006. This contained 199 
field variables and 1246 patient records. Further data became available 
from 4/1/2006 to 27/01/2009 and contained 330 records. The merged final 
dataset contained 1576 records. 
3.4.1 Out of range values (Table 15) 
Acceptable ranges for variables were set to reflect values which were 
compatible with patients in reasonable health undergoing major elective 
surgery, and were set to allow a wide margin of error. Some values clearly 
fell outside these ranges and there were several possible explanations for 
these apparent errors. One example was patients who apparently survived 
uneventful surgery but had reported preoperative arterial pO2 less than 5 
kPa and pCO2 greater than 10 kPa. These values are barely compatible 
with life and appear to be the result of data transposed into the wrong 
columns. These values were labelled as missing. The option to trace medical 
records and ‘patch’ data was discounted because of resource limitation and 
previous experience of large scale retrospective audit with these records had 
proved very difficult, labour intensive and only moderately successful. 
Selective ‘data patching’ of obviously incorrect values may also have 
introduced bias as apparently normal values may also have been incorrectly 
entered and not checked.
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Table 15 Description of variables from NOCGU database and handling of out of range (OOR) values 
Variable Name(original database label) Data procedures & comments Out of range Rule 
(acceptable range 
given) 
Number of out of range values 
(record identifier) 
DEMOGRAPHIC DATA    
MyIndex(pid) Unique key  NA 
Gender(GENDER)  male=1, female=0  0 
Age at surgery (AGE) Calculated new numeric variable: 'operation date' minus 
'date of birth': (OPDATE(numeric)-DOB(numeric))/365 
< 17 years 0 
PERIOPERATIVE MORTALITY    
In hospital mortality (INHOSRIP) All cause ‘in hospital mortality’(survivor=0, non-survivor=1) 0,1 only 0 
Thirty day mortality(30DMort) All cause 30 day mortality (survivor=0, non-survivor=1) 0,1 only  0 
TREATMENT    
Neoadjuvant therapy (NEO-ADJUVANT THERAPY) Free text;   NA 
Surgical procedure: New variable 
(Operation_Classfn1) 
Recoded from free text  All entries valid NA 
GRADE SURGEON Free text  NA 
GRADE ANAES Free text  NA 
TUMOUR CHARACTERISTICS    
Tumour histology (NewHist1Cln) Tumour histology from biopsy; recoded from free text to category  NA 
Final T classification (OVERALL T) Final  T classification; category NA 
Final N classification (OVERALL N) Final N classification; category NA 
Final (OVERALL M) Final M classification; category 22 unclear entries  
NUTRITION STATUS VARIABLES    
Weight loss (Kg) at presentation estimated by patient None specified NA 
Blood white cell count x 109/litre (WCC) 2 to 20 7 plausible values > 20; none 
excluded 
Serum albumen gm/litre (ALB)  25-70 gm/litre 25 
Weight (kg)  40-154 15(Excluded values Ian140, 
1552, not plausible, 12.7 & 11.4; 
probably 'imperial') 
Height (m)  NA NA 
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Variable Name(original database label) Data procedures & comments Out of range Rule 
(acceptable range 
given) 
Number of out of range values 
(record identifier) 
Body surface area(BSA) Calculated field:(Mosteller) sqrt[Ht(cm)*Wt(kg)/3600] NA NA 
Body mass index(BMI)  Calculated field: wt(kg)/[ht(m)]2 NA NA 
COMORBIDITY FIELDs    
COMORBID Categories of comorbidity including ‘cardiac’ & ‘respiratory’ NA NA 
OTHER Free text description of comorbidity NA NA 
DETAILS Free text qualifying details of 'OTHER' NA NA 
ASA American Society of Anaesthesiologists physical status 
classification 
Grade 1 to Grade 5 
allowed 
5 'E' for emergency, 2 zeros, 175 
not specified 
ALCOHOL  NA  
ALCOHOL TEXT Free text NA  
CARDIAC MORBIDITY    
CARDIAC Category: cardiac diagnoses NA NA 
ECG Category: normal, abnormal, not done NA NA 
ECGDETAILS Free text ECG abnormality NA NA 
REVISED CARDIAC RISK INDEX (Lee et al., 1999; 
Poldermans et al., 2009) and variations 
New calculated variables   
TotalRCRI Total score for the ‘Revised Cardiac Risk Index’ calculated 
from 'cardiac', 'comorbid', 'other' & 'details', 'ECG’ variables 
NA NA 
RESPIRATORY MORBIDITY    
Pulmonary disease(PULM) Free text respiratory diagnosis NA NA 
Lung disease category (4 new categories below) New derived field classifying respiratory disease; categories 
listed below 
  
Chronic obstructive pulmonary disease 
(COPDNewCode) 
New categorical code derived from 'PULM' or 'OTHER' & 
'DETAILS' fields 
NA NA 
Other chronic pulmonary disease (ChronicNewCode) New categorical code derived from 'PULM' or 'OTHER' & 
'DETAILS' fields 
NA NA 
Asthma (AsthmaNewCode) New categorical code derived from 'PULM' or 'OTHER' & 
'DETAILS' fields 
NA NA 
3. Dataset from NOGCU (Table: Description of variables from NOGCU database) 
92 
 
Variable Name(original database label) Data procedures & comments Out of range Rule 
(acceptable range 
given) 
Number of out of range values 
(record identifier) 
Recent acute respiratory disease (AcuteNewCode) New categorical code derived from 'PULM' or 'OTHER' & 
'DETAILS' fields 
NA NA 
SMOKING HISTORY    
Smoker or non-smoker (SmokerYesOne) Yes/no ( 1/0) NA NA 
Smoking category (SMOKERCODE) Never/ex- for more than 12 months/current (code 3,2,1) NA NA 
Arterial PO2 (kPa)  9-20 kPa Excluded OOR 997, 166, 472, 
695, 2684, 1543, 412 (probably 
transposed), 1736 (probably 
different units) 
Arterial PCO2(kPa)  3-7 kPa Excluded 133, 166, 472, 2844, 
695, 2625, Ian 127, 1165, 2684, 
1543, 1494, 1104 (probably 
transposed), 1956 (probably 
unit error) 
FEV1 Forced expiratory volume in 1 second(litres) <6 lit/sec Ian285 excluded(out of range) 
FVC Forced vital capacity (litres) 1 to 7 litres  
FEV1/FVC Calculated ratio FEV1/FVC (%) NA 
CXR Chest xray report: Normal, not done or free text description 
of abnormality 
NA NA 
EXERCISE CAPACITY TEST    
Exercise capacity test (EXTOL) Categorical Not done, completed 
satisfactorily, not 
completed satisfactorily 
NA 
Pulse rate before test (PRPRE) Note: acceptable ranges for exercise testing set according 
to observed range of reported values 
40 to 150/min 6 
Pulse rate after test (PRPOST)  40 to 170/min 5 
Respiratory rate before test (RRPRE)  5 to 30/min 8 
Respiratory rate after test(RRPOST)  5 to 60/min 8 
Pulse oximetry before test (OXY SATS PRE) 85 to 100 (%) 2 
Pulse oximetry after (OXY SATS POST)  85 to 100 (%) 5 
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Variable Name(original database label) Data procedures & comments Out of range Rule 
(acceptable range 
given) 
Number of out of range values 
(record identifier) 
Time to complete test (TIME TO COMPLETE) 0.5 to 10 (min) 233 
Time to return heart rate to pre-test min(RETURN TO BASELINE) 0.5 to 10 (min) 133 
OTHER VARIABLES    
Haemoglobin gm/dL (HB)  5 to 20 gm/dL 8 
urea mmol/litre (UREA)  2 to 15 mmol/lit 28 
creatinine μmol/litre (CREAT)  40 to 150 μmol/litre 26 
glucose mmol/litre (GLUC)  3 to 20 mmol/lit 11 
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3.4.2 Missing data 
Surgical procedure, age at operation, operation date, tumour stage and 
histology, gender, weight, RCRI, ‘in-hospital’ survival status, smoker status, 
respiratory comorbidity status, and several biochemistry and 
haematological results all had low percentages (less than 5%) of missing 
values. However, spirometry and arterial pO2 had between 15 & 20% 
missing, weight loss 27%, and all exercise testing variables, ASA grade, 
grade of operating surgeon and anaesthetist, had between 15 and 50% 
missing values (Table 16 on following page).
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Table 16 Frequency of missing values by variable for whole database 
Missing value frequencies N Missing  
  Count % 
Operation date 1574 2 .1 
Age at surgery 1574 2 .1 
In hospital mortality 1572 4 .3 
Weight Loss Kg 1145 431 27.3 
White cell count 1550 26 1.6 
Serum albumen 1527 49 3.1 
Weight loss (% bodyweight at surgery) 1104 472 29.9 
Weight Kg at surgery 1510 66 4.2 
Height m 1365 211 13.4 
P02 1328 248 15.7 
Hb 1553 23 1.5 
Serum K 1535 41 2.6 
Urea 1549 27 1.7 
Creatinine 1549 27 1.7 
Glucose 1303 273 17.3 
Pulse rate pre exercise 1326 250 15.9 
Pulse rate post exercise 1324 252 16.0 
Resp rate pre exercise 1270 306 19.4 
Resp rate post exercise 1269 307 19.5 
O2 saturation pre exercise 803 773 49.0 
O2 saturation post exercise 801 775 49.2 
Time to complete exercise test 758 818 51.9 
Return to baseline after exercise 1260 316 20.1 
FEV1 1457 119 7.6 
FVC 1454 122 7.7 
FEV/FVC ratio 1454 122 7.7 
ASA grade 1313 263 16.7 
Operating surgeon grade 966 610 38.7 
Anaesthetic grade 897 679 43.1 
Total RCRI 1575 1 .1 
Gender 1575 1 .1 
Histology 1576 0 .0 
Comorbidity 1518 58 3.7 
Respiratory comorbidity 1518 58 3.7 
Smoker (yes/no) 1558 18 1.1 
Smoker category(yes/stopped/never) 1548 28 1.8 
Surgical procedure 1573 3 .2 
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3.4.3 Patterns of missing values 
Using SPSS Missing Value Analysis, I examined missing patterns if more 
than 5% of the data was missing, if means of missing and non-missing data 
were statistically significantly different (p less than 0.05 for Student’s t test 
using separate variances) and if data was potentially clinically important. 
Percentage of missing values for survivors and non-survivors were reported 
and data missing in groups were tabulated (Table 17 and Table 18 on 
following pages).
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Table 17 Missing values by perioperative survivor status. Four (0.2%) outcomes are 
missing 
Variable Missing % in survivors Missing % in non 
survivors 
Operation date 0 1.1 
Age at surgery 0 1.1 
Weight Loss Kg 27.3 26.4 
White cell count 1.5 2.3 
Serum albumen 3.0 4.6 
Weight Kg at surgery 4.0 6.9 
Height m 12.8 23.0 
P02 kPa 16.2 8.0 
Hb 1.3 2.3 
Serum K 2.6 1.1 
Urea 1.7 1.1 
Creatinine 1.7 1.1 
Glucose 17.3 16.1 
Pulse rate pre exercise 15.9 14.9 
Pulse rate post exercise 16.0 14.9 
Resp rate pre exercise 19.5 17.2 
Resp rate post exercise 19.7 16.1 
O2 saturation pre exercise 48.5 59.8 
O2 saturation post exercise 48.6 59.8 
Time to complete exercise test 51.6 58.6 
Return to baseline after exercise 20.1 18.4 
FEV1 7.4 9.2 
FVC 7.5 10.3 
FEV1/FVC ratio 7.5 10.3 
Gender .0 .0 
Comorbidity   
Respiratory comorbidity 3.4 8.0 
Smoker (yes/no) .9 3.4 
Smoker (yes/stopped /never) 1.5 3.4 
ASA grade 16.5 19.5 
Operating surgeon grade 38.0 50.6 
Anaesthetic grade 42.4 54.0 
Surgical procedure .1 1.1 
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Table 18 Patterns of missing variables: commonest groups of missing data and variable means for each group 
Missing patterns Means for each pattern of missing data 
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OPDATE Weight Kg 
Pulse post 
exercise 
respiratory 
rate post 
exercise 
Time to 
complete 
Return to 
baseline 
240                 14-Apr-2004 71.58 93.00 19.36 1.038 1.66 
37               X  19-Jul-2006 65.58 96.59 20.38 1.239 1.22 
19               X  06-Jan-2006 70.19 92.63 24.63 1.012 1.22 
20                 03-Aug-2003 74.38 93.90 19.20 1.063 1.41 
43        X  X X X X X   07-Aug-1996 66.97 104.86 25.37 . 2.95 
153          X X X X X   01-Jun-1997 70.47 102.93 21.70 . 2.58 
18            X X X   12-May-1998 77.78 109.44 19.94 . 9.34 
76         X X X X X X   29-Mar-1997 69.13 103.49 22.95 . 2.55 
189                X 24-Mar-2005 78.24 96.12 20.11 .899 1.38 
36               X X 02-Jun-2007 76.34 87.75 19.00 1.404 1.40 
25                X 24-Sep-2004 76.62 101.12 22.48 1.307 1.60 
17 X X       X X X X X X   09-Aug-1998 76.12 99.71 19.29 . 1.78 
31   X X X X X   X X X X X   29-Nov-1994 70.65 . . . . 
22   X X X X X  X X X X X X   18-Jul-1996 69.55 . . . . 
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 Outcome 
The definition of perioperative mortality for this study was any death 
occurring during the hospital admission associated with the primary 
surgical procedure or within 30 days of surgery. The binary ‘in hospital’ field 
(yes/no) was validated against the ‘date of death’ field and compared with 
the ’30 day mortality’ binary field to ensure that none of the latter were 
missed. Survivor status was validated against the ‘follow-up outpatient date’, 
to ensure that they had actually left hospital and been followed up. Three 
records of the total 1575 had missing data for mortality outcome and were 
excluded from the study. No formal data auditing procedures were used in 
this database but in 2010 mortality data was verified against NYCRIS data 
(Northern and Yorkshire Cancer Registry and Information Service). 
 Period of data collection 
There were more missing weight loss and exercise testing values in earlier 
stages of data collection. It appears exercise testing was not started 
regularly until later in the 1990s and data collection may also have been 
less rigorous. Similarly, routinely collected data on grade of surgeon, 
anaesthetist and ASA score were scanty in earlier periods (Table 18). 
 Body Weight and weight loss 
Body weight was associated with the frequency of missing estimated weight 
loss, and inversely with the frequency of missing exercise testing, pO2 and 
height. Perhaps it is easier to miss weight loss in heavier individuals. 
However, it is not obvious why exercise testing values and height were more 
likely to be missing in lighter individuals. However, as missing frequencies 
for both were greater in earlier periods , and measured body weight also 
increased over time (68Kg for the first quartile of data collection against 
75Kg for the fourth, confirmed in multiple regression, p<0.001), this may be 
explained by variations in data collection over time. 
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Exercise testing and other cardiopulmonary investigations 
The exercise capacity test, which was used, incorporates various 
cardiorespiratory measures made before and after walking up flights of 
stairs. This has not been validated and is generally supervised by trainee 
medical staff. There was more missing data in earlier years and 
considerable amounts missing overall. Patients with missing pO2 and 
exercise testing results were associated with lower RCRI scores, suggesting 
perhaps that lower estimated cardiac risk was associated with less 
investigation (Table 18). Shorter time to completion of exercise testing was 
also associated with missing spirometry suggesting less comprehensive 
investigation of fitter patients. These findings would be expected in this 
mixed database if exercise was not deemed standard for all patients 
irrespective of estimated fitness. 
It appeared that these investigations were done less frequently in certain 
categories of operation and in the small number of patients with non-
malignant conditions, who had been entered onto the database. Again this 
might be expected if they did not follow the usual cancer staging. As 
expected, this data was missing more frequently in the cases which may 
have been urgent. 
Frequencies of missing oxygen saturations before and after exercise and 
time to completion were associated with longer post-exercise recovery times 
and higher respiratory and pulse rates, and possibly with poorer spirometry 
results (FEV1 and FVC). It is possible that there may have been a problem 
completing the tests or obtaining observations such as oxygen saturation in 
less fit individuals following exercise. 
 Age at surgery 
Age at surgery was calculated from: ‘operation date’ minus ‘date of birth’. 
This data was almost complete. 
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 Operative procedure  
Oesophagectomy is the focus of this study; in our unit it is almost 
exclusively the Ivor Lewis procedure which entails major intra-abdominal 
and intrathoracic surgery. Total gastrectomy is a major surgical procedure, 
but exclusively intra-abdominal, which has a frequently reported higher 
mortality than oesophagectomy (Cromwell et al., 2010), and is also a 
frequent procedure in this unit. There were also a mix of other procedures, 
which generally incurred a lesser morbidity and mortality. Therefore I 
mapped free text descriptions of surgical procedures into these three main 
categories. The ‘other’ group (including partial gastrectomy, palliative 
procedures, laparotomies and a small number of emergencies), would be the 
reference group for the oesophagectomies, and total gastrectomies. 
 Tumour histology 
I recoded this free text field into adenocarcinoma, squamous cell carcinoma 
and ‘other’ conditions (including benign). 
 Nutritional markers 
Weight, height, weight loss (as reported by the patient in kilograms and as a 
percentage of body weight at surgery), white cell count and serum albumen 
were all subjected to routine data checking. 
 Cardiovascular morbidity 
Preoperative cardiac morbidity was coded in a variety of ways in several 
free text and categorical fields in the original database. One field coded 
cardiac disease as present or absent (‘COMORBIDITY’), one allowed a free 
text description (‘CARDIAC’) with a free text qualifying field (‘DETAILS’), 
and one allowed free text comorbidity descriptions in a field containing any 
comorbidity (‘OTHER’). ‘ECG’ recorded the pre-operative electrocardiograph 
as normal or abnormal, and ‘ECGDETAILS’ allowed a free text description 
of any abnormalities. 
The free text fields were difficult to analyse because of the great range of 
free text entries. For instance there were 184 distinctly different entries in 
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the ‘CARDIAC’ field, 96 in the ‘COMORBID’ field, 751 in ‘OTHER’, 700 in 
‘DETAILS’ and 676 in ‘ECG’. Many of these were accounted for by variations 
in definition, description and spelling. Therefore I decided to try and map 
these to terms which would form the basis of the ‘Revised Cardiac Risk 
Index (RCRI)’, a validated cardiac risk score (Lee et al., 1999; Fleisher et al., 
2007). Using Excel ‘PivotTable’, I summarised all possible entries in the 
cardiac fields and mapped these to terms used in the RCRI using a ‘lookup’ 
table. This enabled each case to be scored using an appropriate form of the 
RCRI. 
 Respiratory comorbidity  
Respiratory comorbidity was also represented by several continuous, as well 
as categorical and free text field variables. Continuous variables included 
spirometry (FEV1, FVC and their calculated ratio) and arterial blood gases 
(oxygen saturation measured by pulse oximetry, arterial oxygen and carbon 
dioxide partial pressures, and pH and bicarbonate concentration). 
Respiratory comorbidity was also represented in free text fields which 
described various comorbidities (‘COMORBID’, ‘OTHER’, ‘DETAILS’). The 
field ‘PULM’ contained 96 distinct free text descriptions of pulmonary 
diseases; three fields described tobacco use (‘yes’/’no’, current/past smoking 
habit and a free text description of smoking history). As in the cardiac data 
fields, there was a large amount of heterogeneous free text information. I 
mapped free text data terms which defined four main groups: chronic 
obstructive pulmonary disease (COPD), asthma, other chronic lung disease, 
or a history of other acute respiratory illness. 
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3.5 Discussion 
The NOGCU has twenty years worth of data and should be a rich source of 
information. I have prepared a ‘cleaned’ dataset of fields from this clinical 
database, in preparation for exploring a clinical prediction model of 
perioperative mortality after oesophagectomy. However, there are several 
sources of potential bias, which can arise from the data in prediction 
modelling, and which were identified in the systematic review and have 
been summarised by Hayden (Hayden et al., 2006). I discuss their 
significance in relation to this database under headings from Hayden’s 
recommendations below (Hayden et al., 2006). 
3.5.1 Does the sample represent the population of interest? 
Patients may be excluded from surgery for a variety of reasons including 
medical fitness, age, and variation in surgical indications between centres. 
This type of selection bias is well recognised  (Delgado-Rodriguez and Llorca, 
2004) and its potential was noted in some primary studies in the systematic 
review (Thomas et al., 1996; Sabel et al., 2002; Ruol et al., 2007(a)). Its effect 
may be to bias results and make application to other groups less reliable. 
The NOCGU database was set up with the intention of including every case 
of oesophagogastric cancer referred to the unit, and there is no evidence to 
suggest that the data does not include a consecutive set of operated cases, 
and should be relatively free of ‘loss to follow up’ selection bias. I internally 
validated survivor status within the database against ‘discharge from 
hospital’ and ‘outpatient follow up appointment’ fields, and the NOGCU 
team validated survivor status with NYCRIS (Northern and Yorkshire 
Cancer Registry and Information Service). However, it is possible that 
patients may have been completely omitted from the database, or may have 
been excluded from surgical treatment on the basis of perceived ‘unfitness’ 
for surgery (e.g. comorbidity, old age); the database did not hold data to 
allow conclusions about this aspect of management until fairly recently. 
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3.5.2 Does the data represent the sample? 
 Data validity 
There were several potential sources of information bias in our data. In the 
early stages much clinical data was entered by various grades of junior staff, 
and therefore subject to their interpretation and errors of which several 
types were reported in the results. This was compounded by the use of many 
free text fields and lack of consistent definition of certain variables e.g. 
cardiovascular comorbidity. Further transcription from data entry form to 
computer and in this study, my recoding of some fields only adds to this risk. 
As the database has developed, many of these issues have been resolved 
with senior medical staff completing data entry forms, and the use of 
standardised and categorical data. 
Data audit is a possible solution to maintaining data integrity. This was not 
formally used in the NOGCU database until the more recent use of  
NYCRIS to validate mortality (Northern and Yorkshire Cancer Registry and 
Information Service) and was infrequently reported in the systematic review 
of primary studies (Adam et al., 1996; Bailey et al., 2003; McCulloch et al., 
2003; Rahamim et al., 2003; Rentz et al., 2003; Tekkis et al., 2004; 
Moskovitz et al., 2006). 
Clinical database studies can also be prone to ‘observer expectation bias’, 
when data is entered by an investigator aware of the study aim or 
hypothesis (Delgado-Rodriguez and Llorca, 2004). This can be partially 
alleviated by ‘blinding’ data entry staff to the outcome, but this is not a 
practical solution in most cases. Entering prognostic data prospectively, 
before the outcome of interest (survival or non-survival) has occurred 
accounts for this problem and data collected for the NOGCU database 
mainly fulfils this criterion. 
 Missing data 
Missing data can reduce study efficiency by reducing effective sample size, 
and can bias the effects of predictors (Steyerberg, 2009f). The latter is more 
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likely if missingness of data (outcome or predictor) depends on outcome, e.g. 
non-survivors have more missing data than survivors. It is also possible if 
the missing and non-missing predictor data have different outcome rates 
(Steyerberg, 2009f). Outcome (mortality) data was virtually complete and 
had been validated so was unlikely to be ‘missing not at random’. However, 
mortality rate was higher in patients with missing values on height, arterial 
pO2, and pre and post exercise test oxygen saturations. Higher mortality in 
association with missing pO2 could have been explained by the inclusion of 
emergency cases, which may not have had this measured. There was also a 
suggestion that patients with poorer cardiorespiratory reserve, for example 
those with poorer spirometry and higher pulse and respiratory rates after 
exercise testing, had more missing pre and post exercise oxygen saturations. 
This could perhaps be explained by an inability to obtain measurements in 
patients possibly struggling with exercise. Mortality was also higher in 
patients with missing oxygen saturations during exercise testing, perhaps a 
reflection that patients unable to manage exercise may have been at higher 
risk. Patients treated earlier in the data collection period were also less 
comprehensively investigated, particularly in respect of cardiorespiratory 
and exercise capacity. This would be expected as the unit was developing 
but makes application to future groups of patients difficult. These 
explanations are all speculation, but together with amount of missing data 
for some exercise testing measurements, decreases confidence for including 
them as candidate predictors. These patterns suggest that for some 
predictors missing data is not missing completely at random, which is the 
usual safe assumption for missing data. This was suggested as Little’s 
MCAR test applied to all potential variables, provided evidence against the 
null hypothesis that data was MCAR (Chi-Square 5119.695, df 3889, 
p<0.001). 
3.5.3 Strengths and weaknesses of this dataset 
1) The NOGCU clinical database is a moderately large database with a set 
of records from a reasonably homogenous case-mix and set of surgical 
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procedures, which has been managed by a professional database 
manager for a long period. 
2) The outcome mortality data and some simpler data such as gender, 
operation, operation date, and tumour histology were nearly complete 
and had been subjected to some degree of validation. 
3) For the purposes of this study it is a ‘convenience’ sample (Harrell, 
2001b), which was not prospectively set up for this purpose. Some of the 
fields of interest lacked definitions, much data was free text, and there 
were several steps where potential bias in data entry could have 
occurred. Some of the fields required a considerable amount of recoding 
into useable predictors, which added to the risk of information bias 
(Delgado-Rodriguez and Llorca, 2004). 
4) Some fields (e.g. weight loss, exercise testing measurements) had 
considerable amounts of missing data. 
3.6 Key findings 
1) I have prepared a set of fields containing candidate predictors from 1575 
cases from the NOGCU database, with which to explore a clinical 
prediction model of perioperative mortality after oesophagectomy. 
2) Perioperative mortality outcome, age, gender, operation and tumour 
histology were nearly complete and reliable. There is no reliable 
information to study patients who may have been excluded from surgery 
because of medical unfitness. 
3) Other predictors of potential interest, for instance comorbidities, were 
entered into the database in extensive free text, without prior definition 
and requiring considerable recoding. These must be open to potential 
bias. 
4) Some fields had considerable amounts of missing data including weight 
loss, measures recorded during exercise testing, grade of surgeon and 
anaesthetist and ASA score. There was more missing data from the 
earlier years of data collection and as expected possibly in fitter patients 
and those undergoing emergency surgery, who may not have undergone 
the test.
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Chapter 4:  Developing a clinical prediction model of perioperative 
mortality after oesophagectomy from the NOGCU clinical database 
4.1 Introduction 
In this section of the thesis I aim to develop a clinical prediction model of 
perioperative mortality using a ‘cleaned’ subset of data from the NOGCU. 
General considerations about the modelling methods are summarised in this 
introduction and have been drawn predominantly from Steyerberg’s 
‘Clinical Prediction Models’ (Steyerberg, 2009e) and Harrell’s ‘Regression 
Modelling Strategies’ (Harrell, 2001e). 
4.1.1 Background to modelling methods 
Perioperative mortality has a binary outcome, for which there are several 
modelling methods. Logistic regression is a flexible and widely used method 
allowing the incorporation of continuous, categorical and non-linear 
predictors and the interactions between them (Kleinbaum, 1994; Steyerberg, 
2009l). The outcome is modelled as the natural logarithm of the odds 
against a linear function of the predictors. Individual predictor and model 
performance can be compared with formal statistical tests. 
Other methods include discriminant analysis, Bayesian methods, 
classification and regression trees and neural networks (Steyerberg, 2009l). 
Neural networks are probably the most familiar of these and are well suited 
to identifying non-linear effects, interactions and unspecified effects. 
However, they identify relationships which are wholly data driven (the 
‘black box’ analogy), may be less acceptable to medical practitioners, and 
model performances are more difficult to compare. In contrast, logistic 
regression requires pre-specification of data relationships and requires some 
knowledge of how the predictors are linked to the outcome, perhaps 
increasing its acceptability to clinicians. Although extensively used in 
medical applications, neural networks have not been shown to perform 
better than logistic regression in classification problems (Tu, 1996; Sargent, 
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2001; Dreiseitl and Ohno-Machado, 2002). Consequently, I have chosen to 
use logistic regression to model perioperative mortality. 
4.1.2 Selection of candidate predictors 
 Age at surgery 
There was strong evidence from the systematic review that age was 
associated with perioperative outcome, and had strong supporting rationale. 
There was also some evidence that its effect may be more marked in 
extreme old age and therefore it may be worth considering a transformed 
age predictor to account for this. A simple example is the ‘squared’ 
transform of age, which I will consider. 
 Surgical operation 
Surgical procedure was included as a 3 category predictor because the study 
focuses on oesophagectomy, and the database contains a mixed surgical 
caseload. The other category was total gastrectomy, which has been 
reported to have a higher mortality (Cromwell et al., 2010), and the 
reference category was “other”, which included operations known to have a 
lower mortality (e.g. subtotal gastrectomy). 
 Cardiovascular comorbidity 
The evidence from the systematic review  for including cardiovascular 
comorbidity as a predictor was weak, however there is a physiological 
rationale for its inclusion, and the Revised Cardiac Risk Index (RCRI) (Lee 
et al., 1999) has been validated in large samples of other major surgical 
procedures. This allocates one point for each of high risk surgery, ischaemic 
heart disease, history of congestive heart failure, history of cerebrovascular 
disease, IDDM, creatinine above 2.0 mg per dl. The points sum categorises 
patients into risk classes 1 to 4 depending on number of risk factors present. 
It has also been used as a two level score (Ford et al., 2010); therefore I 
explored the total RCRI score, and the two and four level scores. 
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 Respiratory comorbidity 
About half the studies in the systematic review found associations between 
various markers of respiratory disease and perioperative mortality. In 
oesophagectomy the lung is subjected to a variety of physiological insults 
and pulmonary complications are common and associated with mortality, 
therefore it seems reasonable to include some marker of respiratory 
comorbidity. The NOGCU database contains multiple measures and 
descriptors of respiratory comorbidity but there is no clear consensus on the 
most useful. 
With the large number of fields representing pulmonary disease in the 
database some degree of data reduction was desirable. It is unlikely that 
patients with acute illness will undergo surgery without appropriate 
treatment, or that ‘burnt out’ chronic disease would impair outcome, 
therefore I focussed on identifying patients with COPD, because it is 
common, progressive and subject to exacerbations. In this dataset there was 
no relationship between categorical or free text descriptions of respiratory 
disease and spirometry and therefore did not allow simple combination of 
these variables. The database did not use a clear definition of COPD, but 
spirometry is central to its diagnosis (National Clinical Guideline Centre, 
2010), therefore I selected this predictor. There is debate about the best 
diagnostic spirometric measure for COPD, for instance, whether spirometry 
should be recorded before or after inhaled bronchodilators (National Clinical 
Guideline Centre, 2010). NICE have recently recommended using post-
bronchodilator FEV1, but most studies use FEV1 without bronchodilator, 
and as this was the reported measure in our database, I selected this as our 
predictor (National Clinical Guideline Centre, 2010). 
 Nutritional status 
Protein-calorie malnutrition is associated with poorer outcomes after major 
surgery (Law et al., 1973; Fekete and Belghiti, 1988; Windsor and Hill, 
1988). About 30% of studies in the systematic review reported associations 
between mortality and measures of loss of body mass and serological 
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markers of malnutrition or immunosuppression. The considerable 
heterogeneity of marker definitions made appropriate selection of predictors 
difficult but three studies identified serum albumen as important (Saito et 
al., 1993; Rentz et al., 2003; Atkins et al., 2004). I selected this as the main 
nutritional marker although weight loss and white cell count were also 
explored. 
 Other candidate predictors 
Various estimates of exercise (Law et al., 1994) or activity capacity 
(Ferguson et al., 1997; Bartels et al., 1998; Bailey et al., 2003) were reported 
to be associated with mortality in the systematic review. However, in the 
NOGCU database general activity was not routinely recorded and the 
exercise test had much missing data, was not consistently standardised and 
not likely to be accepted as a standard test. Other predictors such as renal 
disease, diabetes, and liver disease are also potentially important, but their 
prevalence was very low. These potential predictors will be explored but it is 
unlikely that I will consider them for the prediction models for the reasons 
given above. 
4.1.3  Handling missing data 
Missing values pose a particular problem in modelling studies because they 
may reduce study efficiency by loss of information, and may bias regression 
coefficient estimates, because data may be missing “systematically” rather 
than randomly (Little, 1992). The mechanism of “missingness” is central to 
the effect on the study and how it may be managed. Values which are 
missing due to random factors outwith the study (e.g. administrative error) 
are “missing completely at random”(MCAR) and do not bias the study. 
Observations may be missing at random after controlling for values of other 
variables e.g. more missing exercise data in earlier study periods. This is 
“missing at random” (MAR), and is particularly problematic when 
“missingness” depends on the outcome variable (in this case mortality), 
resulting in biased regression coefficients (Steyerberg, 2009f). Missing 
values may depend on the values which are missing (for instance non-
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survivors missing more than survivors) or other unobserved variables and 
are “missing not at random” (MNAR). The mechanisms, effects and 
handling of missing values have been described in various sources 
(Carpenter et al.; Little, 1992; Vach, 1997; Steyerberg, 2009f). 
Complete case analysis is the common approach to this problem and 
excludes any case with missing values in the outcome or predictors and is 
therefore relatively inefficient. The resulting reduction in sample size 
results in a reduced event to variable ratio leading to overfitting and chance 
associations (Harrell, 2001c; Steyerberg, 2009n). Comparisons between 
models can also be difficult to interpret as differences between univariate 
and adjusted coefficients may be due to varying patterns of missing data, 
rather than correlation between predictors. 
A potential solution is to replace missing values by multiple imputations 
and thereby maximise study efficiency (Steyerberg, 2009f). However, this 
may lack face validity for some clinicians, and I have chosen complete case 
analysis initially and will only consider statistical data replacement later 
depending on initial patterns of missing data. 
Replacement of missing values by multiple imputations is based on the idea 
that the original observations are a random sample from the overall 
population and therefore, the same conclusions should be reached if they 
were replaced by other random observations from that population. The 
missing values can be replaced under the assumption that they are ‘missing 
at random’. That is ‘missingness’ is random after controlling for other 
variables (Carpenter et al.; Howell, 3/7/2009). For example, perhaps 
albumen may have more missing values in younger patients. Under ‘missing 
at random’ we would assume that albumen is missing at random after 
controlling for age. The statistics program (SPSS) would replace the missing 
values with random values from a distribution based on the non-missing 
values from the predictor to be replaced and other auxiliary predictors in 
the dataset. 
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4.1.4 Model validation 
Clinical prediction models should be capable of predicting outcome 
accurately (calibration) and allocating the correct outcome to patients at 
high and low risk (discrimination) (Altman and Royston, 2000). Models, 
which have performed well in development, often fail to deliver satisfactory 
performance when applied to new patients (Justice et al., 1999). Validation 
phases include examining performance of the model on the sample on which 
it was developed (apparent validation), on a separate portion of the sample 
under study (internal validation) and on a new and unseen sample of 
relevant subjects, who have not been used in model building (external 
validation) (Steyerberg, 2009o). This study is on existing data from a 
regional clinical database, which will be used to develop and internally 
validate a prediction model. External validation on “unseen” data is beyond 
the scope of this study. 
Traditional methods of internal validation include split sampling (one for 
modelling and one for development) but newer methods such as 
bootstrapping (Harrell, 2001e), are increasingly used to utilise the entire 
data sample. Split sample validation inevitably leads to reduced size of 
modelling and validation samples. This can lead to random imbalances in 
outcome and predictors, and to unreliable assessment of model performance. 
However, I selected split sampling for internal validation because it is still 
widely used and accepted in clinical studies, and has face validity. It also 
gives some scope to explore data and validate findings in the validation 
sample. I also decided to use random samples, which were balanced for 
mortality outcome. 
4.1.5 Statistical measures to compare and validate models 
The statistical measures used in this study have been described in several 
sources (Justice et al., 1999; Altman and Royston, 2000; Steyerberg et al., 
2010) and I have summarised the main categories below. 
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4.1.6 The amount of information in a model 
This is the amount of variation explained by a model and gives some idea of 
how well it will predict outcome compared to a model with just the mean 
sample outcome. The maximised likelihood value, L, (the probability of 
obtaining the observed data given the stated model and parameters) is the 
basis of the likelihood ratio statistic (-2LL), which has a chi-square 
distribution and is used to compare the predictive ability of two models 
(Kleinbaum, 1994; Steyerberg et al., 2010). The Wald statistic has a 
standardised normal distribution and tests whether individual regression 
coefficients differ from zero. 
Nagelkerke’s R2 is generally reported in logistic regression output. However, 
this is not directly comparable to the R2 of ordinary linear regression, which 
is assessing how well the model minimises the difference between predicted 
values and actual values. Nagelkerke’s R2 is based on the ratio of likelihoods 
of the model with and without predictors. Although it is scaled between 0 
and 1, and independent of sample size the values can only reliably be used 
to compare models on the same datasets. It is also usually small in logistic 
regression and is not a reliable measure of goodness of fit (Steyerberg et al., 
2010; Statistical Consulting Group, October, 2011). 
4.1.7 Calibration and goodness of fit 
This reflects how accurately a model’s prediction of “x%” mortality is 
observed in the sample of interest. Because individual outcomes can only be 
0 or 1, it is only possible to compare mortality rates in groups, and to 
compare predicted and observed means. These values can be demonstrated 
in plots (typically in 10 groups of ascending predicted values) and compared 
using the Hosmer-Lemeshow statistic (Lemeshow and Hosmer, 1982). 
4.1.8 Discrimination 
The ability to correctly allocate outcome is commonly quantified by a 
receiver operator curve (ROC), and in this study represents the probability 
that a randomly selected patient, who died, had a higher predicted risk than 
a randomly selected, one who survived. The value of interest is the area 
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under the ROC curve and is the same as the c statistic for binary outcomes 
(Hanley and McNeil, 1982).Another estimate of goodness of fit includes the 
Brier statistic, which uses a scaled score for a quadratic function of the 
predictions errors (Steyerberg et al., 2010). 
4.1.9 Classification 
The potential impact of a prediction model can be gauged by how many 
cases it can correctly classify into high or low risk groups. Models can be 
compared by assessing how many patients could have benefitted from the 
use of the models. I will examine what impact could have been made on 
treatment decisions had selected levels of predicted mortality been acted on. 
4.1.10 Aim and goals 
I aim to develop, internally validate and assess the performance of a clinical 
prediction model of perioperative mortality after oesophagectomy using data 
from the NOGCU database. 
Goals 
1. To select a set of candidate predictors for inclusion in a clinical 
prediction model of perioperative mortality. I will use current clinical 
knowledge, the systematic review in Chapter 2, and secondarily the 
results of univariate analysis and stepwise regression methods to 
inform the choice of predictors. 
2. To develop a clinical prediction model using complete case logistic 
regression on a random sample from the NOGCU database. I will 
consider the use of imputation methods to optimise study efficiency if 
appropriate. 
3. To assess the performance of the prediction models on a random 
sample of data from the NOGCU database.
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4.2 Methods 
4.2.1 Selection of candidate predictors 
 Age at surgery  
Age and ‘age squared’ were examined as candidate predictors. Age was 
coded as ‘age minus 30’ in decades to give a clinically useful zero reference 
(30 years) and regression coefficients that were large enough to manage in 
SPSS. 
 Surgical operation  
Surgical procedure was included as a 3 category predictor: 
a. Thoracoabdominal oesophagectomy 
b. Total gastrectomy 
c. ‘Other’ operations (laparotomy, subtotal gastrectomy etc) was the 
reference group. 
 Cardiovascular comorbidity 
The Revised Cardiac Risk Index (RCRI) (Lee et al., 1999) was examined as a 
candidate predictor both as a total score, and two and four level categorical 
scores. 
 Respiratory comorbidity 
Respiratory comorbidity was represented by the spirometric measure of 
forced expiratory volume in 1 second, as a percentage of that predicted 
(FEV1) for age gender and height (National Clinical Guideline Centre, 2010). 
Predicted values for FEV1 were calculated from the following equations 
from the European Coal and Steel Community (Quanjer et al., 1993). 
Males: (                )  (               )       
Females: (                 )  (               )      
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 Nutritional status 
Nutritional candidate predictors for examination were serum albumen, 
white cell count and estimated weight loss at surgery. 
 Other candidate predictors 
 I explored various predictors from exercise capacity tests but did not 
consider them for inclusion in the prediction model 
4.2.2 Data exploration 
Summary statistics, distributions, and missing values were reported for 
candidate predictors in the modelling sample, which contained 
oesophagectomies, gastrectomies and a group of other operations. 
Distributions of preselected predictors and their univariate associations 
with mortality were explored with logistic regression. Mortality rates and 
confidence intervals for selected quantiles were plotted using statistics 
packages based on R (Appendix G iii. ). 
4.2.3 General Modelling strategy 
1. The full dataset (n=1575) was split into two approximately equal random 
samples with similar mortality rates, one for modelling and one for 
validation. 
2. I used complete case analysis and multiply imputed datasets to develop 
the prediction model. 
3. I pre-specified a ‘Clinical’ model to reduce selection bias and overfitting 
inherent in data driven methods, which could lead to poor performance in a 
new sample (Steyerberg, 2009k). Predictors included age, revised cardiac 
risk index (RCRI), spirometry (FEV1 % predicted), surgical procedure, and 
serum albumen. I explored the effect of adding or removing certain 
predictors from the main models. 
4. I used the univariate associations and ‘stepwise’ elimination methods to 
explore a range of other candidate predictors, which could be important and 
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considered for inclusion in the ‘Clinical’ model. I also used stepwise 
elimination to generate a ‘Statistical’ model for comparison.  
5. I explored the modelling assumptions of linearity of response on 
predictors, additivity of predictor effects and data fit to model (residuals and 
effects of any extreme values). 
6. Selected models were tested on the random validation sample (50% of the 
sample). The performance of models was also compared with the Steyerberg 
‘Rotterdam’ model (Steyerberg et al., 2006). This model developed a risk 
score from logistic regression, which I used on our dataset. This score 
allocated a score (from -2 to 1.5) depending on age category, the presence of 
pulmonary, cardiovascular, liver or renal disease and diabetes. Points were 
also allocated for hospital surgical volume, and chemo- or radiotherapy. 
Using this model required some recoding in the NOGCU database, and 
therefore direct comparisons with the models derived from the NOGCU 
should be made with caution. 
7. Properties used to examine model performance included: 
 The data variance accounted for by the models was compared using the 
chi-square statistic for -2LL (minus double the log likelihood) and 
Nagelkerke’s R 2. The latter is a logarithmic score of difference between 
predicted and observed outcome, scaled to between 0 and 1 (Steyerberg et 
al., 2010). 
 Discrimination between survivors and non-survivors using plots of 
Receiver Operator Curves (Hanley and McNeil, 1982) and the areas 
under the curves. 
 The fit of predicted to observed values was assessed using the Hosmer-
Lemeshow (Lemeshow and Hosmer, 1982) statistic and calibration plots 
of average predicted risk against average observed mortality for each 
ascending decile of predictions. There is debate around the utility of the 
Hosmer-Lemeshow test, particularly the optimal data groupings and its 
power to detect poor calibration and overfitting (Steyerberg, 2009h). 
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8. Deviations from the initial protocol, which arose during the analysis, are 
described in the results as they occurred. 
4.2.4 Generation of multiple imputation datasets 
Multiple imputation was carried out according to methods and 
recommendations reported by van Buuren (van Buuren et al., 1999). 
Patterns of missing data were examined and the multiple imputation 
carried out in SPSS using the following classes of predictor from the original 
data were used to estimate missing values (van Buuren et al., 1999; Clark 
and Altman, 2003): 
i. Predictors, which were associated with ‘missingness’ of predictors to 
be replaced. This was determined using logistic regression (dependant 
variable ‘missing’ or ‘present’) against a range of predictors. 
ii. Predictors which may be correlated with the predictor to be replaced. 
iii. The outcome variable and all the predictors in the original full 
‘clinical’ model were included. 
The ‘Fully Conditional method’ was used with iterations set to a maximum 
of 10. Constraints on imputed values (FEV1 and serum albumen) were set 
to their original sample ranges. Predictors used to impute values included 
all predictors and outcome in the prespecified model, predictors whose 
values were associated with missingness in the target variables (operation 
date and pO2 for FEV1), and variables which were correlated with the 
target predictors (weight, height, gender). 
4.2.5 Logistic regression 
1. Logistic regression (Analyze, Binary regression) was carried out 
using SPSS 17.0. (Release 17.0.0. 23 August 2008). Predictors were ‘forced’ 
into the model for pre-specified models and also for ‘data driven’ stepwise 
elimination methods, after selection of predictors. Predicted probabilities, 
standardised residuals, Cook’s, leverages, and DfBeta and Hosmer-
Lemeshow statistics were saved for later examination. Correlation between 
predictors was examined and multicollinearity checked by running the 
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model using SPSS ordinary multiple linear regression as suggested by Field 
(SPSS:Analyse, Regression, Linear)(Field, 2000). 
2. For the prespecified ‘Clinical’ model, age, FEV1, serum albumen and 
RCRI were entered as continuous variables and surgical procedure as a 
categorical variable. For categorical variables the ‘indicator’ contrast (SPSS 
terminology) was used and the reference group was generally the lowest risk 
category (e.g. ‘other’ operation). 
2. A ‘Statistical’ model was generated for comparison and to explore other 
potential candidate predictors. Stepwise regression is prone to overestimate 
coefficients and underestimate p values and confidence intervals, and 
therefore an initial global test of no regression was carried out with all 
candidate predictors in the model (Harrell, 2001d). Candidate predictors 
included all from the prespecified ‘Clinical’ model plus smoker status, 
presence of respiratory disease, preoperative arterial pO2, percentage of 
reported weight loss, white cell count, gender, tumour histology and stage, 
and operation date. Backward elimination was used to exclude apparently 
unimportant predictors (p<0.1), and those selected were forced into a model 
to reduce the possible effects of missing data resulting from the initial 
inclusion of all candidate predictors. 
4.2.6 Validation 
1. The regression coefficients from selected models were ‘back substituted’ 
into the logistic function using SPSS, to calculate mortality probabilities for 
individuals in the validation dataset. 
2. Calibration of individual models was examined using the val.prob.ci 
function, which is a modification by Vergouwe (Vergouwe and Steyerberg, 
2009) of the ‘val.prob’ (Harrell, 2012) function from the Regression 
Modelling Strategies (‘rms’) software package (Harrell Jr, 24/03/2011). The 
function ‘val.prob.ci’ adds confidence intervals to the observed outcomes, and 
I inactivated the histogram output of predicted probabilities in favour of 
graphics rendered in ggplot2. I communicated by email with Professor E. 
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Steyerberg for help in using the function and interpreting the output 
(Warnell, 2012(unpublished communication)). 
3. Discrimination was assessed by plotting and calculating the area under 
the receiver operator curves for each model. This was done using the 
‘plotROC’ function (Appendix G vi. ) from the R based PredictABEL package 
(Kundu et al., 2011).  
4. True and false positive rates were generated in SPSS and reported for 
various cut-offs of predicted mortalities for selected models in order to give 
an idea of the potential utility of models as classifiers of risk in practice. 
4.3 Results 
4.3.1 Distributions of candidate predictors and their association with mortality 
The distributions of candidate predictors and their associations with 
mortality are reported in Table 19 and Table 20 and follow on the next 
pages. The unadjusted odds ratios from the logistic regression is the 
multiplier of the odds of the outcome, which results from a one unit change 
in the predictor. For instance, in this sample the effect of a one year increase 
in age is to multiply the odds of perioperative mortality (defined by me as ‘in 
hospital’ mortality), by 1.047(95% CI 1.011, 1.084). Age was also studied by 
decade with a reference of 30 years, to give a more practical interpretation, 
and the odds ratio per decade above 30 was 1.047 10 , which is 1.583(95% CI 
1.119, 2.441). The intercept from the logistic equation gives the baseline 
odds for the outcome, given no predictors in the equation. For this sample 
the odds ratio for the overall ‘in hospital’ mortality was 0.058, or a mortality 
rate of 5.5%.  
Other predictors which were statistically significantly (p<0.1) associated 
with perioperative ‘in hospital’ mortality were, weight loss (OR 1.005, 
p=0.0.075), white cell count (OR 1.006, p=0.075), RCRI as a continuous 
variable (OR 1.251, p=0.049), RCRI as a four level categorical variable (OR 
2.059, p=0.084), male gender (OR 2.238, p=0.05) and thoracic 
oesophagectomy, referenced to ‘other’ procedures (OR 2.190, p=0.074). 
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Table 19 Distribution and mortality rates for outcome and continuous predictors 
Variable cases 
(missing) 
Out of 
range 
values 
Sample 
mean(sd) 
[median 
(min,max)] 
Survivor 
mean(sd) 
[median(min,m
ax)] 
Non-survivor 
mean(sd);median 
(min,max) 
Unadjusted odds 
ratio (OR), 95% CI 
In hospital 
mortality 
787(0) nil Survivors 743, 
non-survivors 44 
(5.6%) 
   0.058, p=0.00 
Age at surgery 786(1) nil 65.4(10.2) 
[67(30, 90)] 
65.21(10.174) 
[67(30,90)] 
69.37(9.757) 
[70(31,86)] 
 
1.047[1.011,1.084],p=
0.01‡ 
Age decade 786(1) nil 3.544(1.019) 
[3.7(0,6)] 
3.521(1.0174) 
[3.7 (0,6)] 
3.937(0.9756) [4(0.1, 
5.6)] 
 1.583(1.119,2.441), 
p=0.01 
RESP        
FEV1lit/sec 722(65) 1 (95 
lit/sec) 
2.5(0.8077) 
[2.5(0.6, 5.4)] 
2.34(0.7235) [ 
2.325(0.7, 4)] 
2.51(0.8118) [ 2.5(0.6, 
5.4)] 
 0.760[0.505, 1.145], 
p=0.189 
FEV1 (% 
predicted) 
636(151) nil  0.871(0.255) [ 
0.8686(0.24, 
2.02)] 
0.874(0.255) [ 
0.875 (0.26, 
2.02)] 
0.819(0.252) 
[0.827(0.24, 1.31)] 
 0.415[0.096, 1.79], 
p=0.238 
FVC lit 721(66) 1(as FEV1) 3.36 (0.991) 
[3.37(0.2, 6.9)] 
3.374 (0.991) 
[3.395(0.2, 6.9)] 
3.164 (0.974) [3.25(1, 
5)] 
 0.804[0.577, 1.121], 
p=0.199 
pO2 kPa 647(140) 8 (<5,>30; 
?data 
entry & 
unit error) 
 12.28 (2.22) 
[12(5.1, 25.8)] 
12.27 (2.157) [ 
12(5.2, 25.5)] 
12.46 (3.066) 
[12.2(5.1, 25.8)] 
 1.038[0.906, 1.188], 
p=0.591 
NUTRITION       
Height m 679(108) nil 1.692 (0.093) 
[1.7(1.43, 1.95)] 
1.69(0.0926) 
[1.7(1.47, 1.95)] 
1.695(0.102) [1.7(1.43, 
1.91)] 
1.441[0.039, 53.53] 
p=0.843 
Weight Kg  749(38) 2 
(11.7,12.4) 
71.90(15.44) 
[71(35.8, 140)] 
71.31(14.79) 
[70(47, 108)] 
 71.93(15.49) [71(35.8, 
140)] 
 0.997[0.997, 1.018], 
p=0.801 
Body surface 
area 
670(117) nil 1.836(0.2286) [ 
1.823(1.221, 
2.668)] 
1.837 (0.2286) 
[1.823(1.22, 
2.67)] 
1.827(0.2319) 
[1.807(1.42, 2.37)] 
 0.839[0.192, 3.670], 
p=0.816 
Body mass 
index 
670(117) nil 25.203(4.615) 
[24.957(13.89, 
46.20)] 
25.224(4.634) 
[24.953(13.89, 
46.20)] 
24.832(4.315)[24.959(
16.26, 32.86)} 
 0.981[0.911, 1.057], 
p=0.620 
Weight loss 565(222) nil  5.96(5.63) [5(0, 
32)] 
 5.86(5.621) 
[5(0, 32)} 
7.79(5.734) [8(0, 20)]  1.005[0.995, 1.119], 
p=0.0.075‡ 
White cell 
count 
778(9) nil  8.29(4.37) [7.7 
(2.9, 74)] 
 8.291(4.448) 
[7.65 (2.9, 74)] 
8.414(2.904) [7.95 
(4.1, 19.3)} 
 1.006[0.944, 1.071], 
p=0.075‡ 
Serum 
albumen 
755(32) nil  41.54(5.454) 
[42(15, 93)] 
41.60(5.508) 
[42(15, 93)] 
40.38(4.333) [42(28, 
48)] 
 0.96[0.908, 1.015], 
p=0.148 
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Variable cases 
(missing) 
Out of 
range 
values 
Sample 
mean(sd) 
[median 
(min,max)] 
Survivor 
mean(sd) 
[median(min,m
ax)] 
Non-survivor 
mean(sd);median 
(min,max) 
Unadjusted odds 
ratio (OR), 95% CI 
CARDIAC       
RCRI  787(0) nil 1.41(1.262) 
[1(0,6)] 
1.38(1.247) 
[1(0,6)] 
1.77(1.461) [2(0,6)] 1.251[1.001, 1.665], 
p=0.049  
OTHER 
PREDICTORS 
      
Hb  gm/dL 774(13) 5(0, 117, 
906) 
13.4(2.141) 
[13.7(5, 19)] 
13.43(2.121) 
[13.7(5.9, 19)] 
12.99(2.432) [13.55(5, 
16.7)] 
 0.915[0.800, 
1.046],p=0.194 
Urea mmol/l 776(11) nil 5.33(3.7533) 
[4.9(1, 73)] 
5.33(3.832) 
[4.9(1, 73)] 
5.35(2.049) [5.15(2.3, 
14.5)] 
 1.001[0.924, 
1.084],p=0.984 
creatinine 
μmol/l 
775(12) 6 
(6,21,8,11,
8,38) not 
excluded 
90.86(20.404) 
[89(6, 313)] 
90.65(20.613)[8
9(6, 313)] 
94.25(16.380) [93(66, 
137)] 
 1.007[0.995, 
1.020],p=0.255 
Glucose 
mmol/l 
651(136) 2 (115, 97) 6.22(1.869) [ 
5.7(2, 18)] 
6.2(1.858) [ 
5.7(2, 18)] 
6.52(2.066) [5.7(4, 
12)] 
 1.081[0.926, 
1.262],p=0.324 
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Table 20 Distribution and mortality for categorical predictors 
Categorical 
predictors 
Missing n 
(%) 
Excluded 
values 
Distribution of 
categories (%) 
Mortality 
rates (%) 
Unadjusted odds ratio, 
95% CI 
GENDER nil     
Male   559(71) 37(6.6) 2.238[0.983,5.096],p=0.055‡ 
Female   228(29) 7(3.1)  
AGE      
Age <70   518(65.9) 25(4.8)  
>70 
  268(34.1) 18(6.7) OR 1.42[0.760,2.652], 
p=0.271 
OPERATION 2(0.3)     
Other   261(33.2) 9(3.4) reference 
Oesophagectomy 
  331(42.1) 20(6) 2.190[0.928, 5.170], 
p=0.074‡  
Total 
Gastrectomy 
  193(24.5) 14(7.3) 1.801[0.806, 4.024], p=0.153 
HISTOLOGY 73 (9.3) nil    
Adenocarcinoma   546(76.5) 34/546(5.9%) 0.661[0.295, 1.484], p=0.316 
Benign   35(4.9)  0/35(0%) 0[0], p=0.998 
Other   40(5.6)  1/40 (2.5%) 0.272[0.033,2.254], p=0.228 
Squamous cell 
carcinoma 
  93(13)  8/93(8.6%) Reference 
TUMOUR (TNM) 
STAGE  
146(18.6)  (119 (TX) &  26 "< equal 2")    
<=T2     Reference 
T0   11(1.7) (0.8) 0[0,], p=0.999 
T1   55(8.5) 2(3.6%) 0.943[0.082, 10.901], 
p=0.963 
T2   75(11.7) 6(8%) 2.174[0.249, 18.961], 
p=0.482 
T3   437(68.2) 25(5.7%) 1.250[0.124, 12.603], 
p=0.850 
T4   63(9.8) 3(4.8%) 1.517[0.197, 11.657], 
p=0.690 
N0   325(41.3) 14(4.3) Reference 
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Categorical 
predictors 
Missing n 
(%) 
Excluded 
values 
Distribution of 
categories (%) 
Mortality 
rates (%) 
Unadjusted odds ratio, 
95% CI 
N1   387(49.2) 27(7) 1.666[0.858, 3.233], p=0.131 
N2   7(0.9) 0 0[0,], p=0.999 
RESPIRATORY      
Smoker 6(0.8%)     
Yes   533(68.2) 13/248(5.2%) 1.078[0.552, 2.105], p=0.826 
No   248(31.8) 30/533(5.6%) Reference 
Smoker 
category  
12(1.5%)     
Smoker   212(26.9) 10/212(4.7%) 0.845 [.363, 1.970] p=0.697 
Ex-smoker   328(41.7) 20/328(6.1%)  1.109 [.540 2.276] p=0.778 
Non-smoker   235(29.9) 13/235(5.5%) Reference 
Respiratory 
disease  
22(2.8%)     
Yes   159(20.8)  5/159(3.1%) 0.499[.193,1.292],p=0.152 
No   606(79.2) 37/606(6.1%) Reference 
Lung disease 
category 
na nil    
COPD  
na  64(8.1) 4/64(6.3%) Logistic regression not 
performed as no valid 
comparator 
Chronic  na  31(3.9) 1/31(3.2%)  
Asthma  na  73(9.3) 0/73(0)%  
Acute  na  13(1.7) 1/13(7.7%)  
CARDIAC      
Cardiac disease 2(0.2%) nil    
Not present   448(57) 23(5.1) Reference 
Present   338(43) 20(5.9) 1.162[0.627, 2.153], p=0.633 
      
      
RCRI category (4 
level) 
nil nil    
0   231(29.4) 11(4.8) Reference 
1   221(28) 9(4.1) 0.849[0.345,2.049], p=0.722 
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Categorical 
predictors 
Missing n 
(%) 
Excluded 
values 
Distribution of 
categories (%) 
Mortality 
rates (%) 
Unadjusted odds ratio, 
95% CI 
2 
  185(23.5) 10(5.4) 1.1143[0.474, 2.753], 
p=0.766 
3 
  150(19.1) 14(9.3) 2.059,[0.908, 4.666], 
p=0.084‡ 
RCRI category     
(2 level) 
nil nil    
1   452(57) 20(4.4) Reference 
2 
  335(42.6) 24(7.2) 1.667[0.905, 3.071], 
p=0.101‡ 
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4.3.2 Selected plots of candidate predictor distributions and their relation to 
mortality 
Mortality was plotted against predictors from the ‘Clinical’ model and those 
with p values less than 0.05 in univariate analysis (Figure 5 and Figure 6); 
these follow on the next pages. With the exception of the 61 to 64 year old 
age group, the relationship between age and mortality appeared non-linear 
with a greater effect in 7th, 8th and 9th decades. It was not clear whether this 
represented the typical logistic function or may instead benefit from the 
addition of a squared ‘age’ term. The addition of ‘age squared’ only changed 
the -2 log likelihood by 0.570 (p=0.45) for the loss of one degree of freedom 
providing evidence against any improvement in data fit. This lack of added 
predictive power for ‘age square’ has also been reported in 4080 patients 
from the Medicare system (Finlayson and Birkmeyer, 2001; Steyerberg, 
2009d) and thereafter I used the simple linear age transformation. 
Mortality also appeared to increase with and possibly accelerated with 
higher scores for the RCRI, as might be expected. However, it can be seen 
from the distribution that the numbers in the high scores were very low, 
and therefore it was possible that this observation could be random. 
There were also hints of increasing mortality patterns as weight loss 
increased, and albumen decreased, although these were clouded by isolated 
deviations from the observed trends. Increasing white cell count was also 
associated with increasing mortality in univariate logistic regression, but on 
the plot it could be imagined that the pattern was U-shaped. This could be 
plausible, as one might imagine that patients with acute illness (high white 
cell count) or immunosuppression after chemotherapy (low white cell count) 
might have more post-operative complications. I ran a univariate 
association for a three category white cell count (low, normal and high), 
which was not statistically significant. 
4. Clinical prediction model of perioperative mortality 
 
127 
 
 
Figure 5 Distribution of candidate predictors and their association with mortality 
[mean & 95% CI] (a) 
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Figure 6 Distribution of candidate predictors and their association with mortality 
[mean & 95% CI)(b). 
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4.3.3 Selection of prediction model 
To aid identification and referencing in text and tables, the individual 
models and their component predictors are listed in Table 21. 
Table 21 Key to models and their constituent predictors 
Model Name Model description and constituent 
predictors 
Clinical  age, operation, albumen, RCRI, FEV1(% predicted) 
Clinical(I) Based on imputed datasets with age, operation, 
albumen, RCRI, FEV1(% predicted) 
Clinical_sex Clinical model with gender 
Clinical(I)_sex(R) Based on clinical model with gender but excluded 
RCRI; based on imputed datasets 
Clinical(I)_ sex Based on clinical model from imputed datasets with 
gender 
Clinical(I)_sex(INT) Based on clinical model from imputed datasets with 
gender and RCRI*age interaction 
Statistical1 Based on stepwise elimination; final model 
contained age, operation, gender, weight loss % 
Statistical2 Based on stepwise elimination which did not 
contain weight loss at outset; final model contained 
age, gender 
Prag A ‘Pragmatic’ model based on simple complete 
dataset with reliable predictors (age, gender, 
operation) 
Prag(INT) Pragmatic with operation*age interaction 
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Clinical model 
The prespecified ‘clinical’ model with age, operation, RCRI, FEV1, and 
serum albumen explained the data better than a constant only (Likelihood 
ratio test: χ2 =16.038, 6 df, p=0.014). The Hosmer-Lemeshow statistic 
(p=0.547) did not provide evidence against a reasonable fit to the data 
(Table 22). Both age and operation remained significant for mortality after 
adjustment (Wald test for coefficients, P<0.1) (Table 23). Serum albumen, 
FEV1 and RCRI were not significantly associated with mortality after 
adjustment for the other predictors. Age was correlated with RCRI (r=0.5), 
so a reduction in significance values for both coefficients was expected, 
however there were 175 missing cases in the clinical model compared to the 
univariate analysis sample, therefore differences between the modelling 
samples may have contributed. Sample sizes and mortality rates for each 
model are shown in Table 22. Odds ratios generally ranged from 0.3 to 3.5 
(thoracoabdominal oesophagectomy), and discrimination was moderate 
(AUC 0.696). Odds ratios for the predictors in each model are summarised 
in Table 23. 
Statistical models 
I have named ‘statistical’ models those which were developed using ‘data 
driven’ stepwise elimination. A global test of ‘no regression’ was performed 
on a dataset containing all predictors which were entered into a backward 
elimination process, as suggested by Harrell (Harrell, 2001d). The following 
predictors were initially included: all predictors from the clinical model, 
smoker status, respiratory disease, preoperative arterial pO2, percentage of 
reported weight loss, white cell count, tumour histology, T and N tumour 
stage (Deans and Patterson-Brown, 2009), gender and operation date. The 
initial model with all predictors explained variation in the dataset better 
than the constant (χ2 =35.698, 14 df, p=0.001). The final stepwise statistical 
model (excluding variables for p<0.05) contained age, percentage weight loss, 
operation and gender, and when run on a full dataset predicted mortality in 
the modelling sample better than the ‘clinical’ model (χ2=36.216, 5 df, 
p<0.001, Nagelkerke’s R 2 0.197, AUC 0.831). However, 30% of weight loss 
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data was missing, which resulted in the stepwise procedure using only 375 
cases with 18 deaths. Repeating the stepwise analysis without weight loss 
resulted in a model with only age and gender (43 deaths) and a reduced 
Nagelkerke’s R 2 of 0.043 and AUC 0.667 (χ2 =11.68, 2 df, p<0.003). These 
findings lend support to the inclusion of age and surgical procedure in the 
pre-specified ‘clinical’ model. Gender and weight loss were not initially 
considered for the pre-specified clinical model, but it would not be surprising 
if they were important, and they will be explored later in the section.
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Table 22 Characteristics of prediction models developed from modelling sample (see Table 21 for key to models) 
 
Prediction model   Model summary   Hosmer-Lemeshow ROC  
 Cases(missing) deaths χ2 df p value -2LL 
Nagelkerke's 
r2 
χ2 p AUC(se) 95% CI 
Clinical  612(175) 30 16.038 6 0.014 223.399 0.08 6.998 0.537 0.696(0.047) 0.605, 0.788 
Clinical(I)  785(2) 43 14.180 to 
15.739 
6 0.015 to 
0.028 
318.627 to 
319.206 
0.052 to 
0.057 
3.603 to 
13.345 
0.101 to 
0.891 
0.680 to 
0.682 
0.599 to 0.604, 
0.760 to 0.763 
Clinical_ sex 612(175) 30 19.843 7 0.006 219.953 0.099 4.38 0.821 0.719(0.04) 0.633, 0.805 
Clinical(I)_sex(R) 785(2) 43 20.246 to 
22.738 
7 0.002-
0.005 
310.648 to 
313.104 
0.074 to 
0.083 
4.152 to 
10.358 
0.241 to 
0.843 
0.698 to 
0.706 
0.623 to 0.631, 
0.773 to 0.779 
Clinical(I)_ sex 785(2) 43 20.034 to 
22.594 
6 0.001 to 
0.003 
310.792 to  
313.351 
0.073 to 
0.082 
1.571 to 
6.375 
0.605 to 
0.991 
0.696 to 
0.703 
0.620 to 0.631, 
0.772 to 0.778 
Clinical(I)_sex(INT) 785(2) 43 23.307 to 
26.280 
8 0.001 to 
0.003 
308.901 to 
310.079 
0.085 to 
0.089 
1.571 to 
6.375 
0.667 to 
0.991 
0.696 to 
0.705 
0.620 to 0.631, 
0.772 to 0.778 
Statistical1 546(241) 27 36.216 5 0.001 178.792 0.197 6.345 0.609 0.831(0.03) 0.772, 0.891 
Statistical2 786(1) 43 11.68 2 0.003 321.819 0.043 3.976 0.859 0.667(0.04) 0.594, 0.740 
Prag  785(2) 43 17.121 4 0.002 316.265 0.062 10.47 0.234 0.691(0.038) 0.616, 0.765 
Prag(INT) 785(2) 43 22.608 6 0.001 310.778 0.082 5.686 0.682 0.712 0.640, 0.784 
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Table 23 Odds ratios (95% CI) and statistical significance for predictors in each prediction model 
 Clinical Clinical_sex  Clinical(I) Clinical(I)_sex Statistical1 Statistical2 Pragmatic Clinical(I)_sex(R) Prag(INT) Clinical(I)_sex(INT) 
Predictors            
RCRI 0.997(0.715,1.392); 
p=0.988 
0.963(0.687,1.351); 
p=0.829 
 1.084; 
p=0.565 
1.063(0.665) NA NA NA NA  0.37; p=0.1 
Albumen 0.945(0.871,1.025); 
p=0.174 
0.953(0.878,1.034); 
p=0.246 
 0.956; 
p=0.136 
0.958(0.169) NA NA NA 0.96; p=0.18  0.961; p=0.191 
FEV1 (%predicted) 0.304(0.065,1.409); 
p=0.128 
0.337(0.071,1.594); 
p=0.170 
 0.438; 
p=0.29 
0.47(0.334) NA NA NA 0.468; p=0.322  0.425; p=0.285 
Age 1.994(1.157,3.434); 
p=0.0129 
2.068(1.190,3.596); 
p=0.010 
 1.665; 
p=0.022 
1.707(0.017) 2.147(1.273,3.622); 
p=0.004 
1.608(1.131,2.286); 
p=0.008 
1.729(1.195, 
2.503); 
p=0.004 
1.79; p=0.003 3.115; 
p=0.014 
1.249; p=0.401 
Operation  
 
 p=0.064    p=0.011  p=0.09 p=0.015 p=0.053  
Thoracoabdominal 
oesophagectomy 
3.504(1.248,9.841); 
p=0.017 
3.347(1.193,9.392); 
p=0.022 
 2.813; 
p=0.02 
2.68(0.026) 6.595(1.914,22.720); 
p=0.003 
 2.160(0.946, 
4.934); 
p=0.068 
2.641; p=0.028 144.631; 
p=0.032 
2.905; p=0.019 
Total gastrectomy 2.655(0.903,7.807); 
p=0.076 
2.746(0.931,8.097); 
p=0.067 
 2.691; 
p=0.028 
2.69(0.028) 3.677(0.976,13.848); 
p=0.054 
 2.563(1.071, 
6.135); 
p=0.035 
2.698; p=0.027 8.828; 
p=0.409 
2.907; p=0.02 
Gender NA 2.665(0.899,7.905); 
p=0.077 
 NA 2.097(0.083) 12.841(1.700, 
97.025); p=0.013 
2.245(0.981, 
5.140); p=0.056 
2.253(0.980, 
5.175); 
p=0.056 
2.123; p=0.077 2.251; 
p=0.057 
2.15; p=0.075 
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 Clinical Clinical_sex  Clinical(I) Clinical(I)_sex Statistical1 Statistical2 Pragmatic Clinical(I)_sex(R) Prag(INT) Clinical(I)_sex(INT) 
% weight loss NA NA  NA NA 1.058(1.017,1.102); 
p=0.006 
 NA NA  NA 
Constant 0.047; p=0.122 0.013; p=0.041  0.047; 
p=0.039 
0.021(0.014) 0.001; p=0.00 0.005; p=0.00 0.002; 
p=0.00 
0.018; p=0.01  0.061; p=0.087 
Interactions            
Age*RCRI interaction           1.289; p=0.066 
Age*operation 
interaction 
         p=0.07  
Age*oesophagectomy 
interaction 
         0.355; 
p=0.05 
 
Age*gastrectomy 
interaction 
         0.776; 
p=0.668 
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4.3.4 Models based on imputation datasets 
Complete case analysis in the pre-specified ‘Clinical’ model resulted in 175 
missing cases and the loss of about 30% of events. Therefore I tried to 
optimise available data using multiple imputations to replace missing 
values from serum albumen (4% missing) and FEV1 (8 % missing), both of 
which had reasonably ‘normal’ distributions. 
SPSS generated 5 imputed datasets for each predictor, all of which had 
means, standard deviations and ranges, which were similar to the original 
data. This increased the number of deaths available to study from 27 to 43 
and reduced the missing cases to 2. Logistic regression (in SPSS) was 
performed on the imputed datasets and SPSS produced pooled averaged 
regression coefficients for each model. The performance measures 
(Nagelkerke’s, -2LL etc.) for the models were not pooled in SPSS and were 
given as ranges for imputation based models in the summary tables. 
The regression results for the ‘Clinical’ models were similar for both the 
original and the imputed datasets, but the odds ratios were reduced for age 
(1.994 to 1.665) and the oesophagectomy operation category (3.504 to 2.813) 
in the imputed data, suggesting possible overfitting in the original smaller 
sample (Table 23). 
4.3.5 Exploration of weight loss, gender, RCRI and operation 
Gender and ‘weight loss’ were identified in the stepwise elimination model 
as potentially important predictors in the model and warranted further 
investigation. 
 Gender 
In the stepwise elimination model, which included ‘weight loss’, gender was 
highly significant (p=0.013) with a large OR (12.84, 95% CI 1.700, 97.025) 
and confidence interval. The odds ratio reduced to 2.665 (95% CI 0.899, 
7.905) when weight loss was excluded from the stepwise model. This was 
possibly caused by an imbalance in deaths between males and females in 
missing and non-missing data, caused by the 30% missing ‘weight loss’ 
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predictor (Table 24). Female mortality rate was 0.6% (one death) when cases 
with ‘weight loss’ were non-missing, and 8.8% (6 deaths) in missing cases. 
This imbalance may also account for the extremely large odds ratio (12.84) 
for gender.
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Table 24 Mortality count (%) within gender for missing and non-missing weight loss 
data 
 Male Female Total 
Non missing 26(6.7%) 1(0.6%) 27 
Missing 11(6.4%) 6(8.8%) 17 
 
It is possible that there was a systematic difference between genders for 
other important predictors, however this did not appear to be the case. 
Males had a modestly higher rate of oesophagectomy relative to other 
operations, a higher rate of adenocarcinoma, and about 15% lower non-
smoker rate. The latter was not a predictor of outcome and there were no 
other significantly unbalanced predictor distributions to explain the results. 
It is possible that other unobserved predictors could have been unevenly 
distributed between genders. The means for continuous variable predictors 
are given in Table 25 and the distributions of categorical variable predictors 
are given in Table 26.  
Table 25 Continuous predictor means by gender 
  Male Female 
Age  65.38 65.59 
Serum albumen  41.45 41.76 
Weight loss (%)  8.86 9.60 
pO2 (kPa)  12.31 12.22 
FEV1 (% predicted) 0.86 0.91 
 
Gender is considered important for many outcomes and perhaps I should 
have considered including it at the outset, but there was no strong evidence 
for its inclusion from the systematic review, and there was a limit on how 
many predictors could have been included given the relatively small sample 
size. This modest evidence of effect together with the background of its 
importance suggests that it should be included in the ‘Clinical’ model. 
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Table 26 The distribution of categorical predictors between genders 
  
Male Female 
Operation Other 180(32.3%) 81(35.5%) 
 
Thoracic Oesophagectomy 246(44.2%) 85(37.3%) 
 
Total gastrectomy 131(23.5%) 62(27.2%) 
Histology Adenocarcinoma 403(81.1%) 143(65.9%) 
 
Benign 22(4.4%) 13(6.0%) 
 
Other 21(4.2%) 19(8.8%) 
 
Squamous cell carcinoma 51(10.3%) 42(19.4%) 
T stage < or equal 21(4.4%) 5(2.6%) 
 
T0 7(1.5%) 4(2.1%) 
 
T1 33(6.9%) 22(11.5%) 
 
T2 51(10.7%) 24(12.5%) 
 
T3 318(66.9%) 119(62.0%) 
 
T4 45(9.5%) 18(9.4%) 
N stage N0 224(44.1%) 101(47.9%) 
 
N1 279(54.9%) 108(51.2%) 
 
N2 5(1.0%) 2(0.9%) 
Smoker status 1 148(27.0%) 64(28.3%) 
 
2 256(46.6%) 72(31.9%) 
 
3 145(26.4%) 90(39.8%) 
Respiratory disease None 425(78.3%) 181(81.5%) 
 
Present 118(21.7%) 41(18.5%) 
 Weight loss 
Weight loss was apparently a strong predictor in the statistical model 
(Nagelkerke’s R 2  0.197, AUC 0.831) and clinical knowledge would support 
this. However, nearly 30% of the data was missing and its effect could have 
been random, therefore it was not considered credible to use a model with 
weight loss. It was also not clear in the database whether blank cells meant 
missing or zero and therefore the replacement of this quantity of data by 
imputation methods seemed to lack ‘face validity’. 
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 Revised Cardiac Risk Index (RCRI) 
There was no missing data for this predictor, but I also investigated its 
apparently weak effect in imputed datasets for the ‘clinical’ model because 
cases were excluded as a result of other missing predictors. Its correlation 
coefficient with age was 0.5 (Table 27), which probably explains its loss of 
predictive effect in the multivariate model (χ2 ranged from 0.08 to 0.136, 2 
degrees of freedom, p values all >0.7 in the imputed datasets) and clinical 
models with and without RCRI had similar predictive power. The inclusion 
of RCRI did not add predictive power but in view of the supporting evidence 
I kept it in the model. 
 Surgical procedure 
The similar odds ratios and confidence intervals for the different operations, 
thoracoabdominal oesophagectomy and total gastrectomy (2.812 vs 2.691), 
compared with ‘other’ operations suggest a two category surgical predictor 
could be used (‘major’ cancer resection and ‘other’). In all imputation sets 
the inclusion of ‘operation’ (χ2 6.498 to 7.233, 2 degrees of freedom, p<0.04) 
improved the clinical model. ‘Operation’ results were similar whether coded 
as two or three categories, and therefore, although this used another ‘degree 
of freedom’, I included the three category ‘operation’ predictor to allow an 
‘oesophagectomy specific’ model. 
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Table 27 Correlation between predictors in the modelling sample (Spearmans rho) 
 Gender RCRI albumen FEV1 (% 
predicted) 
Operation Weight 
loss (%) 
RCRI -0.043; p=0.232 (n=787)    
albumen 0.053; 
p=0.143 
(n=755) 
0.000; p=0.990 (n=755)   
FEV1 (% 
predicted) 
0.056; 
p=0.155 
(n=636) 
0.010; 
p=0.800 
(n=636) 
.156; p=0.000 (n=613)   
Operation 0.054; 
p=0.129 
(n=785) 
.133; 
p=0.000 
(n=785) 
-.169; 
p=0.000 
(n=753) 
-.174; p=0.000 (n=635)  
Weight loss 
(%) 
0.044; 
p=0.307 
(n=541) 
0.025; 
p=0.567 
(n=541) 
-.235; 
p=0.000 
(n=523) 
-0.049; p=0.303 
(n=437) 
.135 p=0.002 (n=540) 
Age 0.023; 
p=0.520 
(n=786) 
.560; 
p=0.000 
(n=786) 
-.137; 
p=0.000 
(n=754) 
.081; p=0.042 
(n=636) 
.152; 
p=0.000 
(n=785) 
.100; 
p=0.020 
(n=541) 
4.3.6 A ‘Pragmatic’ model 
I subsequently considered a model based on simplicity, reliable complete 
data, and with reasonable evidence of ‘face validity’ for its constituent 
predictors, based on the results of this study and other published 
information. This ‘Pragmatic’ model included age (strong evidence), gender 
(some evidence) and surgical procedure (to focus on ‘oesophagectomy’). The 
‘clinical’ models with more predictors explained more variance in the 
modelling sample, and discriminated better then the ‘Pragmatic’ model, as 
would be expected. 
4.3.7 Modelling assumptions 
Logistic regression assumes a binomial distribution for outcome, and 
additivity of predictor effects but makes no distributional assumptions 
about the predictors. Linearity of response is not essential but desirable for 
a stable model (Harrell, 2001a). The natural log of the odds ratio for 
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mortality was linearly related to age but not obviously with FEV1, serum 
albumen and RCRI were less clear. There appeared to be no obvious data 
transformations which could be applied to the predictors. 
4.3.8 Interactions between main predictors 
The relatively few degrees of freedom compared to the number of events 
gave little scope to investigate interactions between the main effects without 
‘overfitting’. One might expect the effects of cardiac, respiratory and 
nutritional comorbidity to be different in younger and older age groups so I 
focussed on these in the ‘clinical’ model and I also examined interactions 
between the main predictors of the ‘Pragmatic’ model. These are 
summarised in Table 28 and Table 29. 
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Table 28 Effect of adding interactions to the ‘clinical’ model for original dataset 
(n=612) and full imputed datasets. Chi-square & p value for likelihood ratio tests 
and OR are given for the addition of each interaction. Medians and ranges are given 
for each of the imputed datasets. 
Original dataset Imputed datasets 
Interaction Chisq (p) Odds ratio 
(p) 
Median chisq 
(min,max) 
Median p 
value(min,max) 
Pooled OR 
(p) 
Age*fev1 0.002(0.962) 0.995(0.962) 0.123(0.01,3.26) 0.726(0.07,0.91) 1.578(0.617) 
Age*albumen 1.069(0.301) 0.952(0.31) 3.05(2.56,4.35) 0.081(0.04,0.11) 0.940(0.083) 
Age*rcri 0.039(0.843) 0.96(0.843) 2.964(2.85,3.29) 0.085(0.07,0.09) 1.273(0.075) 
Fev1*rcri 0.058(0.809) 1.162(0.808) 0.129(0.01,1.5) 0.719(0.22,0.92) 1.231(0.72) 
Age*gastrectomy  1.467(0.617)   0.817(0.739) 
Age*oesophag  0.731(0.617)   0..369(0.06) 
 
Table 29 Effect of adding interactions between main effects in the ‘pragmatic’ model; 
chi square and p value for the likelihood ratio addition step in SPSS. 
Interaction Chisquare(p value) OR (p value) 
Age*gender 0.013(0.918) 1.057(0.907) 
Gender*operation 3.491(0.175)  
Gender*oesophagectomy  0.118(0.091) 
Gender*gastrectomy  0.487(0.467) 
Age*oesophagectomy  0.355(0.05) 
Age*gastrectomy  0.776(0.668) 
 
There was weak evidence that the effect of serum albumen (chronic illness 
or malnutrition) and cardiovascular comorbidity may be altered by age. This 
was only apparent in the nearly complete imputation sets (Table 28). The 
mortality rates by age group and RCRI score are shown in Table 30, where 
it can be seen that most of the cells for old age and high risk are empty 
because of the low prevalence of high risk scores in the elderly. This does 
not give good evidence to conclude an interaction.
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Table 30 Mortality grouped by RCRI score and age quintile (fatalities/total cases 
per cell (%) in original modelling dataset 
RCRI score        
 0 1 2 3 4 5 6 
Age ascending  
quintiles (yrs) 
     
<=58 3/97(3.1) 0/51(0) 0/23(0) 0/5(0) 0/3(0) 0/0(0) 0/0(0) 
<=64 4/72(5.6) 4/44(9.1) 2/17(11.8) 0/8(0) 0/2(0) 0/0(0) 0/0(0) 
<=69 2/44(4.5) 2/48(4.2) 1/39(2.6) 2/15(13.3) 0/3(0) 0/0(0) 0/0(0) 
<=74 2/13(15.4) 0/46(0) 3/59(5.1) 2/37(5.4) 2/10(20) 0/2(0) 0/1(0) 
>74 0/0(0) 3/32(9.4) 4/47(8.5) 4/33(12.1) 2/21(9.5) 0/5(0) 1/2(50) 
 
There was some evidence that the effect of age varied in different operations 
in both Clinical and Pragmatic models (Table 29). For example, the odds 
ratio for the age*oesophagectomy interaction is 0.355 i.e. the ratio of the 
effect of a unit change in age on mortality for oesophagectomy relative to the 
same change in ‘other’ operations. The odds ratio for the age*gastrectomy 
interaction is 0.776, so the ratio of the two suggests that the effect of age for 
gastrectomies is about twice that for oesophagectomies. Calculating the 
same ratios for patients under 64 and over 74 from cross tabulation (Table 
31) gives a ratio of an age effect about three times greater in gastrectomies. 
Comparisons were on slightly different data as the tables were based on age 
group quintiles whereas the logistic regression was on age as a continuous 
variable, but the overall trend was apparent. The explanation is not clear, 
but one could speculate that thoracoabdominal oesophagectomy is seen as a 
more stressful operation, and therefore selection is more conservative in the 
elderly, so only the fittest elderly patients undergo this operation. 
Table 31 Mortality (count (%)) in age groups for each type of operation in the 
modelling dataset 
  Operation (count (%)) 
  "Other" Total gastrectomy Oesophagectomy 
Age ascending  
quintiles 
  
  
<=58 0/49(0) 0/52(0) 3/81(3.7) 
<=64 2/38(5.3) 1/26(3.8) 7/80(8.8) 
<=69 0/50(0) 5/41(12.2) 2/60(3.3) 
<=74 1/63(1.6) 2/36(5.6) 6/69(8.7) 
>74 6/61(9.8) 6/38(15.8) 2/41(4.9) 
Total 9(3.4) 14(7.3) 20(6) 
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4.3.9 Outliers and influential values 
Standardised residuals represent the difference between the predicted 
probability and outcome, which is either 0 or 1, and are therefore difficult to 
interpret. They are normally distributed with a mean of zero and standard 
deviation of 1, therefore one would expect about 95% to be less than 2 and 
99% to be less than 2.5. Ninety five per cent of standardised residuals were 
less than 2 in the clinical model and 98.5% less than 2.5 in the clinical 
model, which included gender. Unsurprisingly all cases with residuals 
greater than 2 were fatalities (low prevalence of mortality and weakly 
predicting model). Only about 1% of residuals exceeded 2 in the Pragmatic 
model. 
Leverage, which should lie between 0 and 1 and gives an estimate of the 
effect on the overall model of that case, was less than 0.1 for all models, 
except for one case in the Clinical model. This (case 557) value was 0.7 and 
its DfBeta (gives an estimate of that case’s effect on the regression 
coefficient and should be less than 1) for the constant was about 1.2 in both 
Clinical models. Case 557 was an elective surgical case, who had a subtotal 
gastrectomy and a hemicolectomy, was obese, chronically ill (serum 
albumen 28 gm/lit and white cell count 19.3), had poor respiratory function 
and various cardiac comorbidities and did not survive. This case was at the 
extreme end of poor health before elective surgery, but I could see no reason 
to exclude it from the model. 
4.3.10 Validation 
I decided to test four base models. Firstly, the prespecified Clinical model 
derived on original and imputed datasets. Secondly the Clinical model 
(imputed) including gender and a ‘Pragmatic’ model which contained 
reliable predictors from a complete dataset i.e. age, gender and operation. 
Finally, I decided to apply the ‘Rotterdam’ model to the validation sample. 
 The validation sample 
The number of cases for continuous predictors and their means are shown in 
Table 32. The number of cases and distributions of categorical predictors are 
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shown in Table 33. There were 785 cases with 43 deaths in the validation 
sample. Missing values were similar in both modelling and validation 
samples. There were considerably more high RCRI scores in the modelling 
sample (Table 33). 
Table 32 Case summary and means of predictors in development & validation 
samples 
 
Development Validation 
 
cases Mean (sd) cases Mean (sd) 
Age 786 65.44 (10.19) 785 65.16 (10.43) 
RSRI (score) 787 1.41 (1.26) 785 1.75 (1.77) 
Albumen 755 41.54 (5.45) 769 41.68 (4.69) 
% weight loss 547 9 (9) 561 9 (9) 
FEV1 (% predicted) 636 0.87 (0.25) 641 0.93 (0.28) 
Table 33 Cases, mortality and distribution of categorical predictors in development 
and validation samples 
Predictor Development (number of cases) Validation (number of cases) 
Total cases 787 785 
Deaths 44 43 
RCRI (total score) 
 0 231 233 
1 221 196 
2 185 140 
3 99 85 
4 39 62 
5 9 36 
6 3 24 
7 0 6 
8 0 1 
9 0 1 
13 0 1 
Operation 
 Oesophagectomy 331 356 
Total gastrectomy 193 184 
Other operation 261 245 
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Predictor Development (number of cases) Validation (number of cases) 
20Gender 
  Male 228 231 
Female 559 554 
 The prediction models and their associated validation sample 
Descriptions of the prediction models, the number of complete cases and 
mortalities (observed and predicted), with which each model was associated, 
are shown in Table 34 on the following page. Models based on the ‘Clinical’ 
model were validated on smaller samples (635 cases and 29 deaths) than the 
‘Pragmatic’ or ‘Rotterdam models (785 cases and 43 deaths) because of the 
missing data on their comorbidity predictors in the validation sample. The 
‘statistical’ model was validated on 561 cases (33 deaths) because of missing 
data in weight loss.
                                            
Cases, mortality and distribution of categorical predictors in development and 
validation samples 
20  
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Table 34 Description of validated models, associated case numbers and observed and predicted mean mortality 
Model 
Description 
 
Cases 
(missing) Deaths 
Observed 
mortality 
Mean predicted 
mortality 
Range of predicted 
mortality (2 dec places) 
Clinical Prespecified with age, operation, RCRI, 
FEV1, albumen 
635(150) 29 0.051 0.051 <0.01, 0.23 
Clinical(I) As above from imputed datasets 635(150) 29 0.051 0.058 <0.01, 0.22 
Clinical(s) Clinical model with shrinkage factor applied 635(150) 29 0.051 0.046 0.01, 0.13 
Clinical(INT) Clinical with interaction between age & 
RCRI (imputed) 
635(150) 29 0.051 0.057 <0.01, 0.3 
Statistical Data driven from stepwise regression; age, 
weight loss, operation, gender 
561(224) 33 0.059 0.031 <0.01, 0.18 
Pragmatic Age, operation, gender 785(0) 43 0.055 0.055 <0.01, 0.2 
Prag(INT) As above with operation * age interaction  785(0) 43 0.055 0.055 <0.01, 0.29 
Rotterdam Rotterdam model 785(0) 43 0.055 0.061 0.02, 0.17 
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 Model Calibration 
Calibration plots were generated using the function val.prob.ci (Vergouwe 
and Steyerberg, 2009). The main components of the output are summarised 
below. 
1) Calibration in the large’ gives a measure of whether the prediction model 
is accurate for the overall mean mortality for the whole validation 
sample. It is reported as an odds ratio for the average under or 
overestimation of the mortality (Steyerberg, 2009h, p. 272) and is given 
as the ‘Intercept’ on the calibration plot. A negative intercept implies the 
model is overestimating mortality in general and vice versa for positive 
values. I confirmed that the ‘Intercept’ values from val.prob.ci tally with 
the calculation which gives the odds ratio for overall calibration (in SPSS) 
(Steyerberg, 2009e, p. 272). This is calculated by running a logistic 
regression of the observed outcomes in the validation sample against 
logit of their predicted probabilities, which have been generated from the 
modelling sample equation. The odds ratio for over or under calibration 
is then the odds (mean [predicted mortality])/odds (mean [new 
predictions]). 
2) The solid line (“Logistic calibration”) is generated from the logistic 
regression of the observed outcomes against the logit of their predicted 
mortalities in the validation dataset. The plot is of the new mortality 
predictions against the logit of the original predictions, representing how 
well the predictions from the model explain the outcomes in the 
validation sample (Harrell, 2001e, p. 250; Steyerberg, 2009h, p. 272). The 
slope quantifies this; a perfect predictor would have a slope of one, 
represented by the dashed (“Ideal”) line in the plot. 
3) Local regions of poor calibration can be shown graphically. One method 
is to plot the mean observed mortality (y axis) against the mean 
predicted mortality (x axis), for deciles of patients after sorting predicted 
probabilities in ascending order, as in the Hosmer-Lemeshow ‘goodness 
of fit’ statistics (Lemeshow and Hosmer, 1982). This plot is represented 
by triangles on the plot and each has confidence intervals (95%) for the 
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observed mortality. The dotted line (“Nonparametric”) uses the LOWESS 
smoother, a non-parametric algorithm which fits a smoothed trend for 
individual points and allows visualisation of local areas of poor fit 
(Cleveland, 1979). 
4) The histograms, which are adjacent to the calibration plots, were 
constructed using ‘ggplot2’ (Wickham, 2009) and show the distributions 
of the predicted mortalities for survivors and non-survivors (Appendix G 
iv. ). 
Calibration plots and histograms for the predicted mortalities of selected 
models are shown in Figure 7 to Figure 10 on the following pages. The odds 
ratios for overall mis-calibration ranged from -0.01 to -0.2 for the ‘Clinical’ 
model and its variants to -0.13 for the ‘Rotterdam’ model and 0.7 for the 
‘Statistical’ model. The ‘Pragmatic’ models were best calibrated overall with 
an ‘Intercept’ of -0.01. The range of predicted mortalities was mostly from 
zero to about 0.2, but up to 0.3 in models, which included interactions (age 
with RCRI in the ‘Clinical’ model and age with operation in the ‘Pragmatic’ 
model). The predictions explained observed mortality best in the ‘Pragmatic’ 
models (slope of 0.85) and worst in the ‘Statistical’ (slope 0.37), with ‘Clinical’ 
based models intermediate. These values reflected a tendency to 
overestimate mortality in the higher prediction ranges, which was also 
demonstrated in the Lowess plots for predictions over about 10%. The 
‘Rotterdam’ model was mis-calibrated in the opposite direction with 
underestimation at predictions over 10%. 
Running the ‘Clinical’ model on imputed datasets improved the prediction 
slope (increased from 0.44 to 0.62) but ‘calibration in the large’ deteriorated 
(from -0.1 to -0.22). Adding the age*RCRI interaction in the ‘Clinical’ 
(imputed) model improved ‘calibration in the large’ but the calibration slope 
deteriorated. All the ‘Clinical’ models overestimated mortality at the higher 
predictions, so I also investigated the application of a shrinkage factor to the 
original ‘Clinical’ model. Prediction was examined with and without 
application of a ‘shrinkage’ factor, which is a method of dealing with 
overfitting. I used a simple uniform shrinkage factor after coefficient 
estimation using the formula: 
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s =(model Χ2  -df)/ model Χ2  (Copas, 1983; Steyerberg, 2009j). 
This considerably solved the problem of overestimation of mortality but at 
the cost of narrowing the prediction range to between 1% and 13%, which 
was unlikely to be practically useful. The calibration plots for the models are 
shown in Figure 7 to Figure 10 on the following pages. 
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Figure 7 Calibration and distribution of predicted mortalities for the prespecified 
'clinical' model and the ‘clinical’ model derived from imputed datasets. 
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Figure 8 Calibration and distribution of predicted probabilities for the 'statistical' 
and 'pragmatic' models 
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Figure 9 Calibration plots and distribution of mortality predictions for the 'clinical' 
model with age*RCRI interaction and 'pragmatic' model' with age*operation 
interaction. 
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Figure 10 Calibration plots and distribution of mortality predictions for the 
'Rotterdam' model and the 'clinical' model with shrinkage applied 
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 Model discrimination 
The c statistic for the receiver operator curves ranged from 0.603 to 0.664 in 
the models developed in this study, and was 0.721 for the Rotterdam model. 
This indicates at best a moderate capacity to discriminate between survivors 
and non-survivors. 
ROC curves generated from the ‘plotROC’ function are shown below 
(Appendix G vi. ). Both sets of plots show that discrimination for these 
models is not particularly good, consistent with the predictors not 
explaining much of the variation in the datasets. The first plot shows the 
effects of modifications to the pre-specified ‘Clinical’ model by using imputed 
datasets and including an ‘age*RCRI’ interaction, which produced marginal 
small improvements. 
 
Figure 11 Receiver operator curves for the 'clinical' model derived from original 
data, imputed data and with an age*RCRI interaction.
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The following ROC plot shows generally poor discrimination for all models, 
but the simple ‘Pragmatic’ model, and the ‘Rotterdam’ model both fared 
better than the ‘Statistical’ model which was developed and validated on 
datasets with much missing data in the weight loss variable. 
 
Figure 12 Receiver operator curves for the 'statistical', pragmatic and Rotterdam 
models. 
Prediction models as classifiers of high and low risk 
I attempted to summarise the capacity of these models to act as classifiers of 
risk. That is, can they successfully allocate patients to high or low risk 
groups? Selecting practically useful cut-offs is somewhat speculative, but 
possibly 20% predicted mortality might be an appropriate minimum. We are 
already hampered as the maximum mortality predictions for any model was 
around 20%, so this limits the capacity at the outset. Therefore I selected 10% 
and 20% as possible cut-offs for high risk. The sensitivities, specificities, and 
incorrect allocations are summarised in Table 35. The ROC values in the 
table were from the identical dataset to that used for the calibration, but 
were generated in SPSS. There are slight differences in absolute AUC 
values generated by SPSS and by the val.prob.ci function, although they are 
close and in the same order. Classification was poor with sensitivity 
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reaching a maximum of only 28% in the Rotterdam model and high numbers 
of false positives, making these models of no practical value for clinical 
decision making. The best performers were those based on fewest predictors 
(the ‘Pragmatic’ models), and the Rotterdam model. 
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Table 35 Sensitivity, specificity, true/false positive & negatives given predicted mortality cut-offs of 10% and 20% 
     Cut 10% Cut 20% 
Model cases missing deaths c statistic TP FP FN sens spec TP FP sens FN spec 
Clinical 635 150 29 0.603[0.49,0.715] 3 63 26 0.045 0.95 0 4 0 29 0.99 
Clinical(s) 635 150 29 0.603[0.49,0.715] 0 14 29 0 0.95 0 0 0 29 1 
Clinical(I) 635 150 29  0.612[0.519,0.741] 5 79 24 0.06 0.95 1 1 0.04 28 0.99 
Statistical 561 224 33 0.620[0.513,0.727] 3 24 30 0.09 0.95 0 0 0 33 1 
Pragmatic 785 0 43 0.664[0.55,0.777] 9 84 34 0.20 0.88 0 1 0 43 0.99 
Clinical(INT) 635 150 29 0.626[0.527,0.726] 5 57 24 0.08 0.96 2 7 0.07 27 0.98 
Prag(INT) 785 0 43 0.637[0.533,0.740] 7 59 36 0.16 0.92 0 6 0 43 0.99 
Rotterdam 785 0 43 0.721[0.608,0.834] 9 23 34 0.28 0.96 0 0 0 43 0.95 
Key: TP, true positive; FP, false positive; FN, false negative; sens, sensitivity; spec, specificity 
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4.4 Discussion 
Ideally this study would have been a straightforward problem of estimation, 
whereby an established model(s) or known predictors and their weights 
could have been validated on our dataset. However, the lack of a consensus 
on predictor selection, and with only one potentially applicable existing 
prediction model, the ‘Rotterdam’ model (Steyerberg et al., 2006), model 
exploration and selection became central to the study. 
4.4.1 Selection of prediction models 
I pre-specified a main ‘Clinical’ model and its predictors to try and reduce 
overfitting and subsequent overoptimism, which can occur when the model 
is matched to the modelling data and its idiosyncrasies too closely 
(Steyerberg, 2009k). The result is that small and large predicted values are 
exaggerated (Harrell, 2001c). The use of imputed datasets increased sample 
size, reduced regression coefficients, and improved the calibration slope. The 
same was true in applying shrinkage measures to the Clinical model, but at 
a cost of reducing the prediction range to very close to the overall mean 
mortality. 
A stepwise elimination model confirmed the importance of age and 
operation as a predictor and also identified weight loss and gender as 
potentially important. As a measure of nutritional state one would expect 
weight loss to be predictive. However, there was no evidence to support the 
inclusion of gender from the systematic review. But it appeared as a 
significant predictor with men having twice the mortality of women. Disease 
incidences vary between men and women e.g. coronary artery disease is 
higher in men (Gabriel et al., 2009) but the reported effects on perioperative 
mortality vary (Hayashida et al., 2012; LaPar et al., 2012). In our sample 
about 70% of the sample was male and there were small between gender 
differences in tumour histology and non-smoking rate, but these were not 
predictors of outcome. This could be a random finding or there may be an 
unmeasured predictor distributed unevenly between genders.  
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The use of stepwise elimination also highlighted the problems of ‘data 
driven’ models, missing data and small samples. The exaggerated effect of 
gender resulted from missing data on another predictor, which was also 
associated with mortality, and the statistical model based on this data 
performed poorly in validation. 
The most important predictor was age, which was supported by published 
evidence from the systematic review, was significant in univariate and all 
the prediction models (Table 23). This is the most reliable predictor we have 
and should be adjusted for in studies of perioperative mortality. 
The Revised Cardiac Risk Index (RCRI) (Lee et al., 1999) was associated 
with mortality in univariate analysis but became non-significant in the 
‘Clinical’ model. The effect of cardiac morbidity is likely to be complex 
because its incidence increases with age (Fleisher et al., 2007) and aging 
also produces cardiovascular changes which could magnify the effect of 
cardiac disease in the elderly (Priebe, 2000). Consequently there could be 
interaction and confounding with age. In this study the RCRI was correlated 
with age. However, the prevalence of the high scores was very low, possibly 
accounting for its overall weak effect (Figure 5). The odds ratio from the 
imputed datasets of 1.084 for RCRI gave plausible predicted mortalities. For 
instance, predicted mortality was 2% with an RCRI score of zero but 
increased to 3% at high risk (RCRI 5) for patients in their forties, and from 
12% to 17% in their eighties, suggesting a possible interaction with age. The 
general size of these effects seems plausible and the inclusion of some 
estimate of stratified cardiac morbidity would seem worth investigating. 
The frequencies of the highest and potentially most important scores were 
also very small and therefore the categorical groupings of counts may be 
more appropriate. A recent systematic review (Ford et al., 2010) confirmed 
that a two level RCRI can distinguish moderately between a low risk (0 or 
one risk factor) and high risk (more than two factors) for cardiac events but 
not for all cause mortality. 
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Evidence for including serum albumen and spirometry was equivocal and 
neither was statistically significant in this study; substituting values within 
plausible ranges into the derived logistic equations produced negligible 
changes in the mortality rate. 
4.4.2 Performance of clinical prediction models 
The use of imputed datasets increased sample size for the development of 
the ‘Clinical’ models. This coincided with a general reduction in size of 
coefficients to possibly more realistic values in development, and improved 
discrimination and calibration in validation samples. Other models based on 
complete datasets (the ‘Pragmatic’ and Rotterdam models) and larger event 
to predictor ratios (the ‘Pragmatic’ model) also showed better performance, 
so that the ‘Pragmatic’ model was the best of those developed on the 
NOGCU database. Overestimation of mortality at higher predictions was 
common to all models to some degree, as it was in validated models from the 
systematic review. 
The ‘Pragmatic’ model with only age, gender and operation calibrated fairly 
well up to about 15% predicted mortality and could be considered for use as 
a  risk adjuster, for instance in provider profiling. However, overall the 
models performed poorly in discrimination and classification. The 
Rotterdam model had the best AUC of 0.721 and sensitivity of 28%, which is 
not of practical value. The best performing NOGCU model was the 
‘Pragmatic’ model with a sensitivity of about 20%. The narrow range of 
predictions reaching only about 20% confirms that these models are only 
capturing a relatively small amount of variance in the sample. Clearly, 
stronger predictors are required if a practically useful model is to be 
developed. 
The Rotterdam model compared favourably with the other models for 
discrimination, and had the best sensitivity, but is not directly comparable 
because the comorbidities required recoding in a different way to the 
‘Clinical’ models (Steyerberg et al., 2006). Its comorbidity score is a 
composite score which increases for each system involved with disease. 
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Perhaps this simple way of stratifying an overall level of ‘illness’ may be 
capturing a general measure of ‘frailty’ as well as quantitative relationships 
with some individual measures of comorbidity. This model was 
unsurprisingly inaccurate overall as it was developed on a different 
population, using different scoring, but perhaps recalibration on a larger 
dataset could be possible. 
4.4.3 Strengths and weaknesses of this study 
 Data quality 
I endeavoured to verify the reliability of the predictors and outcome before 
attempting to construct prediction models. However, ultimately the 
database sample was a “convenience” sample (Harrell, 2001b) because 
although the data was collected before the outcome was known, it was not 
designed specifically for this study. Important predictors were not defined 
prospectively (e.g. cardiac and respiratory comorbidity) and considerable 
amounts of important data were missing (e.g. weight loss). The use of free 
text data entry without reference to prior definition left considerable scope 
for subjective interpretation, and therefore information bias. I consolidated 
and recoded predictors, which were represented by several fields. I also 
attempted to define the new predictor categories prospectively (e.g. the 
revised cardiac risk index) before exploring their relationships with the 
outcome to avoid overfitting. However, since there was inevitably subjective 
interpretation during recoding, there will have been some scope for 
misinformation bias. 
 Sample size 
Sample size in studies with a binary outcome is driven by the number of 
outcome events, and it has been suggested that adequate samples should 
have an event per variable (EPV) ratio of at least ten (or even twenty). A low 
EPV ratio is a cause of bias in estimating regression coefficients and 
variances, and can cause overoptimistic statistical significance and effect 
sizes. This is because the model may closely represent a relatively small set 
of data points, with a large variance. This is particularly so in stepwise 
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elimination models (Peduzzi et al., 1996; Steyerberg et al., 1999). The result 
is ‘overoptimism’ in predictive capability in a new sample, and a tendency to 
exaggerate high predictions and underestimate low predictions. 
Recommendations to minimise such problems in small datasets include 
selecting a small set of predictors from prior knowledge rather than from 
‘data driven’ methods and minimising the inclusion of interactions 
(Steyerberg et al., 2001a). This modelling dataset was relatively small (43 
outcome events) and therefore at risk of overfitting and ‘overoptimism’. 
Consequently I had little scope to investigate main effects and their 
interactions. Clinical knowledge suggests that age may alter the effects of 
other predictors e.g. cardiac morbidity. Introducing an interaction between 
age and RCRI (p=0.06) produced plausible predictions especially in the very 
elderly, and I examined a model, which included this, but at only small 
overall improvement in model performance. 
In this study, the ‘Clinical’ and ‘Statistical’ models all had an EPR less than 
10 and their performance on discrimination and calibration was inferior to 
the models derived from complete datasets with an EPR greater than 10. 
This was particularly so for the ‘Statistical’ model as it is recommended that 
in stepwise models the ‘degrees of freedom’ include all possible included 
predictors, models and interactions. However, I used this mainly as a 
screening tool, added to the evidence that age and possibly weight loss, 
gender and operation should be predictive, in keeping with Clinical 
knowledge. 
The use of imputed datasets to replace missing FEV1 and serum albumen 
values, increased development sample size and consequently, event to 
predictor ratio. The result was a general reduction in coefficient size with a 
modest improvement in performance, perhaps reflecting ‘overfitting’ in the 
original smaller sample. 
 Validation methods 
I used a traditional split sample method for validation, using 50% for each of 
modelling and validation. The samples were generated randomly and in 
4. Clinical prediction model of perioperative mortality 
 
164 
 
such a way to ensure that mortality was approximately equal in both 
samples. However, in these relatively small samples, it is possible for any 
predictor to split unevenly and affect the model performance. This is 
particularly so if the predictor distribution is skewed and a ‘high risk’ low 
prevalence value may not appear at all in one of the samples (Steyerberg, 
2009o). This was observed to a degree with the distribution of RCRI scores, 
where the validation sample had almost all the high risk scores. Splitting 
relatively small samples also leads to increased variance and possibly less 
stable models and validation performance (Steyerberg, 2009o). Sample sizes 
containing up to 100 events may be necessary for reliable validation 
(Vergouwe et al., 2005; Peek et al., 2007), a figure far larger than was 
possible in this sample. A possible approach could be to use bootstrap 
methods which use the whole dataset. Distributions for parameters such as 
regression coefficients are derived by generating bootstrap samples, running 
the analysis on each sample, and obtaining the parameter of interest from 
each one. The samples are the same size as the original sample and each 
member of the sample is randomly selected for the bootstrap, but is replaced 
and could therefore appear more than once. These methods are described by 
Steyerberg (Steyerberg, 2009k) and were used in developing the Rotterdam 
model (Steyerberg et al., 2006), although this did not prevent disappointing 
performance on new datasets during development or by other investigators 
(Zingg et al., 2009). 
4.5 Key findings 
1. The models developed from the NOGCU database discriminated and 
classified ‘high’ and ‘low’ risk poorly. They could not be of practical value for 
this function. The best model was the Rotterdam model, but this was 
developed on a different dataset and required recoding in the NOGCU 
dataset. 
2. All the models predicted mortality over a small range up to a maximum of 
about 20%. They all overestimated mortality to some degree, with the best 
performing being a ‘Pragmatic’ model with age, gender and operation, which 
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was developed on a complete dataset and predicted fairly reliably up to 
about 15% mortality. 
3. Age was the most important predictor of outcome supported in the data 
analysis and also by evidence from the systematic review. Gender and 
operation should also be included in prediction models. Other predictors 
which should be considered include cardiorespiratory comorbidity and 
measures of loss of body mass and activity, but these require much larger 
studies to elucidate their role. 
4. The models based on data driven methods, larger numbers of predictors 
and smaller datasets were the worst performers on validation. Multiple 
imputation based models reduced the sizes of odds ratios derived from the 
original data and improved calibration in validation. 
5. These models are hampered by the ‘low’ prevalence of perioperative 
mortality and some of the high risk predictors. They do not capture enough 
of the variance in this data to make effective prediction models, and 
stronger predictors are needed. 
6. This study was based on twenty years worth of data from a ‘high volume’ 
surgical centre. The sample sizes from single ‘high volume’ centres cannot 
form the basis for Clinical prediction models. 
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Chapter 5:  General Discussion 
5.1 A summary of the work in this thesis 
In this project I have set out to develop a clinical prediction model for 
perioperative mortality after oesophagectomy, which could be applicable to 
patients cared for in the Northern Oesophagogastric Cancer Unit (NOGCU). 
I used clinical information, which has been recorded in the associated 
clinical database since 1990, and has not previously been studied for this 
purpose. Clinical prediction models have been developed on other datasets 
(Law et al., 1994; Zhang et al., 1994; Bartels et al., 1998; Liu et al., 2000; 
Bailey et al., 2003; McCulloch et al., 2003; Tekkis et al., 2004; Sanz et al., 
2006; Steyerberg et al., 2006; Ra et al., 2008) so my first aim was to 
investigate whether any of these were ‘transportable’ to our practise. My 
next aim was to identify candidate predictors, which can be collected 
routinely preoperatively, and to use these to develop and validate a clinical 
prediction model from the NOGCU dataset. 
I carried out a systematic review to identify and investigate published 
clinical prediction models and studies of potential candidate predictors of 
perioperative mortality. At the time of writing this thesis no relevant 
systematic review had been reported. I searched for published clinical 
prediction models and investigations of candidate predictors, which had 
been studied in ‘high volume’ surgical centres since 1990. Ten clinical 
prediction models were identified (Law et al., 1994; Zhang et al., 1994; 
Bartels et al., 1998; Liu et al., 2000; Bailey et al., 2003; McCulloch et al., 
2003; Tekkis et al., 2004; Sanz et al., 2006; Ra et al., 2008; Steyerberg, 
2009a) but only the POSSUM model (Tekkis et al., 2004), Bartel’s ‘Munich’ 
model (Bartels et al., 1998), the ‘Rotterdam’ model (Steyerberg et al., 2006) 
and the ‘Philadelphia model ’(Ra et al., 2008) have been externally 
validated. They generally overestimated mortality in the higher ranges, and 
discrimination was moderate at best, particularly on external validation 
samples. There was considerable variation in predictor definition, and the 
potential for bias was infrequently managed or reported. The only predictors 
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which were broadly comparable to those available in the NOGCU database 
were from Steyerberg’s ‘Rotterdam’ model (Steyerberg et al., 2006). Two 
models had been incorporated into clinical practise (Zhang et al., 1994; 
Bartels et al., 1998) and reported to reduce operative mortality, but none 
were subjected to formal clinical impact studies. 
Age was, by far, the most investigated candidate predictor. Most studies 
categorised patients as above or below 70 years and most concluded that 
there was no association with perioperative mortality. However the samples 
were usually too small to detect important differences and when combined 
in a data synthesis the risk of mortality was greater in those over 70 years 
(pooled odds ratio 1.91). Interpretation of this odds ratio remains 
circumspect as the incidence of extreme old age and potential confounders 
(e.g.  cardiovascular disease) between groups and studies was not usually 
obvious. Of the other study designs about half found an association, and 
there was a suggestion that the effect of age was greater in octogenarians 
(Moskovitz et al., 2006). 
The interpretation of the importance of other candidate predictors from 
studies in the systematic review was hampered by considerable 
heterogeneity in predictor definition and no consensus on optimal predictor 
form. Differences in the reporting of results, in the sample case-mix and in 
the prevalence of potential bias added further difficulty to predictor 
selection. The evidence from the systematic review that other candidate 
predictors should be included was mixed, but supported by some studies for 
cardiac comorbidity (Mangano, 1990; Eagle et al., 1997), respiratory disease 
(Bartels et al., 1998; Abunasra et al., 2005; Alexiou et al., 2005; Alexiou et al., 
2006), nutritional and immunity based measures (Law et al., 1973; Fekete 
and Belghiti, 1988; Windsor and Hill, 1988), other comorbidities (Griffin et 
al., 2002; Bailey et al., 2003) as well as surgical tumour factors (Abunasra et 
al., 2005; Gockel et al., 2005). I concluded that all the above candidate 
predictors should be considered, but this was not going to be a simple 
estimation problem and would require data exploration and predictor 
selection. 
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In the next stage of this project I prepared a subset of data from the 
NOGCU clinical database with which to develop a clinical prediction model. 
I extracted and cleaned data from fields, which I had identified as likely to 
represent candidate predictors for the model. Some fields (e.g. age, surgical 
details, dates, and outcome variables) were nearly complete and were 
verifiable from other fields within this and other databases. Mortality and 
survivor status were validated within the database against items such as 
stated date of death or outpatient follow up dates, and by the database 
manager against the Northern and Yorkshire Cancer registry and 
Information Service (Northern and Yorkshire Cancer Registry and 
Information Service) 
Other potential predictors were difficult to use because they were 
represented by several different fields, often in free text form (e.g. 
cardiovascular and respiratory morbidity), or had significant quantities of 
missing or unreliable data (e.g. exercise testing variables, weight loss). 
Recoding and cleaning of this data involved considerable work and added 
the risk of information bias (Delgado-Rodriguez and Llorca, 2004). For 
instance, cardiac comorbidity was represented in seven different fields, some 
categorical, and some free text. I decided to recode these into a single 
predictor, the previously validated Revised Cardiac Risk Score (Lee et al., 
1999), but this clearly incurred considerable risk of interpretation bias, both 
from the original data entry and my recoding. This process was repeated for 
several other candidate predictors, for example respiratory comorbidity and 
surgical and tumour details.  
Some fields had considerable amounts of missing data, for example some 
exercise testing variables (up to 40% missing) and weight loss (30%). 
Although I explored these variables, I did not feel confident in their validity 
and they were excluded from final models. Both spirometry and serum 
albumen were included in models and both had some missing data (<15%). I 
used multiple imputation methods to replace this data in order to study 
models, which optimised the available data. 
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I took a traditional approach to developing the clinical prediction model and 
split the data into two equal random samples, with similar mortality rates. 
One would be for modelling and one for internal validation. Firstly, I used 
logistic regression to develop a full ‘Clinical’ model containing predictors 
whose selections were supported by published information and clinical 
knowledge. This was to reduce the chance of overfitting, optimism and bias 
in coefficient estimation which might be caused by statistically significant 
chance associations from ‘data driven’ methods (Steyerberg, 2009k). For the 
full clinical model I selected age, RCRI, FEV1 and serum albumen. Surgical 
procedure was also included because this project focussed on 
oesophagectomy and the database also contained data on total 
gastrectomies and a heterogeneous mix of other lower risk procedures. I 
selected serum albumen because it was the most frequent predictive 
nutritional marker in the review, and FEV1 because it is central to the 
diagnosis of chronic obstructive pulmonary disease and appeared complete 
and reliable. 
I also used univariate statistics and stepwise logistic regression in a ‘data 
driven’ analysis to compare with, and perhaps corroborate the ‘Clinical’ 
model. I screened a larger number of predictors, including the various 
different descriptors of comorbidities entered into the database, for example, 
the various free text and categorical entries for respiratory disease. 
Statistically significant predictors from univariate analysis included age, 
surgical procedure, RCRI, white cell count, weight loss and gender. The 
stepwise regression resulted in a strongly predictive final model containing 
age, surgical procedure, gender and weight loss. These findings go some way 
to justifying the selection of predictors for the ‘Clinical’ model. 
Weight loss and gender had also emerged from ‘data driven’ methods as 
candidate predictors and both have rationale. However, I ultimately 
excluded weight loss from the final models, because of the extent of missing 
data. The missing weight loss data also resulted in a gross imbalance in 
gender specific mortality between missing and non-missing data, resulting 
in a spuriously large gender effect. Unsurprisingly, the model with weight 
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loss performed badly on validation, and the effect of gender reduced 
considerably when weight loss was omitted. However, gender remained 
statistically significant. There were no strong differences between genders 
for other predictors in the data and there is some evidence suggesting that it 
should be considered (Gabriel et al., 2009; Hayashida et al., 2012; LaPar et 
al., 2012) so I included it in a subsequent ‘Clinical’ model. 
I attempted to increase the sample size, on which the ‘Clinical’ model was 
developed by using multiple imputation samples to replace missing serum 
albumen and FEV1 values. This resulted in an almost complete dataset. 
Resulting regression coefficients were generally reduced in magnitude, 
perhaps reflecting some overfitting in the relatively small original sample. I 
also used the imputation datasets to run a ‘Clinical’ model including gender, 
which also had a considerably reduced coefficient compared to the ‘data 
driven’ model. Of potential importance, the statistically significant 
univariate effect of the Revised Cardiac Risk Index was lost in the ‘clinical’ 
model containing age, as the two were moderately well correlated (r=0.5). 
The association between cardiac morbidity and age is not unexpected and 
shows the complex relationship between the two for a prediction model. 
On internal validation the models gave predictions over a fairly narrow 
range not far from the sample mean mortality, with the value for the 
highest decile mean being between 10 and 15%. Calibration was best in the 
models based on most complete datasets and fewest, most reliable predictors, 
i.e. age, gender and operation. This finding was also reflected in the ‘Clinical’ 
model based on imputation to maximise dataset size, when compared with 
the model based on the original data. Overestimation of mortality rates 
occurred in models containing RCRI, FEV1 and serum albumen, although 
general shrinkage improved this at the expense of reducing maximum 
predictions to nearer the overall mean. Discrimination was, at best, 
moderate in all models with maximum area under curve values of 0.65 for 
ROCs. Unsurprisingly the ‘data driven’ models, which contained weight loss, 
fared even worse. The ‘Rotterdam’ model (Steyerberg et al., 2006) was poorly 
calibrated and failed to discriminate in this dataset; this was not 
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unexpected as the data required some recoding to adapt for the Rotterdam 
scoring system. 
5.2 The potential applications of clinical prediction models 
The aim of a clinical prediction model should be to improve clinical care. 
This could include providing patients and their clinical teams with 
estimated individual ‘risk specific’ mortality rates to guide treatment choice 
or identifying poorly performing provider centres. It could also include 
classifying patients into high or low risk groups for allocation to research 
interventions or further diagnostic risk stratification. I discuss some of 
these issues in the following paragraphs. 
5.2.1 Guiding choice of treatment 
In July 2010, and subsequently in 2012 the government published their 
vision for the NHS, which included putting patient choice of both treatment 
and provider at the centre of healthcare (Secretary of State for Health, 2010; 
Department of Health, 2012). They embraced the phrase ‘nothing about me 
without me’ as a central part of ‘shared decision making’, a concept which 
ensures patients can take an active role in clinical decisions. The phrase 
‘nothing about me without me’ was adopted as a guiding principle at the 
Salzburg Seminar of 1998, an event which was ‘founded in 1947 in the spirit 
of post war reconciliation to provide a forum to challenge and debate a 
variety of issues and beliefs’(Delbanco et al., 2001). With the backdrop of 
great changes within healthcare systems worldwide, the 1998 seminar 
challenged a wide range of healthcare and patient representatives to plan 
an ideal and utopian healthcare from scratch. Central to their ideas was the 
use of computers to provide the information, which could enhance patient 
choice (Delbanco et al., 2001). 
Treatment of oesophageal cancer may include options, which incur 
considerable risk and lack of certainty about benefit both for survival and 
quality of life. The current development of less invasive therapies, e.g. 
endoscopic resection, photodynamic therapy or thermal ablation (Allum et 
al., 2011) may magnify the importance of information about risk in 
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treatment choice. Decision aids, which present such information, may be 
helpful in enabling patients to make informed decisions. There is some 
evidence that decision aids not only improve knowledge of treatment options, 
and influence expectations of risks and benefits, but may also increase 
selection of more conservative treatments in place of more major surgery 
(O'Connor et al., 1999; Stacey et al., 2011). This has been reported when the 
treatment options include potentially curative major surgery, for instance 
breast and prostate cancer (Auvinen et al., 2004; Armstrong et al., 2005; 
Waljee et al., 2007) and coronary vessel revascularisation (Morgan et al., 
2000). Similar findings have been reported where there is a choice between 
non-surgical treatments with serious risks (Brundage et al., 2001). 
For oesophageal cancer there might be a choice between high risk curative 
surgery with an impaired quality of life, a prolonged recovery period but 
potential curative outcome, and an alternative less invasive palliative 
procedure with a better quality of life but shorter survival. If perioperative 
or medium term mortality were considered to be an important factor in 
decision making, one might think the relative size and certainty of the 
mortality estimates would be important, although I can find no studies to 
confirm this. The models from the NOGCU using only age, operation and 
gender, looked to be reasonably reliable for mortalities up to 15%. However 
from my clinical experience I believe it unlikely that estimates of this 
magnitude compared with an overall mean of 5% would affect an 
individual’s decision to have surgery, where the alternative may be certain 
non-survival. To provide useful information for clinical decision making 
there is a need to develop and validate models which can provide a greater 
range of mortality predictions with reasonable confidence. 
5.2.2 Provider profiling 
Although it has been reported that choice of treatment may be more 
important to patients than choice of location or provider (Coulter, 2010), 
selecting a provider may be a reality for regionally provided specialist 
services. Knowing that mortality for surgery in a particular patient is 10% 
as opposed to 5% may not necessarily affect their choice of treatment, but 
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could be central to appraising and choosing a provider. Perioperative 
mortality represents only one aspect of the quality of care (Lilford et al., 
2004) in high risk surgery such as oesophagectomy but it is always likely to 
attract attention (Shahian et al., 2001). The government have expressly 
stated the provision of outcome information as one of their aims (Secretary 
of State for Health, 2010; Department of Health, 2012), therefore 
presumably this type of information will become increasingly important. An 
example of this has been the national clinical audit database of the Society 
for Cardiothoracic Surgery in Great Britain & Ireland, which records a 
substantial proportion of all cardiac procedures performed in the UK and 
Ireland. Individual provider performance is published at 
http://heartsurgery.cqc.org.uk (Care Quality Commission Society for 
Cardiothoracic Surgery in Great Britain & Ireland, 2010), and the Society 
have developed a methodology for identifying and managing apparent 
divergences of observed from expected mortality rates in providers. The 
statistical methods of provider profiling have also been illustrated on a 
dataset from the Scottish Audit of Gastro-Oesophageal Cancer Services 
(Collins et al., 2011). However, there are considerable methodological 
problems with provider profiling (Shahian, Normand et al. 2001) which 
include the effect of varying case mix between centres, when patient 
prognostic predictors become potential confounders (Steyerberg 2009). 
These can then bias the outcome measure for the clinical centre of interest 
(Julious and Mullee 2000). Risk adjustment scoring (the modified 
EuroSCORE) is central to the appropriate identification of outlying 
performance by the Cardiothoracic Society, to allow for variation in case-mix 
and patient risk factors (Roques et al., 1999). It would seem reasonable that 
the same should apply when comparing outcomes in oesophageal cancer 
surgery. 
5.2.3 Controlling for prognostic predictors in research and diagnosis 
An imbalance of known and unknown predictors between treatment groups 
may bias the results of interventional treatment studies. Adjusting for this 
imbalance by using clinical prediction models to select patients for trials, or 
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to balance risk strata in treatment arms may reduce this bias, especially in 
small sample studies (Assmann et al., 2000; Steyerberg, 2009c). Covariate 
adjustment may reduce bias, improve precision and increase the statistical 
power to detect a treatment effect (Hernández et al., 2004; Steyerberg, 
2009c). A potential area of application of this principle for oesophagectomy 
could be in trials to assess perioperative ‘goal directed therapy’. This is a 
particularly topical and debated therapy based on the idea that achieving 
specific targets for organ oxygen delivery should improve outcome. It might 
be expected that any tangible benefit would be more likely or greater in 
‘higher risk’ patients, and therefore risk stratification could be an important 
aspect of such a study. 
Another topical and debated subject is the use of cardiopulmonary exercise 
testing (CPX) to stratify risk for major surgery (Older et al., 1999; Forshaw 
et al., 2008). This is based on measuring the capacity to increase oxygen 
delivery in response to an increased oxygen demand induced by exercise, 
and is assumed to partially mirror the physiological stress caused by major 
surgery. This seems a rational idea as it provides an individualised response 
to a physiological stress; however it is labour and cost intensive as it 
requires a sophisticated bicycle ergometer and its clinical impact is unclear. 
As with any other prediction model it seems reasonable that it should 
incorporate known important predictors and demonstrate that it can add 
value to models which include simple, reliable and relatively inexpensive 
data, such as age. 
CPX has mainly been utilised as a classifier with a cut-off value to denote 
high and low risk groups. If the subject cannot maintain aerobic respiration 
above about 11 ml/Kg/minute of oxygen consumption, they would be 
considered to be at high risk.  
The new post-test probability depends on the outcome prevalence and on 
test sensitivity and specificity (Sackett et al., 1991). Reported sensitivity of 
CPX has been low, e.g. in Older’s study of patients undergoing major 
surgery, the sensitivity was 60% and specificity was 70% (Older et al., 1999). 
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I have used the data from this study to illustrate its potential utility in the 
plot on the following page (Figure 13).The plot was generated from the 
CEBM Statistics Calculator (Center for Evidence Based Medicine, 2012). 
The x axis represents the pre-test mortality and the y axis represents the 
new prediction given a positive CPX test indicating high risk. (Older et al., 
1999). A positive CPX test with a pre-test mortality of 5% (typical overall 
mortality for many centres) results in a post-test probability of around 10%. 
This level of information is unlikely to be practically useful. A higher pre-
test probability of mortality nearer 15 or 20% results in a post-test 
probability of over 30%, a potentially much more useful estimate. This 
illustrates the difficulty of predicting mortality using tests with low 
sensitivity. It also illustrates the potential importance of identifying higher 
risk patients for such stratification testing, and for generating practically 
useful information.
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Figure 13 The effect of baseline prevalence on post-test probability given a test 
sensitivity of 60% (e.g. CPX testing). The x axis is pre-test prevalence and y axis is 
the post-test probability. See text for explanation. This plot is adapted from the 
CEBM Statistical calculator (Older et al., 1999).
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5.3 What is the current status of the prediction model developed from the 
NOGCU database? 
I could find no research to suggest what level of perioperative mortality 
might sway a patient’s choice away from surgery but I speculated that it 
might need to be at least 20%, given the alternative outcome of unlikely 
survival without surgery. These models cannot currently provide estimates 
beyond about 15% for predicted mortality, so this model is probably not 
useful in this role. Similarly, if the model is used to classify patients as high 
or low risk for perioperative mortality using a specified cut-off, sensitivity 
was poor and the false positive rate high. The high specificity meant that 
low risk predictions would be mainly correct but little or no better than 
knowing the overall mortality alone. I originally set out with the intention of 
developing a clinical prediction model that could provide individual patients 
with enough information about the fatal risks of surgery to help them 
balance risks and benefits and an informed choice about treatment. The 
Rotterdam model, which I adapted to our dataset, appeared to provide the 
best discrimination but was scored differently and derived on different 
populations. It was probably giving a better overall estimation of ill health 
as it represented a collection of comorbidities. Although its performance was 
not practically useful, further development of its application should perhaps 
be considered. Clearly none of these clinical prediction models are currently 
useful for guiding clinical decision making. 
However, the simpler models seem well enough calibrated over a wide 
enough range to potentially adjust for provider profiling. For instance, it 
could be of considerable public interest if a provider was reporting a 
mortality rate of 10%, which is about twice the national average. A simple 
model with reliable predictors such as age and gender could possibly predict 
this level of mortality reliably, and should arguably be part of any system 
comparing centres or operators. Similarly, it seems reasonable that new risk 
stratification techniques, such as cardiopulmonary exercise testing (Older et 
al., 1999; Forshaw et al., 2008) should incorporate such information into 
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their predictions, firstly to demonstrate in validation and impact studies 
that they can add useful information, and secondly to improve predictions. 
5.4 What are the difficulties with clinical prediction models of 
perioperative mortality for oesophagectomy? 
5.4.1 Sample data 
Missing data reduces sample size and can cause bias and spurious chance 
associations between predictors and outcome (Steyerberg, 2009f). In the 
systematic review, the reporting of missing data was frequently poor and in 
this modelling study some predictors had considerable amounts of missing 
data or unreliable data. This necessitated the exclusion of some potentially 
important predictors (e.g. exercise tolerance). The inclusion of a predictor 
with considerable missing data (weight loss) also led to spurious and 
overoptimistic associations between both itself and mortality, and gender 
and mortality. In future prospective studies, data validity and the 
management of missing data should be central to study design. 
5.4.2 Selection of predictors 
Selection of predictors should be based on clinical knowledge and previously 
published evidence rather than, data driven methods, such as univariate 
associations with outcome or stepwise regression methods. This is to reduce 
random associations, overfitting and overoptimism in a model (Steyerberg et 
al., 2001b). A key area of difficulty in this study was that, despite the large 
number of published studies, it was unclear which candidate predictors 
should be included, because of the wide variety of definitions used by 
investigators. It is clear from publications and our model that ‘age’ should be 
included in any prediction model of perioperative mortality after 
oesophagectomy. However, even this was studied in a large variety of 
categorical forms. Ideally age should be included as a continuous variable to 
avoid loss of information (Steyerberg et al., 2001b), particularly the 
distribution of very old age. 
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Definitions and effects of cardiac morbidity were inconsistent across the 
studies in the systematic review of this thesis. I therefore used the validated 
Revised Cardiac Risk Index (Lee et al., 1999), which was associated with 
mortality in this study, but was correlated with age (r=~0.5) and its effect 
was lost in the multivariate model. In sensitivity testing, altering the RCRI 
from zero to the maximum six in the predictor equation produced quite 
plausible results, for instance increasing predicted all cause mortality from 
about 5% to 17% in elderly patients. Most items in the RCRI are risk factors 
for, or indicators of past disease and therefore not especially strong 
predictors. The strongly predicting items (heart failure, unstable coronary 
syndromes, high total RCRI (Fleisher et al., 2007)) have low prevalence and 
therefore because of the relatively small sample size we were struggling for 
predictive power. For instance, in the modelling sample the mortality for an 
RCRI of 5 in patients over 74 was 50%, and in the whole dataset for patients 
with unstable coronary syndromes 25%. Of course the cell count for these 
categories was tiny (2 and 4 respectively), and therefore these could be 
random findings. This is also true of larger databases such as ICNARC 
(Park et al., 2009), where the incidence of preoperative severe heart disease 
was not statistically associated with a plausible 11.1% mortality; the 
incidence of this predictor was only 0.3%. 
The addition of exercise or activity capacity to RCRI adds predictive 
strength (Fleisher et al., 2007). A simple method of assessing this is to score 
a patient’s best self reported activity capacity as multiples of resting 
metabolic energy use (or ‘MET’s), for instance climbing a flight of stairs 
might be 4 METS (Fleisher et al., 2007). Less subjective measures include 
cardiopulmonary exercise testing, which included exercise induced 
electrocardiographic evidence of myocardial ischaemia in original studies 
(Older et al., 1999). However at the NOGCU, we have only recently started 
recording METS for risk assessment, and cardiopulmonary testing has not 
been available. 
The high respiratory morbidity and associated mortality which occurs after 
oesophagectomy, would suggest that preoperative respiratory comorbidity 
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might be an important predictor. This was not the case in our study, in 
which I used chronic obstructive airways disease as the main predictor, 
defined from free text data entry and spirometry. The association between 
respiratory comorbidity and outcome was mixed in the primary studies in 
the systematic review, again hampered by a wide range of definitions. 
Weight loss was also strongly predictive of perioperative mortality in our 
study. This might be expected from clinical knowledge, and a variety of 
other measures of nutritional and immune status were associated with 
mortality in studies from the systematic review. However, the modelling 
sample was plagued by missing and unreliable data for this predictor. The 
missing data produced an implausibly large random effect for gender, 
because of an imbalance in ‘gender specific’ mortality between missing and 
non-missing data. Unsurprisingly, although the statistical model which 
included weight loss was strongly predictive with an impressive area under 
the ROC, it performed very poorly on validation. I rejected models with 
weight loss, based on this dataset, but nutritional based predictors clearly 
have strong rationale and should be investigated further. 
There is a need to agree and standardise a format for candidate predictors 
so that large scale studies can be carried out to definitively characterise 
their role, if any. Standardisation would also allow potential ‘pooling’ of data 
from different studies to optimise the use of available information, and to 
facilitate comparison between different models (Collins and Moons, 2012). 
5.4.3 Predictor strength 
For an effective prediction model strong individual predictors are required. 
The power of a predictor is related to its prevalence and correlation with 
outcome (Steyerberg, 2009l). The prevalence of some of the potentially 
important strongly associated predictors in this study was low, for instance 
high risk RCRI scores. The measure of association in logistic regression is 
the odds ratio, which tends to range from about 1 to 3 in medical prediction 
studies (Pepe, 2005; Steyerberg, 2009m); point estimates of odds ratios for 
predictors in our study were all less than three. The addition of other 
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validated predictors could increase the range of point estimates for 
predicted mortality and enhance the information available to make 
treatment choices. Hence there is a need to clarify the potential impact of 
the predictors which we have studied here, as well as identifying and 
investigating additional other predictors, for example cardiopulmonary 
exercise testing.(Older et al., 1999).  
The other aspect of prediction is to classify patients into groups of survivors 
or non-survivors for the purposes of allocating diagnostic, treatment or 
research interventions. An overall summary of the classification capability 
can be summarised in the area under ROCs for comparisons, but for clinical 
application it is more useful to know the true and false positive and negative 
rates, as their importance is context sensitive. For instance, in this study 
the high false positive rate would exclude many people from surgery if used 
for that purpose, but could be acceptable if used to allocate patients to 
further risk stratification. I used a very simple method to examine 
classification, but statistical devices specifically designed to assess the net 
practical benefit of clinical prediction models are available (Vickers and 
Elkin, 2006; Collins and Moons, 2012).  
In general, a good classifier requires a very large degree of association to be 
effective, for instance an odds ratio of more than 30 (Pepe, 2005). In medical 
prediction studies including this one, odds ratios for predictors are rarely 
over 3. This limits the level of achievable false positive and negative rates, 
which is reflected in the low ROC area, and results in poor classification 
(Figure 14).
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Figure 14 Correspondence between false positive and true positive fractions for 
different odds ratios (Pepe, 2005). Permission granted by John Wiley and Sons May 
09, 2012. 
5.4.4 Study methods and potential biases 
Several potential biases or their inadequate reporting were identified in the 
systematic review and in our own modelling exercise. Of particular note 
were potential case selection bias, missing data, data validation and 
potential misinformation bias. This was an inevitable consequence of 
modelling data from a “convenience” sample (Harrell, 2001b). These are 
problems that should be considered prospectively in future model 
development. 
5.4.5 Sample size 
The important determinant of sample size in prediction models is the 
number of outcome events (Steyerberg, 2009n). Small sample sizes plagued 
many of the studies reported in the systematic review; my study had only 
about 40 events in each of the development and validation datasets. This is 
probably also compounded by the proportion of fatalities caused by surgical 
technical failure, which is not likely to be associated with comorbidity 
predictors. For instance, in an earlier audit I estimated that at least 10% of 
mortality was due to technical failure (Warnell, 2009(unpublished data)). 
This is similar to other reported data (Law et al., 1994; Griffin et al., 2002; 
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Law et al., 2004; Abunasra et al., 2005). The resulting small effective sample 
size probably contributes to model ‘overoptimism’ and lack of precision. For 
instance, if only age were in the model, the predicted mortality for an 80 
year old was a plausible 9.4% but the 95% confidence interval was from 1.7% 
to 38%. In contrast the EuroSCORE (Roques et al., 1999), which collected 
data from 19030 cardiac surgery patients with a similar overall mortality 
(about 910 events) to oesophagectomy, a matching predicted mortality for an 
80 year old would be 7.1% with a 95% confidence interval of 6.6% to 7.6%; a 
much more informative range. These problems of sample size demonstrate 
the difficulty in generating useful prediction models from a single clinical 
centre. After all the NOGCU is a ‘high’ volume surgical centre, which has 
been collecting data for its well resourced clinical database since 1991. 
5.5 Some potential solutions 
The ideal solution would be to develop a clinical prediction model from 
scratch, in a prospective large sample investigation. This was done in the 
euroSCORE study for cardiac surgery, when the data from 19030 
cardiothoracic procedures was collected from 128 European centres in a 
three month period in 1999 (Roques et al., 1999). The euroSCORE has been 
validated and studied many times since then, and an updated and 
recalibrated version is currently used by The Society for Cardiothoracic 
Surgery in Great Britain & Ireland to risk-adjust for provider performance 
audit (The Society for Cardiothoracic Surgery in Great Britain & Ireland, 
2011). A prospective study of this magnitude and resource can deliver risk 
estimates with practically useful precision. 
For oesophagectomy, a project of similar scale to the euroSCORE project 
would take considerably longer, because each clinical unit is likely to do 
fewer oesophagectomies in three months than the approximately 120 cases 
submitted from each cardiothoracic centre. For instance, the National 
Oesophago-Gastric Cancer Audit 2010 (Cromwell et al., 2010), which 
collected data from a similar number of patients and clinical centres took 
nearly two years. Clearly it would take considerable time and resources to 
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complete a study of this magnitude and we should think about alternative 
ways to maximise benefit from limited resources and information. 
A potential solution would be to incorporate currently available information 
into the development of our model (Steyerberg, 2009g) and then to 
prospectively validate, adjust or recalibrate it as necessary (Steyerberg et al., 
2004). Just as I have used clinical knowledge and published studies to select 
predictors, investigators have combined multiple external data sources in 
cancer survival studies to estimate important predictor effect sizes (Look et 
al., 2002), and several statistical methods have been described to achieve 
this (Steyerberg et al., 2000; Steyerberg, 2009g). One option is the synthesis 
of aggregate data summaries from primary studies, however in our 
systematic review the definition of predictors and the reporting of results 
varied considerably (e.g. the various different categorisations of age), 
making this a difficult and possibly unachievable task. A preferable option 
might be an ‘individual patient data’ systematic review (Steyerberg et al., 
2000; Riley et al., 2010), incorporating data from individual patients of 
previously published primary studies and databases. As well as primary 
studies there are large databases, which could help to clarify the importance 
of predictors such as age, comorbidities and surgical details. These include 
the ICNARC database (Park et al., 2009), and the National Oesophago-
Gastric Cancer audits (Cromwell et al., 2010). Hospital Episode Statistics, 
the administrative database of the NHS in England (The Health and Social 
Care Information Centre) is another potential source of much information, 
which has been used to generate hospital mortality prediction models (Aylin 
et al., 2007) and was central to identifying high mortality rates in paediatric 
cardiac surgery at Bristol in the early 1990s (Aylin et al., 1999). However, 
administrative databases have been reported to lack scope of information, 
data quality and the ability to adjust for case-mix and comorbidity 
(Mohammed and Andrew, 2007; Mohammed et al., 2009). Large clinical 
multi-institutional databases focussed on a particular disease or group of 
procedures may provide the volume, scope and data quality suited to 
generate and validate clinical prediction models (Westaby et al., 2007). 
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Clearly any such study would need prospective planning and would take 
more resources than a study using currently available publications of 
primary studies, but it could make maximum use of available information 
and be more reliable (Riley et al., 2010). The results from aggregated data 
could then be used to inform a prospective multicentre project to validate 
and subsequently study the clinical impact (Wallace et al., 2011) of a 
prediction model. 
5.6 Conclusions 
1. There is increasing momentum for the publication of information about 
surgical procedures to both aid treatment decisions by patients and to 
highlight variations in performance amongst providers. Clinical 
prediction models are central to adjusting for individual patient risk 
factors. 
2. The clinical prediction models developed from the NOGCU clinical 
database, along with other published models, did not explain enough 
variation in the data to effectively discriminate between survivors and 
non-survivors after oesophagectomy, and therefore are unlikely to be 
useful as an aid to clinical decision making. 
3. A simple model incorporating age, gender and operation calibrated well 
enough to a maximum prediction of about 15% to risk adjust for provider 
profiling or research. 
4. Age is the most important predictor of perioperative mortality after 
oesophagectomy. There was some weak evidence to suggest that gender, 
cardiac morbidity and weight loss may add value. Despite the number of 
published studies, we do not know which other predictors should be 
included in a clinical prediction model of perioperative mortality after 
oesophagectomy. 
5. In this study I encountered problems with missing data, undefined 
predictors and free text data entry. These potential sources of bias were 
poorly reported or not addressed in many of the studies in the systematic 
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review. Consideration should be given to addressing these issues 
prospectively in future studies. 
6. Sample size was fairly small in this study. This probably contributed to 
overfitting in some models and limited scope for data exploration. This 
study sample is from a database with nearly twenty years of data from a 
‘high volume’ centre. Single centres are unlikely to provide enough data 
to carry out research on clinical prediction for oesophagectomies. 
7. Given the time and resources it would take to develop a clinical 
prediction model in a prospective study, consideration could be given to 
pooling individual patient data from a range of sources, studies or 
databases. High quality prospective validation and clinical impact 
studies could then be carried out. These are likely to require large scale 
studies which could be facilitated within a multicentre clinical database 
for upper gastrointestinal surgery. 
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Appendix A.  Terms used for search strategy in electronic databases  
Search 
concept 
Concept definition Search term notes 
Population Adults  NOT children 
 Oesophagus exp esophagus tw/mp (o)esophagus; 
(o)esophageal 
 Cancer,Neoplasm, Tumour, 
Carcinoma 
exp neoplasms (inc stomach and 
oesophageal); exp carcinoma 
(inc squamous); exp 
adenocarcinoma; carcinoma, 
squamous cell 
tw/mp cancer; 
carcinoma; tumour; 
neoplasm 
 Surgery, Oesophagectomy exp surgical procedures, 
operative; exp esophagectomy;  
Surgery, operative 
treatment, resection 
Study design Cohort, prospective, retrospective, 
case control 
Exp epidemiologic study 
characteristics (inc case-control, 
cohort) 
mp prospective, 
retrospective, 
observational, cohort, 
trial, randomised 
 Randomised controlled trial exp evaluation studies (inc 
clinical trials, reproducibility of 
results) 
 
 Database, clinical or administrative Databases, factual; databases mp (clinical) database 
Clinical 
outcome 
Mortality, including “all cause” 
mortality, 30 day postoperative 
mortality, “in hospital” mortality 
exp mortality Includes fatal outcome, 
hospital mortality, 
survival 
 Morbidity Not used because scope 
note definition: “The proportion 
of patients with a particular 
disease during a given year per 
given unit of population”. 
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Search 
concept 
Concept definition Search term notes 
 Postoperative complications Postoperative complications Not exp; irrelevant 
subheadings 
 Hospitalisation/length of 
stay/critical care/cardiac 
complications/respiratory 
complications 
exp hospitalization (inc length of 
stay);exp critical care; heart 
disease/cardiac output, 
low/heart failure, 
congestive/myocardial 
ischemia/arrhythmia;exp 
respiratory tract diseases 
mp 1. critical, 
intensive, care, 
therapy, length of stay, 
hospitalisat on;mp 2. 
complications, 
perioperative, 
postoperative, 
cardiovascular, cardiac, 
coronary, myocardial, 
heart, respiratory, 
chest 
Risk 
assessment 
Prediction, Assessment, Evaluation 
studies, Estimation, 
Stratification(maps to risk 
assessment, prognosis, statistics, 
exercise test), risk, score, index, 
Incidence(maps from 
epidemiological methods, 
morbidity) 
exp prognosis, exp 
epidemiologic methods 
  
 cardiac risk assessment, 
cardiopulmonary exercise testing, 
physical functional capacity, stair 
climbing capacity, anaerobic 
threshold, cardiopulmonary 
exercise, cardiac risk stratification, 
electrocardiographic exercise 
stress testing, clinical database, 
regression, Bayes methods, 
computational intelligence, 
POSSUM, apache, severity if illness 
index, severity of illness index, 
karnovsky performance status all 
map to exp health status 
indicators, sickness impact profile, 
tool, instrumen 
exp heart function tests, exp 
respiratory function tests, exp 
physical endurance, exp physical 
fitness, exp oxygen 
consumption, exp health status 
indicators, exp epidemiologic 
methods, exp computing 
methodologies 
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Appendix B.  Search filters 
‘Filter source’ Filter details 
Guidelines for prognostic tests from NHS Centre 
for Reviews and Dissemination, York 
Universitywww.york.ac.uk/inst/crd/index_guidanc
e.htm 
Best single terms from ‘effective MEDLINE 
searching strategies for studies of prognosis’: exp 
epidemiologic studies 
Complex search with the highest sensitivity: 
incidence.sh. OR exp mortality OR follow-up 
studies.sh. OR prognos:.tw. OR predict: .tw. OR 
course:.tw. 
(exp denotes exploding the succeeding 
indexing term,”:” truncation symbol in Ovid, sh 
denotes subject heading search, tw textword 
search) 
PubMed Research Methodology Filters 
http://www.ncbi.nlm.nih.gov/sites/entrez?db
=pubmed 
Accessed 2007 
“prognosis”  
sensitive/broad search 90%/80% 
 (incidence[MeSH:no exp] OR 
mortality[MeSH Terms] OR follow up 
studies[MeSH:no exp] OR prognos*[Text Word] 
OR predict*[Text Word] OR course*[Text Word]) 
“clinical prediction guides” 
 sensitive/broad  96%/79% 
 (predict*[tiab] OR predictive value of 
tests[mh] OR scor*[tiab] OR observ*[tiab] OR 
observer variation[mh]) 
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Appendix C.  Search strategy for electronic databases 
1. exp Esophagus/ 
2. esophag$8.mp. 
3. oesophag$8.mp. 
4. 1 or 2 or 3 
5. exp neoplasms/ 
6. exp carcinoma/ 
7. exp adenocarcinoma/ 
8. exp carcinoma, squamous cell/ 
9. (cancer$1 or carcinoma or tumo?r$1 or neoplasm$1).mp. 
10. 5 or 6 or 7 or 8 or 9 
11. 4 and 10 
12. exp esophagectomy/ 
13. (esophagectomy or oesophagectomy).mp. 
14. exp surgical procedures, operative/ 
15. (surg$4 or (surg$4 adj treatment) or (Ivor adj Lewis) or (surg$4 adj 
resection) or operat$4 or (operat$4 adj treatment) or (operat$4 adj 
resection)).mp. 
16. 13 or 14 or 15 
17. (11 and 16) or 12 or 13 
18. exp epidemiologic study characteristics/ 
19. databases/ 
20. databases, factual/ 
21. (prospective or retrospective or observational or cohort or (clinical adj 
trial) or random$).mp. 
22. clinical trial.mp. or clinical trial.pt. or random:.mp. or tu.xs. 
23. exp evaluation studies/ 
24. "validation studies [publication type]"/ 
25. or/18-24 
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26. exp mortality/ 
27. postoperative complications/ 
28. exp hospitalization/ 
29. exp prognosis/ 
30. exp critical care/ 
31. (((critical or intensive) adj (care or therapy)) or (length adj stay) or 
hospitalis$ or hospitaliz$).mp. 
32. exp respiratory tract diseases/ 
33. Heart Diseases/ 
34. cardiac output, low.mp. [mp=ti, ot, ab, nm, hw, sh, tn, dm, mf] 
35. heart failure, congestive.mp. 
36. myocardial ischemia.mp. 
37. arrrythmia.mp. 
38. (mortality or death or fatal$).mp. 
39. (complications adj (post?operative or perioperative or cardiovascular or 
cardiac or coronary or myocardial or heart or respiratory or chest)).mp. 
40. or/26-39 
41. exp heart function tests/ 
42. exp respiratory function tests/ 
43. exp physical endurance/ 
44. exp physical fitness/ 
45. exp oxygen consumption/ 
46. exp health status indicators/ 
47. exp epidemiologic methods/ 
48. exp prognosis/ 
49. exp computing methodologies/ 
50. exp diagnostic errors 
51. (reproducib$ or reliab$ or evaluat$ or predict$ or accuracy or precision 
or calibration or diagnostic or specificity or sensitivity or performance).mp. 
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52. ((health adj (status or indicator)) or database$ or comput$ or bayes$ or 
regression or (artificial adj intelligence) or (neural adj network) or (severity 
adj illness) or apache or karnovsky or (anaerobic adj threshold) or exercise 
or possum or o-possum or p-possum or (stress adj test) or (function$ adj3 
capacity) or cardiac or respiratory or function$ or cpx or 
electrocardiograph$ or cardiograph$ or ecg or ekg or cardiopulmonary).mp. 
[mp=ti, ot, ab, nm, hw, sh, tn, dm, mf] 
53. (risk$ or assess$ or estimat$ or stratif$ or evaluat$ or scor$ or index or 
predict$ or prognos$ or course).mp. [mp=ti, ot, ab, nm, hw, sh, tn, dm, mf] 
54. or/41-51 
55. 17 and 25 and (40 or 54) 
56. limit 55 to (english language and yr="1990-2009") 
57. limit 56 to humans 
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Appendix D.  Ethics and data protection 
Facsimiles of the ethics and data protection documents are shown below 
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Appendix E.  Appendix-Risk of bias in individual primary studies 
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Appendix F.  Data handling procedures 
Some specific data handling procedures which were written for data cleaning 
procedures in Visual Basic for Applications are listed below. Comments are 
preceded by the symbol # or ‘. 
Appendix F i.   Check merged and moved fields are aligned correctly. 
Sub CheckIndexVarAlignment1576() 
#Select first column to check; select second column; insert column to 
left of selected field; check against another index (e.g. unique key); if 
same 0, if different 1, find 1. Target fields moved with ‘index’ &/ ‘date 
of birth’ fields to check alignment in new spreadsheet 
Dim i As Integer 'looping through rows 
Dim j As Integer 'variable for second index variable 
Dim k As Integer 'variable for first index variable 
'input the two index fields to be checked 
k = InputBox("which number column is the first index field in-input as 
column number?") 
j = InputBox("which number column is the second index field?") 
 'insert col and move others to right to make space; note index now in 
k+1 
ActiveSheet.Columns(k).Insert 'Shift:=xlToLeft 
    For i = 2 To 1576 
        If Cells(i, k + 1).Value = Cells(i, j).Value Then         
        Cells(i, k).Value = 0 
        Else: Cells(i, k).Value = 1 
        End If 
        Next i  
End Sub 
'complete check by using Excel FIND to find ‘1’s', which indicate non- 
aligned fields 
 
Appendix F ii.   Clean spreadsheet cells of invisible characters 
Sub clean_textcells() 
‘Removes spaces and unprinted symbols from text; input column for 
original data and column for new data; loops from 2 to 1576 rows 
Dim i As Integer 'looping through rows 
Dim j As Integer 'variable for new data 
Dim k As Integer 'variable for old data 
k = InputBox("which number column is the old data in?") 
j = k + 1 
ActiveSheet.Columns(k).Insert 'Shift:=xlToLeft 
For i = 2 To 1576 
Cells(i, k).Value = 
WorksheetFunction.clean(WorksheetFunction.Trim(Cells(i, j).Value)) 
Next i 
Cells(1, k) = Cells(1, j).Value & "Cln" ‘cln signifies cleaned data field 
ActiveSheet.Columns(j).Delete 
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Appendix F iii.   Conversion macros 
#Create ‘Age at operation’ field 
# ‘Operation date’  minus ‘DOB’ 
=DATEDIF(start_period, end_period, "y") 
#“y” is code for years 
# Create ‘Gender’ logical field 
#Conversion from text to male=1, female=2, blank =”” 
=IF(“male”,1, IF(“female”,2,””)) 
#Convert height field to metres 
‘Conversion from centimeters to metres; non empty cell with value greater 
than 3 (only likely be centimeters) divided by 100; less than 3 can only 
be metres 
=IF(O2="","", IF(O2>3,O2/100,O2)) 
#Body surface area (BSA) (m2) 
Dubois formula for BSA = (W 0.425 x H 0.725) x 0.007184, where H is height 
(cm) and W is weight (Kg) 
=IF(D2="", "", IF(C2="","",POWER(D2*100,0.725)*POWER(C2,0.425)*0.007184)) 
Test for missing data, when leave field ‘BSA’ empty, otherwise use 
function above to calculate BSA 
#Body Mass Index BMI 
BMI = wt (Kg) / Ht(m2) 
=IF(C1576="", "", IF(D1576="","",PRODUCT(C1576,1/POWER(D1576,2)))) 
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Appendix F iv.   Extract fatalities with details from database 
Sub MortalityCauses() 
Option Explicit 
#declarations 
Dim i As Integer 
Dim j As Integer 
Dim k As Integer 
Dim rngMort As Range 
Dim rngCopy As Range 
#set values 
Set rngCopy = Worksheets("OutcomeData").Range("A2:Q1576") 
Set rngMort = Worksheets("Mortality").Range("A2:Q120") 
j =1 
'activate OutcomeData sheet  
Sheets("OutcomeData").Activate 
#loop through each record in OutcomeData worksheet in mortality outcome 
field & copy details into "Mortality" worksheet 
For i = 2 To 1576 
k = i - 1 
    If Cells(i, 2) = "Yes " Then 
    rngCopy.Rows(k).Select 
    Selection.Copy 
    Sheets("Mortality").Activate 
    rngMort.Cells(j, 1).Select 
    ActiveSheet.Paste 
    #Alternative code: 
    'ActiveSheet.Paste Destination:=Worksheets("Mortality").Cells(j, 1) 
    #stops moving border 
    Application.CutCopyMode = False     
    j = j + 1 
    Worksheets("OutcomeData").Activate 
    End If 
Next i 
End Sub 
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Appendix F v.   Checks that all 30 day mortality has matching ‘in hospital’ mortality 
Sub tallyinhosp_30d_mort() 
#checks that all 30 day mortality has corresponding ‘in hospital’ 
mortality 
#declarations 
Dim i As Integer 
Dim strHosp As String 
Dim strThirtyDay As String 
Dim strTally 
#loops through all 30 day mortality 
For i = 2 To 1576 
  strThirtyDay = Cells(i, 5) 
  strHosp = Cells(i, 4) 
  If strThirtyDay = "Yes" And strHosp = "No" Then 
  strTally = 1    'if 30d mort and not inhosp 
  Else 
  strTally = 0 'all other combinations inc no inhosp mort 
  End If 
Cells(i, 8).Value = strTally 
Next i 
End Sub 
 
Appendix F vi.   Checks that all classified as survivor has attended a matching follow up outpatient 
appointment 
Sub InhospMort_Discharge() 
# checks that survivors in mortality field had a reported outpatient 
follow up date 
Dim strHosp As String 
Dim strTally 
For i = 2 To 1576 
If strHosp = "No" And IsEmpty(Cells(i, 3).Value) Then 
strTally = 1 
Else: strTally = 0 
End If 
Cells(i, 8).Value = strTally 
Next i 
End Sub 
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Appendix F vii.   Recodes the comorbidity variable "OTHER". 
Option Explicit 
'Excel code to code the variable "OTHER"; 
'this is a freetext field with preoperative morbidity. cells are searched 
for terms which are mapped to a comorbidity in a lookup table 
Private Sub CommandButton1_Click() 
Dim other As String 
Dim otherpivot As String 
Dim j As Integer 
Dim i As Integer 
Dim rng As Range 
Set rng = Worksheets("Sheet2").Range("C1:V618") 
For i = 2 To 1576 
other = Worksheets("NOGCDAT").Cells(i, 20).Value 
 For j = 5 To 618 
 otherpivot = Worksheets("Sheet2").Cells(j, 1).Value 
If other = otherpivot Then 
Worksheets("NOGCDAT").Range(Cells(i, 21), Cells(i, 40)) = 
rng.Cells.Rows(j).Value  
 End If 
 Exit For 
Next j 
End Sub 
 
Appendix F viii.   Extracting and categorizing free text description of smoker status 
Private Sub smokecode_Click() 
Dim smoke As String 
Dim code As Integer 
Dim i As Integer 
For i = 2 To 1576 
        smoke = Cells(i, 49).Value 
        Select Case smoke 
            Case "Current" 
                code = 1 
            Case "Ex-smoker (> 1 year)" 
                code = 2 
            Case "Never" 
                code = 3 
            Case "Unknown" 
                code = 4 
            Case "" 
                code = 5 
          End Select 
          Cells(i, 50).Value = code 
Next i 
End Sub 
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Appendix F ix.  Recoding the free text ‘OPERATION’ field into surgical categories 
Free text was initially recoded into categories of ‘thoracic oesophagectomy, 
‘transhiatal oesophagectomy’, ‘other thoracic procedure’, total gastrectomy, 
‘other’. Cell contents were mapped to surgical categories in a lookup table. The 
surgical procedure was subsequently collapsed to ‘thoracic oesophagectomy’, 
‘total gastrectomy’ and ‘other’. The free text field ‘operation’ was recoded into 3 
surgical categories from lookup table shown on next page. 
Sub Surgical_classn1() 
'reclassifies surgical recorded according to lookup table 
Dim i As Integer 'loops through spreadsheet to 1576 
Dim j As Integer 'column num for recorded operations data 
Dim k As Integer 'column num for new surgical classification 
Dim l As Integer 'top row of surgical lookup table 
Dim m As Integer 'lowest row of lookup table 
Dim n As Integer 
Dim x As String  'string variable 
Dim p As Integer 
Dim q As Integer 
j = InputBox("which number column is your main data in?") 
k = InputBox("which number column is your new surgical classification 
going in?") 
l = InputBox("which is the top row num of your surgical lookup table?") 
m = InputBox("which is the lowest row num of your surgical lookup 
table?") 
p = InputBox("which col num of the lookup table is the reported 
operation?") 
q = InputBox("which col num is the new surgical classfn in?") 
For i = 2 To 1576 
    If IsEmpty(Cells(i, j)) Then 
    Cells (i, k).Value = ""     
    Else: x = Cells(i, j).Value     
        For n = l To m 
            If Cells(n, p).Value = x Then 
            Cells(i, k).Value = Cells(n, q).Value 
            Exit For 
            End If             
        Next n 
    End If 
     
Next i 
End Sub 
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Appendix F x.   
Original Freetext description of surgical procedure New 
Surgical_Classfn1 
Completion Gastrectomy (stump gastrectomy) Other 
Completion Gastrectomy (stump gastrectomy) and Feeding Jejunostomy Other 
Completion Gastrectomy (stump gastrectomy) and Other specify Other 
Completion Gastrectomy (stump gastrectomy), Feeding Jejunostomy and Other specify Other 
Extended total gastrectomy Total 
Extended total gastrectomy and Feeding Jejunostomy Total 
Feeding Jejunostomy Other 
Feeding Jejunostomy and Other specify Other 
Laparotomy and Thoracotomy Only Thoracot Other 
Laparotomy and Thoracotomy Only & Feeding Jejunostomy Thoracot Other 
Laparotomy Only Other 
Laparotomy Only & Other specify Other 
Laparotomy Only and Feeding Jejunostomy Other 
Laparotomy Only and Other specify Other 
Laparotomy Only, Feeding Jejunostomy and Other specify Other 
Left Thoraco-Abdominal Oesophagectomy Thoracic Oesph 
Left Thoraco-Abdominal Oesophagectomy & Feeding Jejunostomy Thoracic Oesph 
Left Thoraco-Abdominal Oesophagectomy and Other specify Thoracic Oesph 
McKeown 3 Stage Sub Total Oesophagectomy Thoracic Oesph 
McKeown 3 Stage Sub Total Oesophagectomy & Feeding Jejunostomy Thoracic Oesph 
McKeown 3 Stage Sub Total Oesophagectomy, Feeding Jejunostomy & Other specify Thoracic Oesph 
Other specify Other 
Partial Gastrectomy Other 
Right 2 Phase Sub-Total Oesophagectomy Thoracic Oesph 
Right 2 Phase Sub-Total Oesophagectomy & Feeding Jejunostomy Thoracic Oesph 
Right 2 Phase Sub-Total Oesophagectomy & Other specify Thoracic Oesph 
Right 2 Phase Sub-Total Oesophagectomy and Feeding Jejunostomy Thoracic Oesph 
Right 2 Phase Sub-Total Oesophagectomy and Other specify Thoracic Oesph 
Right 2 Phase Sub-Total Oesophagectomy, Feeding Jejunostomy & Other specify Thoracic Oesph 
Right 2 Phase Sub-Total Oesophagectomy, Feeding Jejunostomy and Other specify Thoracic Oesph 
Sub-Total Gastrectomy Other 
Sub-Total Gastrectomy & Other specify Other 
Sub-Total Gastrectomy & Wedge/localised resection Other 
Sub-Total Gastrectomy and Feeding Jejunostomy Other 
Sub-Total Gastrectomy and Other specify Other 
Sub-Total Gastrectomy, Feeding Jejunostomy and Other specify Other 
Total Gastrectomy Total 
Total Gastrectomy & Feeding Jejunostomy Total 
Total Gastrectomy & Other specify Total 
Total Gastrectomy and Feeding Jejunostomy Total 
Total Gastrectomy and Other specify Total 
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Total Gastrectomy, Feeding Jejunostomy and Other specify Total 
Total Gastrectomy, Right 2 Phase Sub-Total Oesophagectomy and Other specify Thoracic Oesph 
Total Gastrectomy, Right 2 Phase Sub-Total Oesophagectomy, Feeding Jejunostomy and Other 
specify 
Thoracic Oesph 
Trans-hiatal Oesophagectomy THOesoph 
Trans-hiatal Oesophagectomy & Feeding Jejunostomy THOesoph 
Wedge/localised resection Other 
Wedge/localised resection & Other specify Other 
Wedge/localised resection and Other specify Other 
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Appendix F xi.  Recoding of histology from free text field to new categories.  
Sub HistNew1_classn1() 
'reclassifies histology recorded in original database into new field 
according to lookup table derived from pivot table_ 
'on original data. Original freetext descriptions and new categories are 
shown after the VBA code 
Dim i As Integer 'loops through spreadsheet to 1576 
Dim j As Integer 'column num for recorded histology 
Dim k As Integer 'column num for new histology classification 
Dim l As Integer 'top row of histology lookup table 
Dim m As Integer 'bottom row of lookup table 
Dim n As Integer 
Dim x As String  'string variable 
Dim p As Integer 
Dim q As Integer 
If IsEmpty(Cells(i, j)) Then 
Cells(i, k).Value = "" 
Else: x = Cells(i, j).Value 
        For n = l To m 
            If Cells(n, p).Value = x Then 
            Cells(i, k).Value = Cells(n, q).Value 
            Exit For 
            End If 
        Next n 
End If 
Next i 
End Sub 
 
Table 36 Lookup table to convert histology free text to new histology code (Abreviations: 
ACA, adenocarcinoma; SCC, squamous cell carcinoma, HGC, high grade dyplasia) 
Old Histology term New Histology category 
ACA ACA 
ACA & Barrett's ACA 
ACA & HGD ACA 
ACA & Intramucosal cancer ACA 
ACA & Other specify ACA 
ACA and HGD ACA 
ACA and Leioyoma ACA 
ACA and Other ACA 
ACA and SCC ACA 
ACA and Small Cell ACA 
ACA, Barrett's & HGD ACA 
ACA, Intramucosal cancer & Lymphoma ACA 
ACA, SCC and Other Other 
ACA, SCC and Small Cell Other 
Adenoid-cystic Other 
Adenosquamous Other 
Barrett's & HGD Benign 
Benign Benign 
Benign and Leioyoma Benign 
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Old Histology term New Histology category 
Benign and Other Benign 
Benign, HGD & Leiomyoma Benign 
Carcinoid Other 
Carcinoid & Other specify Other 
Carcinoma Other 
Dysplasia Benign 
Dysplasia, HGD & Other specify Benign 
EGC Other 
HGD Benign 
HGD & Intramucosal cancer Other 
HGD and Other Other 
Intramucosal cancer Other 
Leiomyoma Benign 
Leioyoma Benign 
Leioyoma and Other Other 
Lymphoma Other 
Melanoma Other 
Neuroendocrine Other 
Neuroendocrine & Other specify Other 
No tumour Benign 
Normal/Benign Benign 
Normal/Benign & Leiomyoma Benign 
Other Other 
Other specify Other 
SCC SCC 
SCC SCC 
Small Cell Other 
Undifferentiated Other 
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Appendix F xii.  Generation of RCRI terms from free text fields of cardiac morbidity 
The contents of the cardiac comorbidity free text fields ‘Cardiac’, ‘Comorbid’, 
‘Details’, ‘ECG’, ‘ECGDETAILS’ were searched using the Excel Pivot-Table 
function. Cardiac terms were extracted and mapped to terms suitable for 
generating the RCRI (Fleisher et al., 2007; Poldermans et al., 2009) in an Excel 
lookup table. The contents of all records were searched and scored 0 or 1 for 
each RCRI item. Any version of the RCRI (total score, 2 or 4 level) could be 
then calculated. The RCRI terms were: PVD(peripheral vascular disease), 
IHD(ischaemic heart disease), valve(acquired valve disease), CHD(congenital 
heart disease), VentOther(ventricular diagnosis excluding IHD or heart 
failure), HF(heart failure), cholesterol(any hyperlipidaemia),SOB (shortness of 
breath), CVD (cerebrovascular disease), unstable coronary(unstable coronary 
syndromes). The lookup tables for mapping the terms from ‘cardiac’ fields are 
in Table 37, and from the electrocardiographic fields are in Table 38. The 
conversion code follows on the next page.
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Extraction and remapping of cardiac comorbidity to new Revised Cardiac Risk Index 
terms. 
Sub CardiacExtraction() 
'extracts txt from field 'Cardiac' & 'Comorbid' & 'Details' and codes it 
to new cardiac categorical fields; 
'These are stored in 'Worksheet.CardiacClassification. The cardiac txt 
and categories were found by using the Excel pivot table function 
Dim i As Integer 'integer counter for loop through 'pulmonary' 
Dim k As Integer 'loop counter for cardiac term lookup table 
Dim j As Integer 
Dim q As Integer 'input 
Dim l As Integer 
Dim m As Integer 
Dim p As Integer 
Dim category As Integer 'column number for each new cardiac category 
Dim emptycellBo As Boolean 
Dim test As Boolean 
Dim r1 As Integer 'input 
Dim s As Integer 
Dim T As Integer 
Dim x As Integer 'counter for each of main data cols 
'set variables for this macro without using input macro 
s = 2 
T = 1576 
r1 = 7 
l = 2 
m = 73 
p = 30 
q = 32 
For i = s To T 
 For j =3 To 6 
  emptycellBo = IsEmpty(Cells(i, j))  'is the cell of the main 
data col empty 
  If emptycellBo = False Then 
   'loop through each row in the new cardiac category 
lookup table 
   For k = l To m 
   test = 
WorksheetFunction.IsNumber(Application.Search(Cells(k, p), Cells(i, j))) 
    'does the cell contain the cardiac text as 
written in the cardiac lookup 
    If test = True Then 
     'colCat = Cells(k, q).Value 
     category = r1 + (Cells(k, q).Value) 
     ‘move to appropriate column, one column for 
each cardiac category 
     Cells(i, category) = 1'code 1 if cardiac 
category present 
    End If 
   Next k 
   End If 
 Next j 
Next i 
End Sub 
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Table 37 Lookup table to convert text terms to RCRI terms 
 Words extracted from 
database 
New cardiac terms Words extracted from 
database 
New cardiac terms 
aaa PVD ischaem IHD 
aneurysm PVD L vent.Impairment VentOther 
PVD PVD LVF HF 
AF arrythmia LVH VentOther 
claudication PVD mitral valve 
angiop IHD ngina IHD 
aortic valve None None 
fem PVD Pacemaker arrythmia 
arrythmia arrythmia palpitations arrythmia 
ASD CHD paroxysmal ventricular 
fibrillation 
arrythmia 
atrial ectopics arrythmia ovale CHD 
atrial fibrilation arrythmia pvd PVD 
atrial fibrillation arrythmia raised blood pressure hypertension 
BP hypertension RBBB arrythmia 
bradycardia arrythmia ablation arrythmia 
bypass. Unknown sob SOB 
CABG IHD stent IHD 
cardiomyopathy VentOther svt arrythmia 
carditis VentOther TIA CVD 
carotid artery stenosis CVD tia CVD 
claudication PVD triple  IHD 
cva CVD unstable unstable coronary 
cvs Unknown Valve  valve 
dvt VTE Wolf arrythmia 
enlarged  VentOther Peripheral Vascular Disease PVD 
failure HF Endarterectomy CVD 
 block arrythmia Arteriopath PVD 
HT hypertension Stroke CVD 
hypercholest cholesterol hyperlipid cholesterol 
hypertension hypertension brain haemorrhage CVD 
hypotension other cerebro CVD 
IHD IHD ETT Unknown 
infarct IHD artery disease Unknown 
irregular arrythmia PM Unknown 
RFV Unknown PMH Unknown 
bypass Unknown mx IHD 
Appendix F (Data handling procedures) 
216 
 
Table 38 Lookup table to convert terms from ECG field to RCRI terms 
Terms used to search 
fields ECG, ECGDETAILS 
New ECG (RCRI) 
categories 
Terms used to search 
fields ECG, ECGDETAILS 
New ECG (RCRI) 
categories 
Bradycardia Arrythmia wave abnormality ST T wave abnormality 
hypertrophy LVH atrial fibrillation Arrythmia 
lvh LVH block Conduction 
AF arrythmia white Arrythmia 
lbbb Conduction junctional Arrythmia 
ischaem ST T wave abnormality T wave ST T wave abnormality 
rbbb Conduction atrial fibrilation Arrythmia 
ST T  ST T wave abnormality tachycardia Arrythmia 
wpw arrythmia pace Conduction 
  prem Arrythmia 
ECG terms LVH(left ventricular hypertrophy), ST/T wave abnormality were mapped to ‘VentOther’ in cardiac morbidity. 
Key: PVD(peripheral vascular disease), IHD(ischaemic heart disease), valve(acquired valve disease), CHD(congenital heart 
disease), VentOther(ventricular diagnosis excluding IHD or heart failure), HF(heart failure), cholesterol(any 
hyperlipidaemia),SOB (shortness of breath), CVD (cerebrovascular disease), unstable coronary(unstable coronary 
syndromes).
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Appendix F xiii.  Generation of respiratory comorbidity categories from free text fields 
The code for extracting respiratory terms form the database fields are given 
below. The Lookup table of old and new terms are shown in Table 39. 
Sub PULMCoding() 
'extracts pulmonary disease txt from field 'PULM' and codes it to new 
pulmonary categorical fields; 
'COPD(chronic obstructive pulmonary disease); CHRONIC LUNG DISEASE; 
ASTHMA; ACUTE PULMONARY DISEASE EVENT. The pulmonary freetext entries and 
categories were summarised using the Excel PivotTable & listed in 'Pulm 
terms from count' field.  
Dim i As Integer 'integer counter for loop through 'pulmonary' 
Dim k As Integer 'loop counter for respiratory lookup table 
Dim j As Integer 
Dim q As Integer 'input 
Dim l As Integer 
Dim m As Integer 
Dim p As Integer 
Dim category As Integer 'column number for each new drug category 
Dim emptycellBo As Boolean 
Dim test As Boolean 
Dim r1 As Integer 'input 
Dim s As Integer 
Dim t As Integer 
'loop through the original field 'pulm' 
For i = s To t 
 emptycellBo = IsEmpty(Cells(i, j))'is the cell of the main data col 
empty 
  If emptycellBo = False Then 
   'loop through each row in the new pulmonary category 
list 
   For k = l To m 
   test = 
WorksheetFunction.IsNumber(Application.Search(Cells(k, p), Cells(i, j))) 
    'does the cell contain the resp text in the 'Pulm 
terms from count' field 
    If test = True Then 
    'colCat = Cells(k, q).Value 
    category = r1 + Cells(k, q).Value 
    'move to appropriate column one column for each 
resp category 
    Cells(i, category) = 1             'code 1 if 
respiratory category present 
    End If 
   Next k 
  End If 
Next i 
End Sub
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Table 39 Lookup table of old database terms and new classification for respiratory 
comorbidity 
Pulmonary free text and categorical terms 
extracted from the database 
New pulmonary classification 
asbestos Chronic lung disease 
asthma Asthma 
copd COPD 
coad COPD 
emphysema COPD 
fibrosis Chronic lung disease 
bronchiectasis Chronic lung disease 
lobectomy Chronic lung disease 
embolism acute 
PE acute 
lung cancer Chronic lung disease 
embolism acute 
chronic bronchitis COPD 
pneumothorax acute 
pneumonia acute 
collapsed acute 
farmer Chronic lung disease 
TB Chronic lung disease 
pigeon Chronic lung disease 
sarcoid Chronic lung disease 
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Appendix F xiv.  Sample code to extract general comorbidities from database. This code extracts terms for 
diabetes 
Code to create categorical diabetes field. 
Sub ExtractDiabetes() 
'extracts txt from field 'Comorbid', 'Other' & 'Details' and codes it 
to new diabetes categorical fields; 
'These are stored in 'Worksheet.Diabetes The diabetes txt and 
categories were found by using the 
'Excel pivot table function 
Dim i As Integer 'integer counter for loop through 'pulmonary' 
Dim k As Integer 'loop counter for diabetes term in search term lookup 
table 
Dim j As Integer,Dim q As Integer 'input,Dim l As Integer,Dim m As 
Integer,Dim p As Integer 
Dim category As Integer 'column number for each new cardiac category 
Dim emptycellBo As Boolean,Dim test As Boolean,Dim r1 As Integer 
'input 
Dim s As Integer,Dim t As Integer,Dim x As Integer 'counter for each 
of main data cols 
'set variables for this macro without using input 
s = 2,t = 1576,r1 = 7,l = 2,m = 4,p = 8,'q = 32 
'loop through all records of the fields 'comorbid', 'other' and 
'details' 
For i = s To t 
 For j =2 To 4 
 emptycellBo = IsEmpty(Cells(i, j))  'is the cell of the data col 
empty 
  If emptycellBo = False Then 
   'loop through each row in the diabetic search term 
lookup table 
   For k = l To m 
   test = 
WorksheetFunction.IsNumber(Application.Search(Cells(k, p), Cells(i, 
j))) 
    'does the cell contain the diabetes text as 
written in the diabetic search term lookup 
    If test = True Then 
    'OPTIONS FOR POPULATING NEW COLS 
    'colCat = Cells(k, q).Value 
    'category = r1 + (Cells(k, q).Value) 
    'IF DIABETIC TERM PRESENT COL IS 1, OTHERWISE 
0 
    'Cells(i, category) = 1             'code 1 if 
cardiac category present 
    Cells(i, 10) = 1                   ' code 1 if 
diabetes category 
    End If 
   Next k 
  End If 
 Next j 
Next i 
End Sub
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Appendix G.  Code for prediction modelling and validation 
The random development and validation samples were generated in Excel. 
Graphics plots were made in software packages based on R , an open source 
statistical software (Crawley, 2007; R Development Core Team, 2011). Code 
is in the text boxes in Courier New font and explanatory notes are preceded 
by the symbol ‘#’. The code for setting up data in R is in sections following. 
Appendix G i.  Creating two randomly split data samples using Excel 
Two approximately equal sized randomly selected samples of data were 
created using VBA for Excel. The following code allocates a random number 
to each record using the RAND function, a pseudorandom number generator 
which satisfies stringent tests for producing random numbers in samples of 
this size (http://i.cs.hku.hk/~diehard, 
http://support.microsoft.com/kb/828795). It separates the data into 
subsets of survivors and non-survivors. The subsets were sorted in 
increasing random number size (0-1), and 50% of each set merged to give 
two approximately equal random samples, each containing approximately 
equal numbers of non-survivors. The following allocates random numbers to 
each record 
Random sample generator 
# RandomSample() was applied to the full dataset of  unique ID field 
(col 1), and mortality field, “yes”/”no” (col2); the random number was 
generated in col 3. 
Public Sub RandomSample() 
Dim myRange As Range 
Set myRange = Worksheets("Randomisation").Range("C2:C1576") 
myRange.Formula = "=RAND()" 
myRange.Font.Bold = True 
End Sub 
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The following code separates mortality status after random number has 
been allocated 
#creates two new triple column sets of survivors and non-survivors 
from three cols (id, mortality status, random number) 
Sub SeparateYesNoMortRandom() 
Dim j As Integer 
Dim i As Integer 
Dim k As Integer 
j =2 
k =2 
 For i =2 To 1576 
  If Cells(i, 2).Value = "Yes" Then 
  Cells(j, 6).Value = Cells(i, 1).Value 
  Cells(j, 7).Value = Cells(i, 2).Value 
  Cells(j, 8).Value = Cells(i, 3).Value 
  j =j +1 
  ElseIf Cells(i, 2).Value = "No" Then 
  Cells(k, 9).Value = Cells(i, 1).Value 
  Cells(k, 10).Value = Cells(i, 2).Value 
  Cells(k, 11).Value = Cells(i, 3).Value 
  k=k +1 
  End If 
Next i 
End Sub 
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The following code populates the random samples with required fields 
Sub ExtractSampleField() 
' ExtractSampleField Macro 
' creates samples based on the random samples 1 or 2. Extracts required field 
from main dataset 
Dim x As Integer 'row of target in sample field "Field" 
Dim i As Integer 'loop counter 
Dim rge As Range 'ID index col number for main dataset 
Dim sampleTop As Integer 'top data row position in spreadsheet of random 
‘sample index field 
Dim sampleBottom As Integer 'bottom data row in spreadsheet random sample 
‘index field 
Dim sampleIndex As Integer 'random sample index column num 
Dim sampleContent As Variant 'contents of sample index cell 
Dim Field As Range ' 
Dim FieldCol As Integer 
Dim sampleNewFld As Integer 
On Error Resume Next 
Application.DisplayAlerts = False 
Set rge = Application.InputBox(Prompt:="Select field which contains IDindex 
‘for main dataset", _ 
Title:="Select Main index column", Type:=8) 
Set Field = Application.InputBox(Prompt:="Select array of columns which 
contain main data index and fields, which contain the data to be extracted", _ 
Title:="Select Main index column and attached fields", Type:=8) 
'DATA INPUT 
sampleIndex = InputBox("What column num is random sample index ID in?") 
sampleTop = InputBox("What is the top row num in worksheet of the random 
sample index ID?") 
sampleBottom = InputBox("What is the bottom row num in worksheet of the random 
sample index ID?") 
sampleNewFld = InputBox("which is the new sample data column") 
FieldCol = InputBox("Which field (relative to the array)of the main data array 
contains the extractable data") 
On Error GoTo 0 
Application.DisplayAlerts = True 
'loop through each sample cell 
For i = sampleTop To sampleBottom 
sampleContent = Cells(i, sampleIndex).Value 
x = Application.Match(sampleContent, rge, 0) 
Cells(i, sampleNewFld).Value = Application.Index(Field, x, FieldCol) 
Next i 
End Sub
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The following procedures are in R. 
Appendix G ii.  Data setup (O'Day, 2011) 
rm(list=ls()) #remove any old variables 
link <- choose.files()#use this to find datafile path and copy into 
script 
#read data 
my_data <- read.table(link) 
skip =0, #skip records 
sep = ",", #records separated by "," 
dec=".",  #decimal place symbol 
row.names = NULL, 
header = T,#include first row as variables names 
colClasses = c( "numeric","numeric","numeric","numeric"),#specify data 
cols 
comment.char = "#", 
na.strings = c("")) 
Appendix G iii.  Distribution & mortality plots for each predictor 
This splits age into 10 groups with preselected cut points to give 
approximately equal numbers of cases in each level. The ‘binom.exact’ code 
from ‘epitools’(Aragon, 2010) created exact 95% confidence intervals for 
mortality proportions in each age decile. The following code generates data. 
b<-c(20,53,58,61,64,67,69,72,74,77,99) 
my_data$bin<-cut(my_data$age, breaks=b, labels = NULL, 
include.lowest = FALSE, right = TRUE, dig.lab = 3, 
ordered_result = FALSE, ) 
##Creates tables of frequencies of mortality by the age groups and 
puts in array 2X10 
bot<-array(table(my_data$mortnum,my_data$bin),c(2,10)) 
x<-bot[2,] 
notx<-bot[1,] 
n<-x+notx 
agetable<-as.data.frame(binom.exact(x, n, conf.level = 0.95)) 
agetable$binlevels<-levels(my_data$bin) 
agetable$binlevels##adds binlevel vector to dataframe 
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The following code generates the plot in ggplot2 (Wickham, 2009) 
library(ggplot2) 
age_gpl<-ggplot(agetable,aes( agetable$binlevels, 
agetable$proportion)) 
age_gpl<-age_gpl+geom_point(size=4, shape=18)+ 
geom_linerange(aes(x=agetable$binlevels, ymax=agetable$upper, 
ymin=agetable$lower,),size=1) + 
xlab("Equal groups of ascending age with exact 95% CI")+ 
ylab("Mortality rate%")+ 
###sets markers 
opts( 
#panel.grid.major = theme_blank(), #removes grids 
panel.grid.minor=theme_blank(), 
title="Mortality by age group", 
plot.title=theme_text(size=sizetitle,hjust=0.5,face="bold")) 
#panel.background = theme_rect(fill="grey95",colour=NA) ) 
age_dist<- ggplot(my_data,aes(age)) 
 age_dist<-
age_dist+geom_histogram(binwidth=3,fill="grey60")+labs(x="Age at 
surgery in years", y="Number of patients")+ 
opts(title="Age distribution",plot.title=theme_text(size=sizetitle, 
hjust=0.5,face="bold")) 
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Appendix G iv.  Code to plot histograms of predicted mortality in validation samples 
#set variables 
y<-my_data$mortnum 
xlabel_title="Predicted mortality" 
model<-my_data$pred_clin 
plot_title<-"Prespecified clinical model" 
#Generate histograms of mortality predictions in survivors and non-
survivors  
pred_dist<- ggplot(my_data,aes(x=model, group=mortnum, fill=factor(mortnum)))   
+scale_fill_manual(values = c("grey60", "black"), 
 name="Key", 
 breaks=c("0", "1"), 
 labels=c("survivors", "deaths"))  
pred_dist<-pred_dist+geom_histogram(binwidth=0.01, , position="dodge") +    
labs(x=xlabel_title, y="Number of patients")+ 
 
 opts( 
 title=plot_title, 
 #panel.grid.major = theme_blank(),  #######removes grids 
  panel.grid.minor=theme_blank(), 
 legend.key=theme_blank(), 
 legend.name=theme_blank(), 
 legend.background=theme_blank(), 
 #legend.text=theme_blank(), 
 legend.title=  theme_text(hjust=0), 
 legend.justification=c(1,0), 
 legend.position=c(0.7,0.7), 
  panel.background = theme_rect(fill="grey95",colour=NA), 
 plot.title=theme_text(size=15,colour="black",hjust=0.5), 
 axis.text.x = theme_text(), 
 axis.title.x=theme_text(size=15,face="bold")) 
#Save output to "png" file 
png(filename = "hist_clin.png", width = 760, height = 760, 
    units = "px", pointsize = 12, bg = "white", res = 150, 
    restoreConsole = TRUE) 
dev.off() 
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Appendix G v.  The function ‘val.prob.ci’  
This generates a set of calibration plots and summary validation statistics, 
which are written to a table and can be inserted into an Excel spreadsheet 
(Vergouwe and Steyerberg, 2009). This is a modification of the val.prob 
function but with 95% confidence intervals for observed events in the 
validation sample. 
#load libraries 
library(ggplot2)  
library(epitools)   
library(rms)   
library(reshape2) 
library(grid) 
library(PredictABEL) 
library(digest) 
library(proto)  
#val.prob.ci 
clin_model_df<-as.data.frame(val.prob.ci(model, y, pl = T, smooth = T, 
xlim = c(0, 0.35), ylim = c(-0.05, 0.3), legendloc =  c(0.15 , 0.05), 
statloc = c(0.01,0.25), dostats=c(12,13,2,15,3),roundstats=2, 
logistic.cal = T, xlab=xlabel_title,g=10,  emax.lim=c(0,1), d0lab="0", 
d1lab="1", cex = 0.75, mkh = 0.02, connect.group =  
 F, connect.smooth = T,  cex.d01=0.8, dist.label=0.04, 
line.bins=-.01, dist.label2=.03, cutoff, cex.lab=1, las=1, 
length.seg=1.5)) 
write.table(clin_model_df,"clipboard",sep="\t",col.names=NA) 
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Appendix G vi.  The ‘plotROC’ function (Kundu et al., 2011) 
This function plots ROC operator curves from predicted outcome and 
observed binary outcomes. Sample code for comparing two models is shown 
in the box below. 
#shows ROC plots for 2 models 
cOutcome<-my_data$mortnum 
predrisk<-
cbind(my_data$clin_corr,my_data$clin__imp_corr,my_data$clin_int_corr) 
labels<-c("clinical","clinical_imp","clinical & age*rcri") 
plotitle<-c("'Clinical' model variations") 
fileplot<-c("ROC_clinical") 
plotROC(data=my_data, cOutcome=2, predrisk=predrisk, 
labels=labels,plottitle=plotitle,fileplot=fileplot,plottype="png") 
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